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CHAPTER ONE 
INTRODUCTION 
In today's global marketplace, individual firms no longer compete 
as independent entities with unique brand names, but rather as 
integral parts of supply chain links. As such, the ultimate 
success of a firm will depend on its managerial ability to 
integrate and coordinate the intricate network of business 
relationships among supply chain members (Drucker 1998; Lambert & 
Cooper, 2000). A supply chain is referred to as an integrated 
system which synchronizes a series of inter-related business 
processes in order to: (1) acquire raw materials and parts; (2) 
transform these raw materials and parts into finished products; 
(3) add value to these products; (4) distribute and promote these 
products to either retailers or customers; (5) facilitate 
information exchange among various business entities (e. g. 
suppliers, manufacturers, distributors, third-party Logistics 
providers, and retailers). Its main objective is to enhance the 
operational efficiency, profitability and competitive position of 
a firm and its supply chain partners. Also, supply chain 
management is defined as the integration of key business 
processes from end-users through original suppliers that provide 
products, services, and information and added value for customers 
and other stakeholders' (Cooper, 2000). A supply chain is 
characterized by a forward flow of goods and a backward flow of 
information. 
By reviewed the available literature it became obvious that there 
is lack of published research work in the field of health care 
supply chain in comparison to literature published about 
manufacturing industry. It becomes worst if we go deep to the 
chemistry Lab papers, which is rarely available. But with what 
has been reviewed in the research it can be concluded the need to 
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have a supply chain model can provide health care provider with a 
baseline roadmap for effective change at all levels of the 
organization. It can provide also an insight into functions and 
practices needed in this time as well as the following benefits: 
1. Learn from the experience of others how to best 
organize the health care firms. 
2. Achieve significant saving in cost and improve the 
process of handling supply chain 
3. Minimize the impact on staff time and resources during 
reengineering project. 
4. Provide better monitoring and assessment. 
S. Allows for accurate requirements analysis. 
6. A mean of evaluating the impact of process changes 
prior to implementation. 
7. A concrete benchmarking example to build better health 
care process. 
8. Provide an automated health care business process. 
9. Provide a framework for identifying points and outcome 
metrics. 
10. Provide a foundation for continues improvement of the 
supply chain process. 
11. It gives the measuring tools for quality and 
efficiency process. 
There is a strong research need in the health care supply chain 
to create a streamline environment, which guarantees the 
availability of the needed supplies at the right time, the right 
place, and the right cost. The nature of the product in the 
health care system is very different than the product managed in 
the manufacturing supply chain system. The supply chain (in terms 
of liability) is the highest cost and risk segment of the health 
care delivery process. Improving the supply chain yields readily 
apparent benefits in the lower costs and improving health care 
delivery. The product of health care supply chain is human health 
and life and an error or a mistake generated by the health care 
system may be very costly which impossible to recover. Therefore, 
the model that will be created must guarantee that, created 
system improves the quality and availability of HC supply. 
2 
An integrated supply chain model is developed, in the Healthcare 
environment, in particular focusing on the Chemistry Laboratory. 
This research focuses on relative performance modeling through 
cost, and system performance modeling. It is not only giving 
particular benefit to reduce the cost or to improve the quality 
or to have an, overall, improved system, but a continuous 
monitoring mechanism is developed, to measure all of these 
parameters for adjustment, as required. Also, to know the effect 
of any change, like manpower or selling cost, of a material, to 
the entire system. The developed model can be beneficial for 
other Healthcare services, as well. 
The Two Major Components of the Model 
  Cost Modeling 
Measuring the cost involved in healthcare supply 
chain. 
  Performance modeling 
To create an efficient Healthcare supply chain 
system based on certain criteria to measure the 
system effectiveness: these performance measures 
are envisioned as: 
o Lead time 
o Material flow time 
o Throughput 
o Inventory status 
o Work in process 
o Cost of each test 
o Material order size 
o Queue size 
o Equipment utilization 
o Staff utilization 
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The brief summary of the contents of this thesis is provided 
below chapter by chapter review: 
Chapter 2- This chapter presents Supply Chain and Health care 
the working mechanics of Supply Chain in HealthCare. 
Chapter 3- This chapter presents a comprehensive Literature 
review in supply chain, costing and health care system in 
general and related technologies. The chapter provides a 
systematic review of the research published in recent 
years to build a solid background for this research and 
to give an opportunity to the readers to compare the 
available published research and this research so that 
the contribution of this research work is made more 
visible. 
Chapter 4- This chapter explains the research aims and 
objectives as well as the contribution of this research 
to the knowledge in health care supply chain operations 
and analysis. This chapter further explains the 
methodology used and its benefits in this research. 
Chapter 5- This chapter presents the simulation model created 
for the modeling, operation and analysis of the health 
care system in a supply chain environment. This chapter 
also presents the modeling environment, parameters, data 
used, performance metric used as well as the limits of 
this study. 
Chapter 6- This chapter presents the results found through the 
modeling of health care supply chain. Different aspects 
of the supply chain problems are modeled through number 
of scenarios to create a better understanding for the 
true nature of the problems encountered in this area. A 
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comprehensive analysis is provided for each of the 
scenario-based model using the two sets of performance 
metrics. This provides a better understanding of the 
complicated problems in health care supply chain and 
creates a more solid platform for the possible solutions. 
Chapter 7- This chapter presents further comments made on the 
modeling and analysis presented in the previous chapter. 
It provides further insight into the understanding the 
true nature of the problems experienced in health care 
supply chain and the major contribution made through this 
study. 
Chapter 8- This is the chapter that presents the conclusions 
drawn from the comprehensive modeling and analysis of the 
health care supply chain. This chapter further presents 
the possible research extensions based on the findings of 
this research work. 
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CHAPTER TWO 
SUPPLY CHAIN SYSTEM 
2.1 Introduction 
This chapter presents the supply chain system within the 
context of manufacturing and healthcare so that readers 
who are familiar with manufacturing would be able to 
understand the healthcare supply chain better and could 
compare the similarities and differences. Further, the 
components of supply chain system, their functionalities 
and integration with other elements of supply chain are 
also presented to give background information to the 
readers to understand the model created and presented 
better in following chapters. 
2.1.1 What is a Supply Chain? 
A supply chain consists of all stages involved, directly 
or indirectly in fulfilling a customer request (Chopra & 
Meindl, 2001). The supply chain not only includes the 
manufacturer and suppliers, but also transporters, 
warehouses, retailers, and customers themselves. With 
each organization, such as a manufacturer, the supply 
chain includes all functions involved in filling a 
customer request. These functions include, but are not 
limited to, new product development, marketing, 
operations, distribution, and finance and customer 
service. 
A supply chain is the constant flow of information and 
product between different stages. Each stage of the 
supply chain performs different processes and interacts 
with other stages of the supply chain. Supply chain 
activities begin with a customer order and end when a 
satisfied customer has paid for his or her purchase. The 
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term supply chain conjures up images of product, or 
supply, moving from suppliers to manufacturers to 
distributors to retailers to customers along a chain. It 
is important to visualize information, funds and product 
flows along both directions of this chain. The term may 
also imply that only one player is involved at each stage 
(Chopra & Meindl. 2001). In reality, manufacturer may 
receive material from several suppliers and then supply 
several distributors. Therefore, most supply chains are 
actually networks. 
A typical supply chain may involve a variety of stages. 
These supply chain stages are shown in Figure 2.1 and 
include the following: 
Customers 
Retailers 
Wholesalers/distributors 
Manufacturers 
Component/raw material suppliers 
Each stage in Figure 2.1 needs to be present in a supply 
chain. The appropriate design of the supply chain will 
depend on both the customer's needs and the roles of the 
stages involved in filling those needs. 
supplier Manufacturer Distributor Retailer ---F Customer 
Figure: 2.1 Supply Chain Stages 
2.2 The Objectives of a Supply Chain 
The objective of every supply chain is to maximize the 
overall value generated. The value a supply chain 
generates is the difference between what the final product 
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is worth to the customer and the effort the supply chain 
expends in filling the customer's request. 
For most commercial supply chains, value will be strongly 
correlated with supply chain profitability, the difference 
between the revenue generated from the customer and the 
overall cost across the supply chain. 
2.3 Supply Chain in the manufacturing process and its drivers 
A supply chain is a sequence of processes and flow that 
take place within and between different supply chain 
stages and combine to fill a customer need for a product, 
There are two different ways to view the processes 
performed in a supply chain, cycle view and push/pull 
process. (Chopra & Meindl, 2001) 
2.3.1 Cycle View of Supply Chain Processes 
The processes in a supply chain are divided into a series 
of cycles, each performed at the interface between two 
successive stages of a supply chain. A cycle view of the 
supply chain is very useful when considering operational 
decisions, because it clearly specifies the roles and 
responsibilities of each member of the supply chain. The 
cycle view provides clarity, for example, when setting up 
information systems to support supply chain operations, 
as process ownership and objectives are clearly defined. 
In the following sections, descriptions of the various 
supply chain cycles. 
Given the five stages of a supply chain shown in figure 
2.1, all supply chain processes can be broken down into 
the following four process cycles. 
S 
2.3.1.1 Customer Order Cycle 
The customer order cycle occurs at the customer/retailer 
interface and includes all processes directly involved in 
receiving and filling the customer order. 
2.3.1.2 Replenishment Cycle 
The replenishment cycle occurs at the retailer/distributor 
interface and includes all processes involved in 
replenishing retailer inventory. It is initiated when a 
retailer places an order to replenish inventories to meet 
future demand. 
2.3.1.3 Manufacturing Cycle 
The manufacturing cycle typically occurs at the 
distributor/manufacturer interface and includes all 
processes involved in replenishing distributor inventory. 
The manufacturing cycle is triggered by customer orders, 
replenishment orders from a retailer or distributor, or by 
the forecast of customer demand and current product 
availability in the manufacturer's finished product 
warehouse. 
2.3.1.4 Procurement Cycle 
The procurement cycle occurs at the manufacturer/supplier 
interface and includes all processes necessary to ensure 
that materials are available for manufacturing to occur 
according to schedule. During the procurement cycle, the 
manufacturer orders components from suppliers that 
replenish the component inventories. 
The relationship is quite similar to that between a 
distributor and manufacturer, with one significant 
difference: Whereas retailer/distributor orders are 
triggered by uncertain customer demand, component orders 
can be determined precisely once the manufacturer has 
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decided what the production schedule will be. Component 
orders are dependent on the production schedule. 
2.3.2 Push/Pull View of Supply Chain Processes 
All processes in a supply chain fall into one of two 
categories, depending on the timing of their execution 
relative to customer demand. In pull processes, execution 
is initiated in response to a customer order. Push 
processes are those that are executed in anticipation of 
customer orders. At the time of execution of a push 
process, demand is not known with certainty. Pull 
processes may also be referred to as reactive processes 
because they react to customer demand. Push processes may 
also be referred to as speculative processes because they 
respond to speculated (or forecast) rather than actual 
demand. (Chopra & Meindl, 2001) 
A push/pull view of the supply chain is very useful when 
considering strategic decisions relating to supply chain 
design. This view forces a more global consideration of 
supply chain processes as they relate to a customer order. 
Such a view may, for instance, result in responsibility 
for certain processes being passed on to a different stage 
of the supply chain if making this transfer allows a push 
process to become a pull process. 
2.3.3 The Supply Chain drivers 
To study supply chain performance in terms of 
responsiveness and efficiency, we must examine the four 
drivers of supply chain performance: inventory, 
transportation, facilities, and information. These 
drivers not only determine the supply chain's performance 
in terms of responsiveness and efficiency, they also 
determine whether strategic fit is achieved across the 
supply chain. The following sub-sections provide a brief 
of each driver: 
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2.3.3.1 Inventory 
Inventory exists in the supply chain because of a mismatch 
between supply and demand. The mismatch is also 
intentional at a retail store, where inventory is held in 
anticipation of future demand. An important role that 
inventory plays in the supply chain is to increase the 
amount of demand that can be satisfied by having the 
product ready and available when the customer wants it. 
2.3.3.2 Transportation 
Transportation moves the product between different stages 
in a supply chain. Like the other supply chain drivers, 
transportation has a large impact on both responsiveness 
and efficiency. 
Faster transportation, whether in the form of different 
modes of transportation or different amounts being 
transported, allows a supply chain to be more responsive 
but reduce its efficiency. The type of transportation a 
copy uses also effects the inventory and facility 
locations in the supply chain. 
2.3.3.3 Facilities 
Facilities are the places in the supply chain network 
where supplies are stored, assembled, or fabricated. The 
two major types of facilities are production sites and 
storage sites. Whatever the function of the facility, 
decisions regarding location, capacity, and flexibility of 
facilities have a significant impact on the supply chain's 
performance. 
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2.3.3.4 Information 
Information could be overlooked as a major supply chain 
driver because it does not have a physical presence. 
Information, however, deeply affects every part of the 
supply chain in many ways. Consider the following: 
1. Information serves as the connection between the supply 
Chain's various stages, allowing them to coordinate their 
actions and bring about many of the benefits of maximizing 
total supply chain profitability. 
2. Information is also crucial to the daily operations of 
each stage in a supply chain. For instance, a production 
scheduling system uses information on demand to create a 
schedule that allows a factory to produce the right 
products in an efficient manner. A warehouse management 
system uses information to give the warehouse's inventory 
visibility. The company can then use this information to 
determine whether new orders can be filled. 
2.4 Supply Chain in the Healthcare 
Healthcare environment is very broad and it consists of 
hospital as a main center, clinic, companies, equipment 
and supply companies, insurance regulatory body, Ministry 
of Health. It is mainly representing patient as customer, 
hospital as a provider, supplier as support service. The 
following subsection provide more detail about the 
hospital as representing healthcare, also Material 
management department which responsible and controlling 
all supplies needed by the patient. (Mckone-sweet, 2005) 
2.4.1 Hospital 
Patient care is the primary function of the hospital 
whether in-patient or outpatient. To understand how the 
managerial decisions take place, it is important to know 
the organization structure of the hospital as well as the 
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type of management, which will help to understand the 
obstacles of improving the supply chain in healthcare 
(refer to 4.4). The hospital organization is consisting of 
five major functions: 1) Medical, 2) Finance and business, 
3) Management, 4) Ancillary services and 5) Support 
service. 
Hospital is mainly a bureaucratic organization and use 
bureaucratic principles. A principle of bureaucratic 
organization that supplies effectively to hospitals is the 
grouping of individual positions and clusters of positions 
into a hierarchy or pyramid. Communication among these 
position governed by certain rules, hospital rules are the 
guidelines of official boundaries for actions within the 
hospital. 
The major sources of power in the hospital are the board, 
the CEO or management, and the hospital's medical staff. 
These relationships may be regarded as a kind of three- 
legged stool or a tripartite hospital governance concept. 
Just as the activities of the medical staff impact 
significantly on the management and governance of the 
institution, so do the board's actions impinge on the 
doctors. The main organizational units that enable the 
medical staff to relate formally to the board are the 
medical staff's executive committee and the board's joint 
conference committee. 
However, the more dynamic links between the board and the 
medical staff are in the informal day-to-day dealing 
between the two groups, both in the hospital setting and 
socially outside the institution. 
The tripartite relationship is now challenged by the 
increasing pressure to provide high-quality, low-cost 
services that require a greater cohesiveness between the 
physician and administrative staffs. More common goals and 
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motivators must be sought as the industry moves toward the 
probability of fewer payees, bundled (hospital and 
physician) reimbursement, and capitation. 
Hospital in this time, is trying to join each other under 
one umbrella, to overcome the increasing cost especially 
management, personnel and purchasing. It is also the 
ability to provide a wide spectrum of care and increased 
access to capital market. 
2.4.2 Materials Management in the Hospital (Logistic) 
Material management (logistic) can be defined as: "the 
management and control of goods, services, and equipment 
from acquisition to disposition. "(Ferrier, 1984) 
The essence of this definition is that there should be 
centralization of the purchasing, receiving, inventory, 
and distribution functions within the hospital. 
It is commonly estimated that 30-35% of a hospital's 
budget is related to materials and equipment, including 
managing and storing them. (Dacosta-Clavo, 2002) 
Prior to 1970, the management of materials was often 
performed in a haphazard fashion, which was one of the 
contributing factors to the escalation of the cost of 
hospital care. In the 1970s, as these costs reached 
increasingly unacceptable levels, the concept of 
centralized materials management (which collects all sub 
inventories in the hospital and centralize it in one 
department called Material Management) began to gain 
favor. As a result, methods of controlling expenses like 
group purchasing, that had been used for many years in 
other industries began to be routinely applied in the 
health care industry. (Croom et al, 2000). 
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During the 1980s, greater emphasis was placed on group 
purchasing programs (refer to 2.4.2.2.1), centralized 
management of total inventories, and increased reliance on 
vendors to provide additional services such as consignment 
buying, (refer to 2.4.2.2.4) and "just-in-time" shipments 
(refer to 3.3.1.1). In fact, this shift to the practice 
of using the vendor to actually provide hospital support 
services has continued into the 1990s to such an extent 
that some people have difficulty defining the rightful 
place of a materials manager in the hospital. 
As the national debate over health care cost control 
intensifies, so does the need to find ways to reduce the 
total cost of acquiring and managing materials and 
services. 
Regardless of how the job of materials manager is 
structured, the need to successfully perform the function 
of reducing cost will continue to be critical. While one 
would think that by now every hospital would have an 
effective materials management department, this is not the 
case. Therefore, it is still worthwhile for administrators 
to take a serious and critical look at how this function 
is being performed in their organizations. 
The two most critical elements in a materials management 
program are (1) a corporate strategy for ensuring that 
materials-goods, services, and equipment-are purchased at 
the lowest total cost and (2) a related strategy to ensure 
that the inventories and their associated carrying costs 
are aggressively monitored and controlled(Eastaugh, 2001). 
Material or Supply Management in the hospital is very 
complex, it is a network of each department, and one 
relies on each other. The following sections will 
represent all elements that participate in supply chain in 
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the hospital, sharing these functions, the path of supply 
information, and the problems and challenges. 
2.4.2.1 Originating Department 
The actual decision to acquire supplies and equipment 
almost always takes place in individual departments 
throughout the hospital. However, the materials manager 
can assist the head of the originating department in a 
number of ways, such as helping forecast needs for the 
coming year, providing information on sources of supply 
and prevailing market conditions, conducting negotiations 
with vendors, and designating effective systems for 
storing and maintaining materials until they are consumed 
(Eastaugh, 2001). 
Also, it is noticeable that the originating department 
does not exercise sufficient care in accepting and 
documenting the delivery. A second problem is the vendor 
may overstock the department in order to increase sales. 
These kind of change needs to be addressed and to find a 
proper solution. 
2.4.2.2 Purchasing Department 
There are different techniques to deal with procurement of 
the supply: 
The primary contribution of the purchasing department is 
to lower the price of goods and services acquired by the 
hospital. The two main tools to be used in accomplishing 
this objective are competitive bidding and direct 
negotiation (Bruss, 2005). 
The three purposes of the purchasing department are to: 
1. Assist all departments in obtaining products and 
services of appropriate quality from reputable and 
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reliable vendors at the lowest total cost to the 
organization. 
2. Ensure that appropriate and ethical business practices 
are applied throughout the organization. 
3. Serve as a source of information for the rest of the 
hospital concerning available products, sources of supply, 
current and anticipated market conditions, and application 
of effective purchasing techniques. 
The following sub sections show different methods the 
purchasing department trying to adopt for reducing cost. 
2.4.2.2.1 Group Purchasing 
Group Purchasing; start with number of small hospital 
suffering from increasing price of items comparing with 
larger hospital. These hospitals assign an office to 
coordinate and facilitate the contractual obligations with 
the supplier on the agreeable items and large quantity. 
Each hospital will have the vote of the selected item. if 
the vote goes to unwanted brand by one of the member, he 
can not to join the group of that particular purchase. The 
membership money is used to run the group purchase office. 
Larger purchase generally results in lower prices. As a 
result, groups of buyers can, by pooling their buying 
power, gain even lower prices than any of the individuals 
acting alone (Ayers, 1999). 
However, there are costs involved in belonging to a 
purchasing group. These include the direct cost of 
membership, usually expressed as an annual fee, and a 
certain loss of control in product selection. The members 
of the group must meet periodically to evaluate vendor 
proposals, products, and performance and to monitor well 
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the group itself is performing. There are also costs 
associated with participating in these meetings. 
The question of whether a hospital should either join or 
maintain its membership in a group is an economic one. 
Will membership result in lower total costs to the 
hospital? If so, membership is worthwhile. However, 
before committing to a particular group, some additional 
issues should be considered. The following are 
considerations to be studied involving the group itself: 
  How well do group goals and objectives correlate 
with those of the institution? 
  Is the group program well focused and mature or does 
the group still has to get its program fully 
organized? 
  What are the administrative costs of the group? How 
efficiently does the group operate? 
  How skilled is the group at negotiation? Is the 
group going to negotiate major contracts on the 
hospital's behalf; is the institution satisfied that 
the group can do that job well? 
  How does the group handle product evaluation and 
standardization? Since product standardization is 
an essential element of group purchasing, is the 
hospital sure it can participate effectively in that 
process? 
  How does the group track record overall compare with 
other groups-or with what the hospital can do on its 
own? 
As for the vendors who hold agreements with the group, are 
the products, quality, and service they offer generally 
18 
acceptable to the hospital? As for the other hospitals in 
the group: 
Are they larger or smaller than the hospital? Generally, 
smaller hospitals benefit most from being in groups with 
larger ones. 
  What is the level of commitment of the member 
hospitals? More committed groups generally produce 
lower prices. 
  How well managed are the other hospitals in the 
group? Are they institutions with which the 
hospital will be comfortable working closely? 
  Has though been given to the competitive position of 
the hospital via-ä-vis others in the group? 
Other hospitals, including members, should be asked about 
the group. So, too, with other hospitals that might have 
belonged to the group but do not. Why not and hospitals 
that once belonged to the group but left-Why did they? 
Almost every hospital now belongs to at least one 
purchasing group and many belong to more than one group. 
This presents a dilemma in that a group's effectiveness 
depends in part on its ability to deliver agreed upon 
blocks of purchases to its vendors. If members 
participate in more than one group, and each group 
provides contracts for the same items, which group's 
contract will the members utilize? The answer for the 
hospital is usually to use the contract that provides the 
lowest price, or that provides a preferred brand at a 
satisfactory price. 
2.4.2.2.2 Prime Vendors 
Another approach to obtaining lower prices and better 
service is to establish a relationship with a single 
vendor to which major portions of the hospital's purchases 
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are directed (Ayers, 2000). In return, the vendor is 
expected to provide: 
o Lower prices 
o Extended price protection 
o Minimal back orders 
o Lower in-hospital inventory levels 
o Simplified paperwork in purchasing, receiving, and 
paying for items 
o other special services 
Potential disadvantages of using a prime vendor include 
the following: 
o Economic competition may be reduced over a period of 
time 
o Inconsistent quality may exist across the vendor's 
complete line of products 
o The hospital may become overly dependent on the vendor, 
and a change in vendors may be disruptive to hospital 
routines 
o Prices may "creep" upward if inadequate controls are 
placed on the relationship 
Overall, a prime vendor relationship can provide 
significant economic and operational advantages to the 
hospital if it is well thought out effectively negotiated, 
designed with adequate controls to protect the hospital, 
and carefully monitored. If any of these elements is 
missing, it can have a negative effect on the hospital. 
2.4.2.2.3 Buying on Consignment 
Buying on consignment, the hospital takes physical 
possession of items, but does not pay for them until they 
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are actually consumed. Obviously, this method provides a 
cash flow advantage to the hospital. It also should cause 
the vendor to work more aggressively with the hospital to 
reduce inventory levels, because higher inventories mean 
more supplies for which payment has not yet been received 
(Bruss, 2005). 
As in any special arrangement, however, there are 
potential disadvantages, including the following: 
o Proper inventory control practices are necessary to 
avoid payment for lost or damaged goods. 
o Prices may raise more than a normal amount to cover the 
vendor's additional costs. 
o The vendor may place too little stock in inventory. 
o The vendor may place too much stock in order to obtain 
free warehouse space. 
o If the vendor "buys out" existing supplies, it becomes 
difficult to terminate the relationship because a major 
one-time expense will be required to re-establish the 
hospital's inventory. 
Consignment buying has traditionally been applied most 
often to expensive, specialized items that show relatively 
slow usage but to which the hospital must have immediate 
access. Examples include orthopedic hardware, intraocular 
lenses, and special types of sutures. However, a number 
of companies are now providing consignment programs for 
broad categories of medical/surgical supplies. 
2.4.2.2.4 Stockless Purchasing 
In this technique certain categories of supplies are 
removed from the hospital's inventory and are carried only 
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in the vendor's warehouse. Hospital departments send 
requisitions for supplies directly to the vendor, instead 
of the hospital storeroom. The vendor then prepares the 
orders for shipment directly to the individual departments 
(Rivard-Royer et al, 2002). 
The hospital's purchasing staffs do not review orders, nor 
do the receiving department staffs check them in. As the 
items sent directly to the end user, but consolidated 
invoices are reviewed by the accounts payable department 
only to verify that they are generally reasonable in size. 
The risk, of course, is that payment will be made for 
items that were not received. The control on these 
purchases must reside in the individual ordering 
departments, as they both check on their orders when they 
are received and reconcile charges against their 
departmental budgets at the end of the month. 
The advantages to the hospital in this system involve 
improved cash flow because of reduced inventories, and 
operating savings because of the simplified paperwork and 
reduced workload in purchasing, receiving, and, to some 
extent accounts payable departments. Another advantage to 
the hospital is the ability to make use of the large- 
volume buying power of the vendor. 
For example, items that might be important, but of low 
volume to the hospital, would normally have a relatively 
high price. The vendors, because they buy for multiple 
accounts, can usually achieve a lower price. Part of this 
price reduction should be passed on to the hospital as a 
benefit of the program. 
One disadvantage is that both the vendor and the 
individual ordering departments must be reliable in 
maintaining the accuracy of shipments and receipts. No 
emergency stock is maintained in a central on-site 
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inventory, which makes accurate forecasting and ordering 
by the individual departments even more important. 
This can be somewhat mitigated by building a small reserve 
in the basic supply level of the ordering department. 
This should be done carefully, however, in order not to 
diminish the inventory reduction savings. As in 
consignment buying, the removal of supplies from the 
hospital's inventory has the effect of tying the hospital 
closely to the particular vendor. As a result, it would 
be difficult to terminate the relationship. 
This technique can afford the hospital significant 
savings. However, it is vital that the vendor be 
carefully selected and that performance, in terms of 
prices, order fill rate, and stock picking/billing 
accuracy, be closely monitored. In addition, the hospital 
should identify a list and bind the vendors to never being 
out of stock on these items. Finally, the hospital should 
always maintain final authority over product selection. 
This should never be relinquished to the vendor. 
2.4.2.3 Receiving Department 
The primary contribution of the receiving department is to 
ensure that the correct items, in proper condition, are 
officially received into the organization (Jarrett, 1998). 
The challenge to the receiving supervisor is to make sure 
that when goods bypass the receiving dock and to directly 
to the originating department, they are properly inspected 
and recorded into the inventory and payment records of the 
hospital. 
This department's contribution to the hospital's bottom 
line rests largely on two key functions: 1) invoice 
matching, and 2) adjusting the timing of payments to 
vendors. It is essential that the vendor's invoice be 
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accurately matched to the documents and accurately there 
is a high risk of paying for goods not actually received. 
In general, payments should be held for as long as 
possible up to the point that a discount will be lost. 
Excessive delays in making payments damage a hospital's 
business reputation and weaken its future negotiating 
power. However, excessive speed in making payments results 
in unnecessarily giving away the use of the hospital's 
money. 
In order to successfully maintain an effective schedule of 
correct payments, there must be a smooth flow of 
communication between the purchasing, receiving, and 
accounts payable departments. 
2.4.2.4 Inventory Control 
The goal of inventory control is to hold the least 
possible number of supplies in the hospital, while not 
running out of critical items. Inventory in hospitals has 
usually been considered to be only that material stored in 
the official storeroom and carried as an asset in the 
accounting records (Lancioni, 2000). 
It is more appropriate, however, to also classify as 
inventory those supplies stored in the various operating 
departments of the hospital, even though they have been 
charged out as an expense to the departmental accounts. 
These are so called unofficial inventories can be worth up 
to three times the value of the official inventory. 
Obviously, they provide a significant opportunity for 
total cost reduction. 
Most areas do not use a perpetual inventory system; that 
is, one that keeps constant track as supplies are added to 
and deducted from storage. It is harder to calculate the 
inventory of these areas, because in addition to finding 
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and listing each item, it is necessary to look up the most 
recent price of the items. 
There is a significant cost reduction potential in all 
inventories in the hospital whether official or 
unofficial. 
2.4.2.5 Distribution 
The selection and design of systems for distributing 
materials throughout the hospital and for replenishing 
stocks of supplies in user departments are key variables 
in the ability to manage inventory levels effectively. 
There are four basic options for distributing material: 
(1) requisitions, (2) PAR-level systems, (3) point-of-use 
replenishment systems, and (4) exchange carts (Power, 
2005). 
Any of these can be enhanced through the application of 
computer software programs, which can more accurately and 
more quickly handle the large volume and data generated by 
the multitude of daily transactions. However, 
computerization does not change the basic systems 
themselves. 
2.4.2.5.1 Requisitions 
This is the most traditional system and generally the 
least effective. Control of the process of deciding when 
and how much to order is retained by the personnel of 
individual departments. 
It is common either to find highly paid, clinically 
trained employees spending time performing this function 
or for this function to be delegated to lower-paid 
employees. in either case, it is often a low priority and 
does not receive adequate attention. As a result, the 
quality of the ordering process is inconsistent and 
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random, which can lead to both unnecessarily high 
inventory levels and at other times, unacceptably low 
levels. This system also has the effect of inflating the 
inventory in the central storeroom, as the storeroom 
supervisor builds an extra cushion to protect against 
random requests for large orders. A final result of this 
system is that it generates a large number of extra 
requisitions and telephone requests for additional 
supplies. These are time consuming and expensive for both 
the ordering department and the central storeroom. 
The only advantages to this system are that it is simple; 
easy to understand, if not to do well; and requires 
minimal capital investment. 
2.4.2.5.2 PAR-Level Systems 
In this system a person from the central storeroom visits 
each ordering department on a scheduled basis, counts the 
supplies, writes an order, obtains supplies, returns them 
to the department, and brings the supplies up to a 
standard or PAR-level. A variation of this system, 
utilizing computer support, analyzes data about past 
consumption and calculates a predicted order, and the 
storeroom employee delivers this order to the unit. 
Additional supplies that may be required are delivered on 
a later trip. 
In either case, this is a relatively Labor-intensive 
system. In addition, it provides somewhat weaker control 
over the productivity of the employees who deliver the 
orders. 
One of the advantages of this type is that it more 
effectively links the disbursement of supplies to actual 
usage. It also places performance of the distribution 
function in the hands of employees who are lower paid than 
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clinical employees and for whom the function is a high 
priority. Finally, it requires a relatively low capital 
investment. 
2.4.2.5.3 Point of Use Replenishment 
Whenever a supply item is taken for use, it triggers a 
request for replenishment. This is usually supported by 
automatic computer generation of an order. However, it can 
be done by hand, through the total number of transactions 
makes this cumbersome and prone to errors of omission 
(Appold, 2002). 
Replenishment orders can be filled from the hospital's 
central inventory or directly from vendor's warehouse. In 
either case, the orders for single units of an item can be 
held for a period of time and consolidated into a 
reasonable size order to make more efficient use of 
delivery system. 
2.4.2.5.4 Exchange Carts 
In this case, all or most of the supplies for a department 
care placed on a movable cart. The standard quantities 
can be adjusted dynamically through the application of a 
computer software program if desired (Langabeer, 2005). A 
second identical cart is also prepared. On a scheduled 
basis, the first cart, which has been depleted, is taken 
from the user department, and the second cart, filled, is 
exchanged with it. 
The primary advantage of this system lies in having 
greater control over the productivity and performance 
quality of the employees who fill the carts. By 
replenishing all carts in a central area, the storeroom 
supervisor is better able to monitor performance. In 
addition, compared to the PAR-level system, travel time is 
reduced by replacing multiple trips between the ordering 
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department and the storeroom with a single trip for 
delivering the cart. 
However, this advantage does not exist when comparing 
exchange carts with a computerized point-of-use 
replenishment system. In the latter case, orders are sent 
and consolidated by computer into a single order for 
delivery. The trend will continue to be more toward the 
installation of point-of-use systems, whenever possible. 
However, the capital cost of the point-of-use installation 
will be a deterrent for some organizations. The 
disadvantages are that a large capital investment in carts 
is required, and space is needed for holding carts in both 
the user department and the storeroom. 
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CHAPTER 3 
LITERATURE REVIEW OF HEALTHCARE SUPPLY CHAIN 
3.1 Introduction 
The aim of this literature review is to provide a review 
of supply chain management within the health care sector. 
The review covers the problems encountered. A discussion 
of related research work in this area and the factors 
influencing the performance of the health care supply 
chain system would be studied. 
First, the general concept of supply chain in 
manufacturing and healthcare is presented. 
A cross-section of different models of supply chain 
systems and an evaluation of each with the emphasis on 
suitable model for health care supply chain is reviewed. 
The last section will present the health care supply chain 
performance measures and the existing methods of 
calculating supply chain cost. 
3.2 Supply Chain Management - general overview 
The main objective of studying supply chain is to 
eliminate waste and improve the flow of materials. This is 
what most authors agreed on. This is yield to cost 
reduction, quality and efficiency improvement. 
Since the supply chain term has been used in the 
manufacture setting until now, it passes through different 
improvement stages, and has been attractive to other 
industry like healthcare. 
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For many years, researchers and practitioners have 
primarily investigated the various processes of the supply 
chain individually, whether supply chain management term 
or other term such as network sources, supply pipeline 
management, value chain management and value stream 
management have become subject of increasing interest in 
recent years, to academics, consultants and business 
management (Croom et al, 2000). 
Langabeer (2005) pointed out the need of adapting the 
manufacturer system to healthcare. He suggest that the 
hospitals create an evolutionary path for supply chain 
technologies to increase vendor collaboration, 
implementing better business practices, optimize pricing, 
and improve the prediction of required order quantities. 
As the supply chain represents one of the largest 
opportunities for cost savings and value creation in the 
healthcare enterprise, extended studies are needed to 
assist hospitals to understand and implement any changes. 
The estimation of purchased materials and services account 
form between 50% and 80% of the total product 
manufacturing cost and it is further estimated that the 
suppliers product for 30% of the quality problem and 80% 
of the product lead-time. On the other hand, it is 
estimated 35% to 40% of the total budget of any hospital 
goes directly to the suppliers used in the healthcare 
setting (Dacosta-Clavo, 2002). 
The term supply chain management is a new concept 
illustrated in 1958 by Jay Forrester. This concept has 
been crystallized recently to be defined as "as the 
integration of key business processes from end users 
through original suppliers that provide products, services 
and information and add value from customers and other 
stakeholders" (Cooper et al, 1997). 
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A supply chain is characterized by forward flow of goods 
and a backward flow of information. 
A value chain is concerned with several theorized 
objectives: 
o Optimizing the overall activities of firms working 
together to create bundles of goods and services 
o Managing and coordinating the whole chain from raw 
material suppliers to end customers, rather than 
focusing on maximizing the interests of one player 
o Developing highly competitive chains and positive 
outcomes for all firms involved 
o Establishing a portfolio approach to working with 
suppliers and customers; that is, deciding which 
players to work with most closely and establishing the 
processes and information technology (IT) 
infrastructure to support the relationships (Gordon, 
2000) 
3.2.1 Supply Chain Management in the Service Industry 
and the relationship with the manufacturing 
The service industry is becoming increasingly dominant in 
our world, and employment numbers are shifting from 
manufacturing towards services. The problem is the 
separation between the service industry and manufacturing 
is not always as black and white as many experts thought 
(Cooper et al, 1997). Sometimes there is a gray area, a 
mixed industry that blends both the manufacturing and 
service sectors. An effective supply chain is needed to 
link these sectors. 
As defined before, supply chain can be narrow and broad 
depending on the definer. But the definition by Ayers 
(2000) can be covering all supply chain aspect; 
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Supply Chain: "Life cycle processes supporting physical, 
information, financial and knowledge flows for moving 
products and services from suppliers to end-users". 
The following is a breaking of the definition further: 
o Life cycle refers to both the market life cycle and the 
usage life cycle. These aren't the same for both 
durable goods and services. 
o Physical, information and financial flows are 
frequently cited dimensions of the supply chain. The 
traditional viewpoint of supply chains as only physical 
distribution is too limiting. 
o Services also have supply chains. Production planning 
for the product development department, which produces 
designs, not products, can benefit from the same 
techniques used by product manufacturers. 
o The term product describes the basic product or service 
the extended product includes the basic product or 
service, the supply chain that delivers it, plus other 
features and factors that go along with the product or 
service. 
Supply chain management has received attention since the 
early 1980s, yet conceptually the management of supply 
chains is not particularly well-understood, and many 
authors have highlighted the necessity of clear 
definitional constructs and conceptual frameworks on 
supply chain management (Saunders, 1995,1998; New, 1995; 
Cooper et al, 1997, Babar and Prasad, 1998). Saunders 
(1995) warns that pursuit of a universal definition may 
"lead to unnecessary frustration and conflict", and also 
highlights the fragmented nature of the field of supply 
chain management, drawing as it does on various 
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antecedents including industrial economics, systems 
dynamics, marketing, purchasing and inter-organizational 
behavior. The scientific development of a coherent supply 
chain management discipline requires that advancements be 
made in the development of the theoretical models to 
inform our understanding of supply chain phenomena. 
The development of supply chain over the years has been 
slow. Companies developed individual parts of their supply 
chains beginning first with the transportation component 
and moving on to include warehousing, finished goods 
inventory, materials handling, packaging, customer 
service, purchasing, and finally, raw materials inventory. 
The goals of supply chain systems are multi-dimensional 
and include cost minimization, increased levels of 
service, improved communication among supply chain 
companies, and increased flexibility in terms of delivery 
and response time. 
Today, much of the reluctance to interface with other 
firms in supply chains is breaking down. The change in 
attitude is due to variety of factors including just-in- 
time (JIT) programs, electronic data interchange, and 
point-of-sale data sharing programs. Each factor made 
traditional Logistics managers realize that there is more 
to gain by working with other supply chain firms than 
there is to lose. 
For example, one of the greatest barriers to JIT was the 
fear that sharing production information with vendors 
would hurt a company by revealing its production-planning 
schedule to the competition. The fear was groundless, 
because what mattered most was keeping inventories low and 
reducing the resulting administrative costs of carrying 
inventory at manufacturing, plant, and dealer locations. 
Such influencing factors are explained as follows: 
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1. Electronic data interchange (EDI) had same effect on 
the fears of the data sharing in the supply chain. 
Here, firms were actually linking up their companies 
with computer-to-computer ordering and data exchange. 
The fear was greatest among small companies. 
Implementation of EDI required an investment in 
companies and software, on the parts of both the vendor 
and the buyer. Standardization was also a requirement 
that made the switch to EDI a lot slower than with JIT 
(more detail can be seen in 3.3.1.4). 
2. Point-of-sale information programs were a major 
influence in altering among Logistics managers the 
thinking that data exchange in the supply chain can be 
beneficial to all parties involved. 
3. The growth of the Internet has presented supply chains 
with many significant opportunities for cost reduction 
and service improvements. 
Supply chain management was perceived mainly as a 
manufacturing terms although it is applied to any service 
sector using materials, it is in fact very attractive to 
healthcare industry as the cost is extremely high without 
proper mechanism to control it. 
The following sub-sections highlight some of the 
solutions offered in the literature and indicate the 
relationships among the manufacturing industry, the 
service sector and customers. 
3.2.1.1 Relationships with customer 
The most important contributor to success in the service 
industry is building strong relationships with customers. 
Companies can benefit in numerous ways from loyal 
customers, including increased revenues, predictable 
sales and profits, low customer turnover, generation of 
34 
new business and costs that can be amortized over a 
longer (Gwinner et al, 1998). However, for the 
relationship to be successful and long term, the customer 
must also benefit. 
3.2.1.2 New technology adaptation in supply chain 
Changes in technology have extreme effects on how a firm 
manages its supply chain. Specifically, electronic 
commerce (EC) is extending value within the SCM process. 
Businesses use EC to integrate their internal functions 
with the applications of shippers, suppliers, and 
customers (Scarborough and Spatarella, 1998). Electronic 
commerce allows shipment status messages to be received 
instantaneously and provides vendor-managed and 
continuous replenishment inventory programs (DeCovny, 
1998). This new technology decreases inventory risks and 
maximizes the sale of product with short life cycles by 
reducing the time it takes to reach the broadest possible 
market (Scarborough & Spatarella, 1998). EC also promotes 
competitive advantages by having a more accessible order- 
entry process, decreased paper handling, and less re- 
keying of information (DeCovny, 1998). 
3.2.1.3 Forecasting in supply chain 
A company can effectively use customer date to 
synchronize its supply chain operations with consumer 
needs. This can be done through customer-supplied 
forecasts, which many people deem a necessary part of 
managing a supply chain. Robert Altabet, who is vice 
president of business management in the Duracell North 
Atlantic Group, states that, "the latest emphasis of 
forecasting has been in the areas of scheduling and 
Logistics, renamed "Supply Chain Management" (Altabet, 
1998). Another article says, "Forecast horizons could 
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impact a host of functional areas in the supply chain" 
(Saran, 1998). 
An accurate sales forecast can have numerous advantageous 
results in the process of SCM. Effective forecasts 
provide vendors with more accurate data, improve 
efficiencies in product distribution, reduce supply chain 
inventories, and enhance customer service (Kiely, 1998, 
1999). In general, forecasting helps businesses serve 
their customers more efficiently, without the constant 
fear of excess inventory. However, if SCM uses an 
erroneous forecast, the result will be felt throughout 
the entire system. 
3.2.1.4 Outsourcing in supply chain 
Manufacturing and service industries are grappling with 
the decision of whether to make or buy the parts used to 
manufacture their products. To answer this question, a 
company must weigh the cost factors. Experts believe that 
companies are heading toward greater specialization and 
outsourcing for the materials needed to make their product 
(Laios and Moschuris, 1999). Product complexity and 
commercial uncertainty is linked to how much technology is 
involved and the degree of risk for the business (Laios 
and Moschuris, 1999). In the service industry satisfying 
the customer is the highest priority. Businesses must link 
the decision to make or buy based on which option provides 
optimal customer satisfaction and the most cost-effective 
methodology. This is why procurement is being recognized 
as an important tool for improving a service corporation's 
bottom line (Anderson & Katz, 1998). Generally, the end 
product and ultimately the customer will benefit from 
outsourcing in the service industry. This importance is 
being pushed on the outsourcer to ensure that materials 
will arrive on time and in good condition. Service firms 
must consider quality, reliability, transportation costs, 
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the costs of acquiring and managing, and the value of the 
final product to the customer. 
In the healthcare outsourcing the distribution of non- 
critical items is always a viable alternative. (Nicholson 
et al, 2004). 
3.2.2 The integration of supply chain management 
As improvement of supply chain management the integration 
of supply chain have been introduced. Power, (2005) stated 
"implementation of technologies and methodologies for the 
management of supply chains is likely to be accompanied by 
significant intra and inter-organizational change" 
The purpose of supply chain management is described by 
(Kaufman, 1997) as to bring to "remove communication 
barriers and eliminate redundancies" through coordinating, 
monitoring and controlling processes. The integration of 
supply chains has been described by Clancy as: 
"attempting to elevate the linkages within each component 
of the chain, (to facilitate) better decision making and 
to get all the pieces of the chain to interact in a more 
efficient way and thus create supply chain visibility and 
identify bottlenecks" (Clancy, 1998). 
The main drivers of integration are listed by (Handfield 
and Nichols, 1998) as: 
3.2.2.1. Information flows 
Effective application of information technology to the 
integration of supply chain activities has the effect of 
reducing levels of complexity. Senge (1990) defines two 
types of complexity, detail and dynamic. Detail complexity 
exists when there are many variables, like demand, needing 
to be managed. Dynamic complexity exists where cause and 
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effect are separated, and difficult to associate, in both 
time and space. 
There are a large number of software applications 
developed to allow better flow of information throughout 
the supply chain including order management systems to 
automate the order fulfillment process, demand planning 
system for managing and monitoring forecasts (Huson and 
Owens, 2000). These systems have suffered from the fact 
that they are not linked together within the organization 
they are considered as a short-term solution. Christopher 
(2000) states, "The use of information technology to share 
data between buyers and suppliers is, in fact, creating a 
virtual supply chain. Virtual supply chains are 
information-based rather than inventory-based". 
3.2.2.2 Physical logistics 
The importance of the management of physical inventory is 
being amplified by the following factors; decreasing 
product life-cycles; decreasing levels of standardization 
of products and demands for customization; customers 
demanding shorter delivery lead times; increased levels of 
competition due to globalization and lowering of tariff 
barriers; and increasing levels of dynamism (rate of 
change), complexity (number of changes) and uncertainty 
(what will change) in global markets (Stalk and Hout, 
1990; Pine, 1993; Handfield and Nichols, 1999). Levels of 
inventory in supply chains are directly linked to cycle 
times, and cycle times in physical Logistics are largely a 
function of distance, uncertainty and complexity (Bowersox 
and Calantone, 1998). From the point-of-view of the 
movement of physical goods, an integrated supply chain 
offers the opportunity for firms to compete on the basis 
of speed and flexibility, while at the same time holding 
minimum levels of inventory in the chain. 
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3.2.2.3 Partnerships, alliances and cooperation 
Handfield and Nichols (1999) also emphasize the importance 
of relationships for the effective management of supply 
chains. They state that the technological and physical 
transfer elements are understood, and that the issue of 
relationships is more difficult, less well understood and 
therefore more fundamentally important. 
For Lambert and Cooper (2000) the key to these 
relationships is the level of management and integration 
required, with highly strategic inputs requiring the 
highest levels of management and integration by the focal 
company. They also make a valid point about the importance 
of monitoring the relationships suppliers and customers 
have with competitors. 
A key component of this infrastructure will be based on 
robust and durable collaborative arrangements with trading 
partners. The most effective of these networks will be 
those that are able to get the mix of information 
requirements, physical Logistics and collaboration right, 
providing shared benefits to a majority of partner 
organizations. 
The requirement for integration of supply chains is 
inherently strategic, and a potential source of 
competitive advantage for multiple trading partners. The 
nature of the integration model is an implementation issue 
that needs to be addressed with a view to customer needs 
and other variables such as industry and market 
characteristics (Damien Power, 2005). 
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3.3 The supply chain in health care 
Historically, the healthcare industry has viewed itself 
as being operationally different from other businesses. 
Unpredictably, patient mix leads to uncertainty of supply 
consumption. This is one of the factors most researchers 
have concentrated on supply chain process improvements. 
Despite well-documented evidence of significant 
competitive advantage and cost reduction resulting from 
supply chain management (SCM) practices, the healthcare 
industry has been extremely slow to embrace these 
practices. (McKone-Sweet et al, 2005) 
However, in the past few years supply chain situation has 
started to change since healthcare financial resources 
are increasingly limited, researchers focused to study on 
the method for operational improvement in order to 
maintain the care services required by healthcare 
benefactors and to reduce costs. Hence, different studies 
about resource utilization strategies in healthcare 
organization (Giokas, 2001). 
3.3.1 Current view of the medical supply management 
Healthcare has been learning the supply chain practices 
from manufacturing supply chain, such managing inventory, 
demand, quality planning and control, also trying to 
adapt these practices in health care. However, most of 
these practices have been developed in industry over the 
year according to the need of manufacturing sector. These 
practices need to be changed or modified to suite the 
health care environment to get the best out of them. The 
supply chain practices in health care, therefore, show 
strong similarities with manufacturing practices. This is 
mainly because of the similarities in the problems 
encountered in both sectors. The health care industry 
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lagged in bringing effective solutions to its problems in 
recent years. Therefore, learning from manufacturing 
supply chain would contribute to the faster solutions to 
the sector problems and this learning should be 
encouraged in health care. 
The following sections review the methods and 
technologies that the researchers and healthcare 
practitioners try to implement, as it is successful in 
the manufacture industry. One of these technologies is 
the (Just In Time) which is proven to be very effective 
in bringing solutions to many manufacturing problems 
yielding a substantial savings in the manufacturing 
industry. 
3.3.1.1 Just In Time (JIT) 
A JIT delivery system can help to reduce the non value- 
added activities such as procurement, receiving and 
inventory management. Although these activities are done 
routinely, they do not add any positive value to the 
services provided by the healthcare organization. So the 
required items would be delivered to the needing 
departments in the hospital directly at the time they are 
required. The objective of JIT is to minimize inventory 
(medical supplies) to levels that satisfy customer demand 
and eliminate all the waste, which is defined to be non- 
value adding activities (Papadopoulou and Ozbayrak, 
2005). One of the most important issues in JIT is to 
choose the suppliers very carefully so the organization 
can expect a fast (and high quality) delivery of supplies 
when they are needed. JIT purchasing requires that 
suppliers deliver materials just in time. Thus, supplier 
linkages are vital (Hansen & Mowen, 1997). In a JIT 
environment, the number of suppliers is relatively 
limited and the purchase contracts are long-term. With a 
long-term contract, the supplier's uncertainty is 
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reduced, and the mutual confidence between supplier and 
purchaser can be built more easily (Monden, 1998). 
Management of medical supplies is one of the most 
important managerial aspects of the healthcare industry. 
Inventory management in most industries has improved 
(Baker et al, 1996), and the level of inventory has been 
reduced by implementing methods, such JIT. Nevertheless, 
some healthcare organizations still hesitate to reduce 
the level of inventory because the costs of lack of 
inventory (such as loss of lives) are much higher than 
the costs of keeping additional inventory. However, 
current trends and market pressure on the healthcare are 
making healthcare providers seeks ways to reduce 
operating costs. Reducing the cost of carrying medical 
inventory is such an item. 
The majority of current supply chain research has been 
focused on refinement to existing JIT systems used in the 
manufacturing industry. With specific regard to the 
health care industry there has been very little research 
directed toward implementation of the JIT concept. Most 
research in the health care industry has been directed 
toward process and information system improvements. 
Rather than being contradictory, current health care 
Logistical research has been to focus on specific supply 
chain processes. 
3.3.1.2 Why Has The Healthcare Industry Not Implemented 
Just-In-Time? 
Healthcare industry, by nature, provides a very vital and 
critical service to the public. Its main activity is to 
provide solutions to human health and well-being. 
Traditionally human health and life cannot be measured by 
cost and there is no equivalent unit of measurement of 
saving a human life. This type of cultural concept in 
health has prevented the sector to consider more cost 
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effective approaches to the problems they have been 
experiencing. Therefore, the sector has long neglected the 
effective solution technologies such as JIT in their every 
day problems. Another major problem in healthcare is the 
high level unpredictability in determining the level of 
medical supplies. The sector, by nature, is highly 
unpredictable and most of the time, a well-working 
technology in manufacturing industry, not necessarily is 
enough to work well in healthcare sector. Therefore, the 
practitioners in the sector approached to these 
technologies with reservations with fear of not getting 
enough benefit out of them, which prevented them from 
adapting JIT technology in healthcare sector. Third reason 
could be the lack of a proper information system to be 
used between the hospital and the suppliers to track all 
the item trafficking. The fourth reason is the fear of not 
having enough medical items once the hospital needs them, 
because one of the main goals of JIT is to have zero 
inventories. 
However, since the resources such as capital and assets 
are becoming more and more limited in the industry the 
health care providers have to find effective solutions to 
its problems. 
With introduction of managed care, public pressure to 
reduce escalating cost, and increased competition for a 
shrinking inpatient market, healthcare leaders now have 
the incentive to evaluate their supply chain management 
practices and consider implementing JIT. (Jarrett, 1998) 
The manufacturing industry shares many similar business 
processes with the health care industry, especially in the 
areas of supply distribution, inventory control, and 
product production. While the health care industry has 
been trying to manage its escalating operational cost and 
heal its sickly supply chain with many new supply-chain 
management strategies, it has been reluctant to make the 
43 
comparison between itself and the manufacturing industry 
and take advantage to the savings associated with 
adaptation of manufacturing's (JIT) system. 
Therefore, JIT technology, since it has already been 
proven that it is very effective in manufacturing 
industry, has began becoming one of the most effective 
tool to provide solutions to healthcare problems. 
3.3.1.3 Stockless Distribution 
Stockless distribution refers to product delivered in the 
lowest unit or measure either to the dock or directly to 
the using department in the hospital. 
In the early 1990s the two terms quickly became buzz 
words, used interchangeable by hospital administrators 
and materials managers to describe a canned approached 
for taking costs out of the supply system. Meanwhile, the 
rest of the hospital staff lived by "Just in Case", the 
traditional belief that it was necessary to see, touch 
and feel lots of inventory, (Rivard-Royer et al., 2002). 
In the early days of stockless, few materials managers 
looked at the total cost when evaluating stockless 
distribution as a means of improving the bottom line. 
Instead, they pointed to the quick benefits, such as FTE 
reductions that followed cutbacks in inventory. A decade 
later, there is better understanding of the components of 
total costs in an organization such as a hospital. 
Benchmarks help determine costs and point to what the 
most sense for a particular organization. 
Hospital and distributors have learned to design 
contracts that align incentives between the parties, 
promoting mutual benefits and savings. 
As a result of this better understanding of costs and 
benefits, hospitals have begun to look at stockless 
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distribution as just one of a variety of options to help 
remove costs from the supply chain. 
Stockless distribution is not the answer for everyone. 
For example, it wouldn't be advisable for a small rural 
hospital, 300 miles from the nearest distributor 
warehouse, with only a rudimentary computer system, or 
none at all. For another hospital, perhaps in an urban 
location, with a well-organized standardization program 
and high Labor costs, even stockless distribution might 
not go far enough. This hospital may want outsource the 
entire materials management function. (Eastaugh, 2001) 
As for hospitals that have already gone stockless or JIT, 
it may be time to rethink the decision. Stockless is now 
just one piece of a much larger distribution pie. If it 
once provided 100% of the solution to a particular 
hospital, it may now account for only 15% or less of the 
total picture. 
Not only is stockless losing its status as the ultimate 
distribution option, but also distribution itself is not 
as powerful a cost driver as materials managers once 
thought. 
Product utilization reviews, activity based costing, risk 
sharing with vendors, procedure based delivery, 
outsourcing, and electronic data interchange are just a 
few of the more recent cost saving strategies for 
hospitals. (Refer to 2.4.2.4 for saving by inventory 
control) 
3.3.1.4 EDI to Improve Supply Chain 
Electronic data interchange (EDI) is rapidly growing 
technology, even though it has been widely available 
since the beginning of the 1980s (Lim and Palvia, 2001). 
Among many benefits of EDI are: faster processing speed, 
greater accuracy, reduced costs, competitive advantage, 
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improved operations, security, tracking and control, 
intra and inter company communications, and customer 
service (Craig 1989; Gourley 1998; Hansen and Hill 1989; 
Male 1999; Richardson 1988). 
In 1996, manufacturers, distributors, and providers in 
the healthcare industry in USA conducted a study of ways 
to make the healthcare supply chain process more 
efficient. The study, Efficient Healthcare Consumer 
Response (EHCR), improving the Efficiency of the 
Healthcare Supply Chain, 
The EHCR study found that achieving targeted savings 
would require widespread adoption of EDI throughout the 
healthcare industry. The EHCR study identified $11 
billion in annual supply chain costs that could be 
eliminated by increasing efficiencies at manufacturing, 
distribution, and provider organizations. 
The study identified four areas where efficiencies could 
be realized to the benefit of all participants in the 
healthcare supply chain: distribution, transportation, 
order management, and inventory management. A potential 
41% savings identified for distributors and the 33% 
savings identified for manufacturers. According to the 
study, healthcare financial managers are responsible for 
the areas that have the potential to yield the greatest 
savings for providers. 
Efficiencies in order management-defined as the 
processing of price catalog updates, purchase orders, 
shipping notices, invoices, and related payments-offer 
providers the greatest potential savings. 
The study recommends that about 90% of all order- 
management-related document exchanges be completed 
electronically in order for providers to reap the 
projected savings. (Jarrett, 1998) 
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3.3.1.5 Integrated delivery system 
Today's integrated delivery systems (IDSs) require 
efficient supply chain processes to speed products 
delivery to users at the lowest possible cost. Most 
excess costs within the supply chain are a result of 
inefficient and redundant processes involved in the 
transport and delivery of supplies from suppliers to 
healthcare providers. By integrating and assuming control 
of these supple chain processes, improving supply chain 
management practices, and organizing and implementing a 
disciplined redesign plans, IDSs can achieve substantial 
savings and better focus their organization on their core 
patient care mission. 
Many integrated delivery systems have reached the size, 
geographic coverage, and scale of operations at which the 
traditional model of decentralized support services 
creates inefficiencies and excess costs. To manage these 
services more efficiently, IDSs have sought ways to 
centralize management of core operational functions; 
create production centers for food preparation, laundry, 
and other scale sensitive services; and implement 
standard policies and procedures system-wide. 
To achieve and maintain the level of service efficiencies 
that will help ensure their long-term success, IDSs 
increasingly will need to focus on integrating the entire 
supply chain. The supply chain is the chain of 
activities, information, and flow of funds that extends 
from manufacturers to the customers, or patient. 
Traditionally, marketing, distribution, planning, 
manufacturing, and purchasing have been independent 
processes within the supply chain, and the objectives of 
these processes within the supply chain, and the 
objectives of these processes have often conflicted. 
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Effective supply chain management integrates these 
disparate processes to bring finished goods to customers 
faster and less expensive. (Brennan, 1998) 
3.4 Supply Chain Models 
Considerable improvements have been made in supply chain 
management in many industries, but there has been limited 
success in making system wide SCM improvements in the 
healthcare industry. Yet, there is significant evidence 
that this industry is in need of broader changes. 
Research by McKone-Sweet, et al, (2005) found that 
hospital spending accounted for 47% of the overall 7.2% 
increase in healthcare costs during 2000. 
Everand (2001) attributed the lack of progress in SCM to 
the fact that each link in the healthcare supply chain 
operated solely in its own best interests. Although most 
healthcare professionals generally agree that change is 
necessary, fear of making the first move limits progress. 
Considering a broad spectrum of the supply chain concept, 
there may be various classification schemes to categorize 
supply chain models. To minimize confusion, (Min and 
Zhou, 2002) developed a taxonomy based on classical 
textbook guidelines to indicate the mathematical models: 
as deterministic and stochastic (Bradley et al, 1983). As 
noted by Budnick et al, (1988), Silver (1981) and Zipkin 
(2000), some supply chain models based on inventory 
theory and simulation contain both deterministic and 
stochastic elements and consequently should be treated as 
hybrids. Therefore, they added a hybrid model to the 
category. Another category called 'IT-driven models' was 
added to the taxonomy to reflect the current advances in 
IT for improving supply chain efficiency. These 
categories are somewhat different from the taxonomy 
developed by (Beamon, 1998) who did not report the 
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evolution of IT-driven models. To elaborate, they (Min, 
and Zhou, 2002) classified supply chain models into four 
major categories: (1) deterministic (non-probabilistic); 
(2) stochastic (probabilistic); (3) hybrid; (4) IT- 
driven. Deterministic models assume that all the model 
parameters are known and fixed with certainty, whereas 
stochastic models take into account the uncertain and 
random parameters. While Beamon (1998), classified this 
to: 1) deterministic analytical models, in which the 
variables are known and specified, 2) stochastic 
analytical models, where at least one of the variables is 
unknown, and is assumed to follow a particular 
probability distribution, 3) economic models and 4) 
simulation model. It is important to have simulation be 
an individual as it reflects the dynamic of process of 
supply chain. 
Deterministic models are showing as single objective and 
multiple objective models. This category was developed to 
reflect the increasing need to harmonize conflicting 
objectives of different supply chain partners. Stochastic 
models are sub-classified into optimal control theoretic 
and dynamic programming models. Hybrid models have 
elements of both deterministic and stochastic models. 
These models include inventory-theoretic and simulation 
models that are capable of dealing with both certainty 
and uncertainty involving model parameters. 
Shapiro (2001) observed that IT development was the major 
driving force for supply chain innovations and the 
subsequent re-engineering of the business process. 
Considering the proliferation of IT applications for 
supply chain modeling, we decided to add the category of 
IT-driven models to the taxonomy. IT-driven models aim to 
integrate and coordinate various phases of supply chain 
planning on real-time basis using application software so 
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that they can enhance visibility throughout the supply 
chain. 
Modeling practitioners developed supply chain model for 
the better understanding of functional relationships 
between the organizations. The following sub-section 
presents the supply chain models in more detail. 
3.4.1 Deterministic Models 
One of the earliest efforts to create an integrated 
supply chain model dates back to (Glover et al, 1979). 
They developed a computer-based production, distribution, 
and inventory (PDI) planning system that integrated three 
supply chain segments comprised of supply, 
storage/location, and customer demand planning. The core 
of the PDI system was a network model and diagram that 
increased the decision maker's insights into supply chain 
connectivity. The model, however, was confined to a 
single-period and single-objective problem. 
Cohen and Lee (1989) developed a mixed-integer; non- 
linear, value-added chain model that coordinated the 
supply chain process comprised of sourcing, centralized 
production planning, and inter-plant transshipment. The 
model incorporated capacity, demand, and production 
constraints, but failed to capture risk factors inherent 
in a global setting. 
(Arntzen et al, 1995) presented a mixed-integer 
programming model, called global supply chain model 
(GSCM), which evaluated global supply chain alternatives 
involving multiple products and multiple stages 
(echelons). More specifically, GSCM took into account the 
inter-dependence of production, inventory and delivery 
processes to minimize activity days and costs associated 
with production, inventory, material handling, and 
transportation. 
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In an effort to integrate inventory, transportation and 
location functions of a supply chain, (Nozick and 
Turnquist, 2001) proposed an approximate inventory cost 
function and then embedded it into a fixed-charge 
facility location model. The fixed-charge facility 
location model was designed to consider a trade-off 
between demand coverage and cost associated with the 
location of automobile. Although the model deals with 
multiple objective (service-cost trade-off) issues, it is 
confined to a single period, single echelon problem with 
no capacity constraint. 
3.4.2 Stochastic Models 
In an increasingly competitive environment, there are 
many uncertain or random elements in the supply chain 
such as customer demands, lead times, and production 
fluctuation. The stochastic models take into account 
these uncertain and random elements. One of the 
pioneering works dealing with the stochastic nature of 
the integrated supply chain is credited to Midler (1969), 
who developed a dynamic programming model based on 
optimal control theory for selecting an optimal 
combination of transportation modes, commodity flows, and 
re-routing of carriers from customers to suppliers over a 
multi-period planning horizon. 
(Tapiero and Soliman, 1972) utilized optimal control 
theory to solve multi-commodity transportation, multi- 
regional production and inventory planning problems over 
time with uncertain demand. Despite its merit, the model 
combining linear and parametric programs created severe 
computational difficulty. 
(Lee and Billington, 1993) attempted to integrate the 
material flows of marketing, manufacturing, and 
distribution processes by developing a stochastic 
program. Their model was designed to determine the 
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material ordering policy, the customer service level for 
each product, and postponement strategies. Similarly, Lee 
and Swaminathan presented stochastic models to formulate 
postponement (delayed product differentiation) 
strategies. In particular, (Swaminathan and Tayur, 1999) 
solved a so-called vanilla box problem where the 
inventories of semi-finished products were stored in 
vanilla boxes and then were assembled into final products 
after a customer actually ordered them further into the 
supply chain. Their model considered random customer 
orders. 
In the meantime, several attempts have been made to 
quantify the effects of imbalance between supply and 
demand in the supply chain. These attempts include 
(Fisher, Hammond, Obermeyer, and Raman, 1997) who 
developed a stochastic program that aimed to minimize 
underproduction and overproduction costs as a result of 
imbalance between supply and uncertain demand in the 
supply chain. Similarly, (Lee et al, 1997) investigated 
the bullwhip effect that might arise when order variances 
distorted customer demand and consequently created 
imbalance between supply and demand in the supply chain. 
(Metters, 1997) followed up on (Lee et al, 1997) by 
developing a dynamic programming model that aimed to 
minimize the expected costs of production, inventory 
holding, and excess demand penalty, subject to production 
obeying capacity constraints. 
3.4.3 Simulation Models 
Simulation has traditionally been used in manufacturing 
modeling very widely. Parallel to the developments in 
computer technology and software engineering, simulation 
became more reachable to many people to use in modeling 
and analysis of systems, in particular manufacturing 
systems. The use of simulation in health care is 
certainly not new. Many simulation applications in health 
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care industry have appeared in recent years (Jun et al 
1999; Issenbery et al, 1999; Weinstein et al, 2003; Lake 
2005; Scalese and Issenberg 2005; Murray et al, 2005). 
Simulation modeling is preferred because it has the 
ability to model the systems in more detail than any of 
the modeling tools can. Further, it can introduce certain 
level of stochastic to reflect the true nature of 
randomness. However, it has some drawbacks as well. One 
of the major drawbacks is that it needs some substantial 
time to collect the data set to use and build the model. 
It needs a certain level of expertise in probability, 
statistics and computing. Another shortcoming of the 
model is severe computational complexity that may 
prohibit its application to a real-world problem. (Singh 
and Vrat, 1984) developed a more practical model that was 
designed to determine the optimal location of repair part 
stocking points and the allocation of repair part 
inventory to that location. 
Petrovic (1998) developed a fuzzy generative supply chain 
model to determine target order-up-to levels of 
inventories along a supply chain under uncertain demand 
and external supply of raw material. The results of the 
fuzzy model were then used as input data for an 
evaluative simulation model that aimed to calculate 
replenishment quantities during a finite planning 
horizon. The simulation model also provides the user with 
the assessment of supply chain performance (e. g. end- 
product delivery performance). These fuzzy and simulation 
models, however, were confined to a single product 
problem with no capacity constraint. (Petrovic, 2001) 
extended these models by incorporating the element of 
uncertain lead times during the replenishment process 
into the fuzzy model framework. Both of these simulation 
studies are useful for understanding supply chain 
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dynamics under uncertainty, but are still limited to 
periodic review inventory systems. 
The details as well as further explanation of the 
simulation and simulation modeling can be found in 
Section 5.2 and Section 6.2 for the reference model. 
3.4.4 Information Technology Driven Models 
One of the most critical drivers of supply chain success 
is the enhanced visibility through an information sharing 
mechanism linking supply chain partners. Considering the 
significant role of IT in supply chain success, IT driven 
models are high demand. Although IT-driven modeling 
efforts are still in their infancy, they are used widely 
in supply chain models (Ayers, 2000). 
3.5 Performance measures in the Health Care Supply Chain 
The following literature review will be the basis for 
selecting the performance metrics of the proposed 
healthcare supply chain model in Sections 4.2. Smith and 
Swinehart (2005) pointed that the healthcare is looking 
for a measure to determine the organization success. 
Efficiency, effectiveness and cooperation are important 
to achieve, but first it needs to be measured. An 
important component in supply chain design and analysis 
is the establishment of appropriate performance measures 
(Beaman, 1998). Different researchers have attempted to 
assess SCM performance in different ways, but most 
performance measures up to now are more oriented towards 
economic performance than to other aspects of performance 
such as customer satisfaction (Harland, 1996). Garwood 
(1999) cautions that old yardsticks for SCM performance 
such as purchase price variance, direct Labor efficiency, 
equipment utilization, and production development budget 
are no longer adequate, and a new set of metrics to 
motivate and reward the right behavior is needed. 
Combining different set of performance measurement to 
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focus on the healthcare supply chain is crucial for 
successful measurement, which can be seen in Section 4.2 
which is the aim of the research. Lack of measurement 
slows acceptance and implementation of major changes in 
the supply chain (Owen and Richmond, 1995). It is 
becoming more important to achieve fully integrated 
supply chain than individual performance measure 
(Gunasekarn et al, 2001). 
A number of researchers have suggested different measures 
of SCM performance. For example, Stevens (1990) suggest 
that an organization measure the performance of supply 
chain in terms of inventory level, service level, 
throughput efficiency, supplier performance, and cost. 
Narasimhan and Jayaram (1998) use the customer 
responsiveness and manufacturing performance as the 
measure for SCM performance. Spekman et al, (1998) use 
cost reduction and customer satisfaction as the SCM 
measures. Hewitt (1999) recommends customer satisfaction, 
return on trading assets and flexibility as the 
measurements for a supply chain performance. Beamon (199B) 
identifies several qualitative SCM performance measures; 
customer satisfaction, flexibility, information and 
material flow integration, effective risk management, and 
supplier performance. It can be seen that each of above 
researchers, more or less, has addressed some dimensions 
of SCM performance measures, but not all. Among all 
measures, customer responsiveness/satisfaction receives 
the most recognition. Synthesizing above findings, five 
major dimensions of SCM performance are studied and 
discussed below. 
3.5.1 Supply Chain Flexibility 
In general, flexibility reflects an organization's ability 
to effectively adapt or respond to change. Flexibility 
describes the organization's ability to meet the needs of 
the market without excessive cost, time, organizational 
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disruption, or loss of performance (Aggarwal, 1997). 
Vickery et al, (1999) suggest the flexibility should be 
viewed from the perspective of the entire value-adding 
system and examined from an integrative, customer-oriented 
perspective. They define flexibility as encompassing those 
flexibilities that directly impact an organization's 
customers (i. e. flexibilities that add value in the 
customer's eyes) and all the shared responsibility of two 
or more functions along the supply chain, whether internal 
(e. g., marketing, manufacturing) or external (e. g., 
suppliers, channel members) to the organization. 
3.5.2 Supply Chain Integration 
Supply Chain integration is defined as the extent which 
all activities within an organization, and the activities 
of its suppliers, customers, and other supply chain 
members, are integrated together (Wood, 1997; Narasimhan 
and Jayaram, 1998). As shown in Section 4.6.2 and 4.7, 
There are two interrelated forms of integration along the 
supply chain: the first type of integration involves 
coordinating and integrating the forward physical flow of 
deliveries between suppliers, manufacturers, and 
customers; and the other prevalent type of integration 
involves the backward coordination of information 
technologies and the flow of data from customers, to 
manufacturers, to suppliers (Frohlich & Westbrook, 2001). 
A highly integrated supply chain is a real representation 
of superior SCM performance. Organizations that operate in 
isolation are placing themselves at competitive 
disadvantage (Wood, 1997). Not only must organizations 
collaborate internally across business functions, but also 
they must establish external strategic linkages with other 
organizations. One true indicator of supply chain 
integration is that there is no distinction, and certainly 
no disconnection, between a myriad of transaction 
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processing applications within an organization, and the 
organization's ability to optimize and utilize decision 
support capabilities to improve integration of suppliers 
and customers and to better serve customer needs. 
3.5.3 Customer Responsiveness 
Customer Responsiveness is defined as the speed of an 
organization's response to the customer requests 
(Narasimham & Jayaram, 1998; Beamon, 1998). The 
performance of SCM must ultimately be measured by its 
responsiveness to customers (Lee and Billington, 1992). As 
mentioned by Owens and Richmond (1995), while SCM strategy 
varies from organization to organization, its overall 
objectives are clear: to become increasing responsive to 
customer needs, to drive costs out of the system, and to 
turn savings into additional value for the customers. BY 
measuring the performance of activities critical to 
ensuring satisfaction of customers, managers can target 
their efforts more effectively and can assess the results 
of their actions more objectively. 
3.5.4 Supplier Performance 
Supplier Performance is defined as suppliers' consistency 
in delivering materials, components, or products to an 
organization on time and in good condition (Beamon, 1998). 
In the literature, supplier performance is considered one 
of the determining factors for the organization's 
operational success (Shin et al, 2000; Vonderembse and 
Tracey, 1999) and a very important dimension of SCM 
performance (Stevens, 1990; Beamon, 1998; Gunasekaran et 
al, 2001). Poor vendor quality and delivery performance 
result in higher levels of inventory and order backlog 
(Shin et al, 2000). 
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3.5.5 Partnership Quality 
Partnership Quality is defined as how well the outcome of 
a partnership matches the participants' expectation (Lee 
and Kim, 1999). One big problem in SCM measurement system 
is that it usually consists of hard, objective measures 
which are in direct conflict with the shared destiny 
principles of partnership and long-term relationships 
underlying SCM (Harland, 1996). Marketing-based and 
service -based views have emphasized the importance of 
customers' perception in measuring relationship 
(Christopher, 1992). These issues are of far greater 
importance in measuring long-term relationship 
performance. From the standpoint of service-based view, 
partnership quality is considered as a soft measure for 
SCM performance, which represents the result of a partner 
comparing with the expectations with against the 
perception of supply chain performance. Previous research 
in channel relationship has indicated that satisfaction of 
a channel member is instrumental in increased morale, 
cooperation between channel members, few terminations of 
relationships, and reduced litigation (Ganesan, 1994). 
With the escalating cost of providing healthcare, 
politicians and hospital operators are searching 
continuously for innovative ways to contain costs without 
sacrificing quality of services. The increasing cost of 
providing health care is due to changing disease patterns, 
which in turn lead to advances in medical knowledge and 
technology, and to a greater use of medical technology. 
Hospitals have become aware of the acute need to cap 
rising operating costs and to meet or even exceed a higher 
level of expected patient quality (Butler, 1995). 
in order to achieve the goal of "providing healthcare 
efficiently and cost-effectively", one of the requisites 
of achieving medical excellence, numerous studies and 
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investigations have been done on diagnostic and 
therapeutic techniques, advanced technology 
implementations and cost sharing. However, there is little 
or no research on the measurement of the results of the 
goals to be achieved, in this case the performance 
measurement of the system. 
Alt (1997) points out that the increase in healthcare 
costs and inefficiencies are due to inadequate and tedious 
purchasing procedures. The health care cost escalation has 
been based on the explicit assumptions that medical supply 
purchasing information systems are inadequate, and that 
the delivery of the healthcare has been inefficient. 
Inefficiencies in the healthcare supply chain could be 
significantly improved through the application of supply 
chain best practices from other industries. Prior to the 
changes, there was an urgent need to assess assumptions 
that medical supply purchasing information systems are 
inadequate, and that the delivery of health care has been 
inefficient. 
3.6 Cost Management of Health Care Supply Chain 
Cost Management in the healthcare setting does not enter 
into decision-making and action of the matter concern 
medical aspect (Cleveley, 2000). So the evolution of 
health care created a climate in which cost was 
subordinate to medical treatment. Current reimbursement 
constraints have increased the need for providers to be 
cost conscious, but they have discovered that current 
accounting practices do not provide the appropriate 
information to determine the cost of service or make 
decisions. 
One of the greatest challenges facing health care 
providers is cost determination. Health care providers do 
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not know what it costs to provide services. In addition, 
standard accounting systems are of little help and can 
provide misleading information. 
Literature survey of cost management in health care 
supply chain is not as in the manufacturers it is 
relatively new concept. 
Traditional costing systems break costs into direct and 
indirect expenses. Activity-based costing (ABC) however, 
defines costs in terms of organizations' processes or 
activities and determines costs associated with 
significant activities or events. For example, using ABC, 
a healthcare organization is able to better understand 
costs associated with patient assessment or the provision 
of diagnostic tests, as well as factors influencing cost 
(eg, Labor). Thus, ABC can help healthcare organizations 
achieve their strategic objectives. 
Traditional costing systems have several shortcomings. In 
the manufacturing industry, for example, costs are based 
on production measures relative to volume, such as the 
number of cars produced. 
Overhead traditionally is allocated proportionally among 
all work centers in the form of indirect cost. These 
costs are allocated to final products by using direct 
Labor hours or machine hours as their bases for 
allocation. 
This system is relatively successful, except when 
overhead is allocated using an appropriate base. For 
example, allocating the overhead for electrical expense 
at a soft drink bottling plant using direct Labor hours 
rather than machine hours as the allocation base is 
inappropriate. Clearly, expensing electrical power as a 
function of Labor output is inappropriate. 
ABC more accurately distributes indirect costs by 
choosing the most appropriate cost base for allocation. 
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Furthermore, it allows for more than one base to serve as 
a factor influencing cost. 
3.6.1 Traditional Cost Accounting 
Most organizations have three distinct costs: 1) direct; 
2) indirect; and 3) overhead. Direct costs are 
expenditures for resources that can be tracked to 
specific products or customers (Lindahl, 1997). These are 
costs, such as Labor or supplies that are consumed in 
creating a product or service. They have a clear cause 
and effect relationship with output and the costs 
associated with acquiring these resources rise and fall 
with output. Managers can see where the resource was 
used, how many units were employed and their cost. There 
is a little ambiguity as to why these expenditures are 
incurred and who should pay for them. 
Traditional cost accounting relies on cost allocation to 
distribute support costs originating outside revenue 
producing departments back to user departments and 
subsequently to outputs and/or customers. 
This is where cost accounting and real-world production 
begin to part ways. Production relies on cause and effect 
relationships to create products and services. Accounting 
often relies on easily available measures to allocate 
production costs to output and customers. 
3.6.2 The ABC Model 
ABC starts with the identification of resources consumed 
by the production process. These are function specific 
aggregates (i. e., how much is spent for resources used in 
the production process). The next step is to identify to 
cost driver. Cost drivers are the things that cause work 
to be undertaken. A cost driver is an event that results 
in activities being performed and causes the expenditures 
of resources (Cagwin and Houwman, 2002). In this example, 
the primary cost driver is ER visits and they determine a 
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large percentage of costs incurred. ABC attempts to trace 
how the arrival of patients in the ER creates demands on 
resources used for direct care (i. e., Labor and supplies) 
support services (i. e., maintenance, materials 
management, utilities, housekeeping) and overhead (i. e., 
A&G, finance, marketing). 
According to Brimson, "activities represent the 
orchestration of technology, people, raw materials, and 
skills that go into the delivery of health care. 
Furthermore, they describe what an enterprise does, the 
way time is used, and the final outcome of the process. 
Activity mapping, which involves mapping activities in an 
illustrated sequence; activity analysis, which involves 
defining and assigning a time value to activities, and 
bill of activities, which involves generating a cost for 
each main activity. 
3.6.2.1 Resource and Activity Drivers 
ABC relies on resource and activity drivers to trace 
expenses to their source (e. g., why were resources 
purchased, how were they used in the production process, 
and what did they produce or who benefited from their 
expenditure). Resource drivers specify the cost to 
produce an activity and activity drivers specify the 
amount of work required to produce an output. A prime 
benefit of ABC methodology is the explicit recognition of 
work activities (Canby, 1995). 
3.6.2.2 Benefits of ABC 
As stated by Cooper and Kaplan (1991), they report that 
ABC is not just a way of accurately calculating products 
costs, but is an extremely useful management guide which 
can help in decision making and directly lead to higher 
profits. According to Cooper and Kaplan, ABC can give 
management a clear idea of how products, brands, 
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customers, regions and distribution channels can make 
profits and consume resources. 
This can be achieved by the willingness of managers to 
separate expenses incurred to produce individual units of 
a specific product from the expenses required to produce 
different products, irrespective of how many units are 
bought or sold (Cooper and Kaplan, 1991) Once this is done 
managers must be willing to act, and explore ways of 
reducing the amount of resources required for various 
activities, then either reduce spending on those resources 
or increase output, only then can higher profitability be 
achieved (Cooper and Kaplan, 1991). 
Chan (1993) discusses the issue of how ABC can guide 
managers to effective cost reduction by focusing on non- 
value added activities. Chan then elaborates that cost 
can be reached by Ramsey is that he was able to 
theoretically illustrate how ABC could be successfully 
applied in a health care environment. 
Carr (1993) was able to illustrate how ABC allows 
management to efficiently manage staffing and obtain a 
more accurate cost assessment for services provided. 
Braintree Rehabilitation center was used as an example to 
show how ABC could be both developed and implemented on a 
center, which provides nursing services. Skill levels of 
the nurses were divided into three categories and the 
relating pay scales were chosen to range from low to 
high. Routine and special nursing events were monitored, 
and a database was built up which would illustrate the 
distribution of nursing care against type of activity and 
patient diagnosis. Results of the study found that as the 
patient's health progressed, the lower skilled nurses 
usually took over from the higher skilled nurses. 
Therefore, ABC was able to recognize this and 
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consequently such information allowed management to 
manage staffing more efficiently. 
Lawson's (1994) study used ABC on a health care 
organization working in five geographical locations, and 
found regional variations in the overheads consumed, in 
some cases this variation was up to 30% in some 
localities. Therefore Lawson reached the conclusion that 
TCA methods can create problems and can give distorted 
information when used in the health care industry, just 
as it does when it used in the manufacturing industry. 
Caltrider et al, (1995) recount how ABC was used in a 
junior hospital in America, as an important part of their 
continuous quality improvement (CQI) approach. Hospital 
reviews highlighted that the orthopaedic outpatients 
clinic was a high cost area, and consequently an ABC 
review (combined with the CQI) method, was able to reduce 
costs by up to 20% on some forms of patient treatments. 
Shields (1995) concur with these results as he also 
reports that using ABC alongside other quality 
initiatives (amongst other factors) will aid in 
successful ABC implementation. 
Speeding and Sun (1997) assert that ABC can be inserted 
into simulation tools, and describes how such simulation 
models can be developed. This is done by observing the 
Actual processing times of activities in a system and 
then characterizing their variation by statistical 
distribution. Representation of the manufacturing system 
using a simulation program acts as a visual tool and this 
technique is commonly used by the management of such 
organizations, when exploring tactical moves or decision- 
making. Therefore, Speeding and Sun (1997) provides 
mathematical equations, which allow the implementation of 
the ABC model on to a simulation program. 
Cagwin and Bouwman (2002) investigate the association 
between improved financial statuses with the adoption of 
ABC. Cagwin and Bouwman employed the use of the 
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confirmatory factor analysis and structural equation 
model to investigate the relationship, and the results 
yielded a positive link between the use of ABC and 
improved financial performance, thus illustrating the 
success of ABC. Furthermore, Cagwin and Bouwman (2002) 
were able to identify factors under which such financial 
improvement could be achieved, these factors include 
using ABC simultaneously with other strategic business 
initiatives (such as Just in Time), implementation in 
complex and diverse firms and when ABC is sued in firms 
where costs are relatively vital. Such a study gives 
positive encouragement to the healthcare industry, as ABC 
can lead to improved financial status. Moreover, Cagwin 
and Bouwman findings are supported by previous studies, 
which also illustrate that ABCs potential benefits are 
somewhat limited by environmental factors. 
Gordon and Silvester (1999) studied the event of the 
stock market reaction to the installation of ABC and the 
results yielded a lack of any noteworthy reaction. 
Therefore this appears to suggest that ABC may have 
different effects, which are specific to the firm, and 
the benefits of ABC are dependant upon the way the 
company is structured and functions (Gordon and 
Silvester, 1999) . Devine et al, (2000) also concurs with 
these studies, as they claim that in order for ABC to be 
successfully implement in a health care setting, 
management must be fully committed via resources and 
training. 
Greasley (2000) uses a variety of tools, namely Business 
Process Simulation (BPS) in association with ABC. By 
using a case study of a police custody case, in order to 
redesign processes, Greasley was able to show that ABC 
can be sued to show where costs are being generated. 
Ozbayrak et al, (2004) focuses on ABC estimation in an 
advanced manufacturing system, and they assert that while 
it is extremely valuable to possess high automation 
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levels, high product quality and flexibility, if this is 
now backed up with an accurate and realistic costing 
method, then companies run a high risk of becoming 
uncompetitive. Ozbayrak et al, (2004) provides a 
simulation model that uses ABC to estimate manufacturing 
and product costs, within an advanced manufacturing 
industry. While, Ozbayrak et al's paper was specifically 
for the manufacturing industry, it is needless to say 
that there are many similarities between the 
manufacturing and healthcare industry (such as an 
increase in the level of automation), and therefore it is 
highly possible that this paper may have some relevance 
in applying ABC on the healthcare industry. 
3.7 Conclusions 
It may be concluded that the literature review given in 
this chapter reveals that the available research in 
health care supply chain mainly focuses on isolated 
operational problems in any health care unit ignoring the 
connection of this care unit with wider systems such as 
supply chain and makes some over-optimistic assumptions 
which hinder the validity of the model built to analyze 
the problem. The extensive literature review provided has 
proven that there is a considerable lack of proper 
research in health care supply chain and this thesis aims 
to fill this gap by providing a comprehensive supply 
chain modeling in health care to analyze a number of 
problems encountered in health care industry to improve 
the system performance. 
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CHAPTER 4 
Modeling and Analyzing a Health Care Supply Chain System 
4.1 Introduction 
This chapter presents the aim, objectives, motivation and 
framework of this PhD study. It also presents the research 
need and the main contributions of this study to the 
health care supply chain research. 
4.2 Aim 
The aim of this study is to develop a healthcare supply 
chain model to be used as a guide in improving the 
efficiency while reducing the escalated cost. 
For this reason, a comprehensive health care supply chain 
model has been built using simulation-modeling technique. 
The model concentrates on modeling the relative 
performance of the healthcare supply chain, in particular 
focuses on system performance modeling as been recommended 
from the literature review as discussed in the section 
3.4, also based on the author experience which found the 
following measuring metrics represent the healthcare 
supply chain performance: lead time, throughout, WIP, cost 
of test, waiting time (Queuing), material order size, flow 
time, inventory level, and equipment, staff utilization, 
the motivation for the selection of these performance 
metrics is to observe the system performance within the 
organization as individual and interacting activities, so 
that a better picture could be obtained in understanding 
the system behavior. The classification of the performance 
metrics is based on the level of explanation about the 
system behavior they could provide. The first set of 
metrics is used to measure the direct relationships of 
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activities such as throughput, lead time, flow time and 
WIP with the factors such as supply level and quality, 
inventory level, and demand pattern that affect the 
quality and dimension of aforementioned activities. The 
second set of metrics are used to measure the secondary 
activities such as staff and equipment utilization, queue 
size and supply order size with the general supply chain 
factors that influence the overall system performance. 
These metrics are needed to get a better picture about the 
system behavior as well as to understand the interactions 
between the different elements of the processes. These 
performance metrics are chosen for the ability to measure 
the system's performance in different dimensions. These 
metrics give the opportunity to the modelers and analysts 
to measure the different aspects of system's performance 
so that they can understand whether the system performs 
and functions as expected or not. Further, they give the 
opportunity to the analysts to interfere to the system in 
case of diverting from the expected performance levels or 
when any malfunction arises. 
Also it calculates the cost of each test including all 
related resources as part of the simulation model using 
the ABC method, (see Sections 3.6.2 for further 
discussion). 
The model created has particularly concentrated on a key 
health-care unit and sample-testing Lab in a very large 
local hospital. The model deals with supply chain elements 
and gives detailed analysis of the events take place in 
this unit considering the supply chain boundaries. 
A number of real-life scenarios have been modeled using 
the reference simulation model, which assumes that all the 
elements in supply chain work properly and no malfunction 
would happen during the operation of the system, to 
capture all the activities take place in a chain focusing 
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on the Lab to explore the health care system better to 
create a stream-line Supply Chain System in Health Care 
industry. (See Section 6.2 for further discussion on 
Reference Model) 
4.3 Objectives of the research 
The following objectives are envisioned in the context of 
this research work: 
" Building an integrated health care supply chain 
model composing; the system performance and health 
care cost. 
" Utilizing this simulation model to capture the 
relationship among all supply chain parties: 
Logistic, Chemistry Lab, Patient, and the Supplier. 
" Building a performance-modeling tool using 
simulation to measure the healthcare supply chain 
performance. 
" Utilizing the structure of the developed model to be 
used in different department in the hospital 
This research is examining why Healthcare Supply Chains 
lag behind the manufacturing supply chain system and 
tries to identify the areas and amount of savings 
available, estimate the impact of supply chain management 
"best practices", identify: efficiency improvements, cost 
reduction and reductions in medical error through a 
relative performance modeling. The integrated model which 
connecting all elements of healthcare supply chain system 
with fowrwrd of information and backword of information 
as will be covered in the section 5.3. 
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4.4 Outline of the Problem and the Research Needs 
One of the major causes of inefficiency in the health 
care system is that isolated or localized expertise. in 
the past several years this situation has started 
changing. Since health care financial resources are 
increasingly limited, manager's focus on methods for 
operational improvements in order to maintain the care 
services required by the population and to reduce the 
costs. Hence, different studies about resource 
utilization strategies in health care organization (Li et 
al, 2002; Pasin et al, 2002; Van Merode et al, 2002; Jun 
et al, 1999) or total quality management (TQM) 
implementation techniques (Eisenberg et al, 2001) have 
been developed. According to 1998 OECD reports on health 
care expenditures for several countries, the UK spends 
6.7 percent of her GDP on health care and with the recent 
government decision related to National Health Service 
(NHS), this expenditure will increase further (Department 
of Health Report 2002). Despite this scale of high 
expenditures, the UK health care system has been 
suffering from many malfunctions, including shortage of 
nurses and specialist doctors, long waiting lists and 
times, low quality of treatments, and most importantly 
high cost of health care delivery. 
There are several reports that highlight the magnitude of 
the problems NHS facing in the key areas of safety, 
effectiveness, and responsiveness to patients, 
timeliness, efficiency, and equity (Department of Health 
Report 2002). Escalating health care costs have prompted 
hospitals and in particular the NHS to get serious about 
major cost producing problems such as inefficient 
hospital operations management, inventory control and 
cost recovery, but, unless the effecting factors become 
integrated, costs will continue to spiral out of control. 
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Even the short view of the problems listed above can 
prove that the health care system has been suffering from 
serious malfunctions and a close examination can reveal 
that the most of these problems originate from poor 
management of the supply-demand balance across the health 
care supply chain system. 
Therefore, this research intend to examine why Healthcare 
Supply Chain lag behind those utilized within the private 
sector, and manufacturing supply chain system and tries 
to identify the areas and amount of savings available, 
estimate the impact of supply chain management "best 
practices", identify: efficiency improvements, cost 
reduction and reductions in medical error through a 
relative performance modeling. 
It is illogical to assume that old processes will meet 
future challenges. Instead, healthcare managers must look 
to other industries for proven approaches to become more 
cost-effective and efficient in the delivery of health 
services. Application of activity based cost modeling 
and Business Process Reengineering (BPR) has enabled 
American manufacturing to regain its worldwide leadership 
position, and can enable similar improvements within 
applied healthcare. (Wisnosky, 2000) 
The problem facing today's Healthcare leaders has 
become: "How can we provide care to the same number of 
patients at a greatly reduced cost without harming 
quality"? Revenues per patient visit are declining at a 
faster rate that the rate of cost reduction. In order to 
remain viable, any money of lost revenue must be matched 
by money in reduced variable expense. 
Since the end result of the supply chain is customer 
service (patient care), all aspects, both human and 
mechanistic, support the goal of quality, cost effective 
care. 
71 
Since the healthcare supply chain system is too 
complicated with too many sections, departments, input, 
output and parameters, it is beyond any study to model 
the entire healthcare supply chain. Therefore, a 
chemistry Lab, which contains many health care supply 
chain activities and has a key position in supply chain, 
is considered in this study to develop a model and 
understand activities happen in the supply chain system. 
Consequently, the Chemistry Laboratory has been chosen as 
an example of other departments in the Hospital, as it 
has all variable components like equipment, manpower, 
supply. The Lab outcome is the test's results, which can 
be considered as a manufacture's product. Finally the Lab 
has the capability of integrated with other section like, 
logistics, clinical and technical departments. 
By reviewing the literature listed above it is obvious 
that there is a lack of research in healthcare supply 
chain in comparison to the research carried out in 
manufacturing supply chain. It becomes worst if we go 
further to the chemistry Lab centered research, which is 
rarely available in the literature. As a result, from 
the reviewed literature it can be concluded that there is 
a strong need to have a model that can help the health 
care providers with a baseline roadmap for effective 
change at all levels of the organization to improve the 
system performance and reduce the cost. It can provide 
also an insight into functions and practices needed for 
supply chain as well as the following benefits: 
" Learn from the experience of others how to best 
organize the health care firm. 
" Achieve significant saving in cost and time start and 
complete heath care process improvement project. 
" Minimize the impact on staff time and resources during 
reengineering project. 
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" Provide better monitoring and assessment. 
" Allows for accurate requirements analysis. 
"A mean of evaluating the impact of process changes 
prior to implementation. 
"A concrete benchmarking example to build better health 
care process. 
" Provide an automated health care business process. 
" Provide a framework for identifying measuring points 
and outcome metrics. 
" Provide a foundation for continues improvement of the 
supply chain process. 
Therefore, since the availability of resources is limited 
this model must also improve resource utilization, 
efficiency of resource utilization and related cost. 
4.5 The Methodology of the Research 
The following are the methodology used in this research 
1- Understand the supply chain management in manufacture 
and adapt it to the healthcare and defined the need 
Healthcare is suffering of the un-efficient mechanism of 
controlling the supplies. The needs to learn from the 
experience of manufacture how to best organize and 
optimize the supplies. By understanding the manufacturing 
process, it can be adapted to be used in the healthcare 
setting. 
2- Literature review 
An extended literature review was conducted covering 
supply chain management in the healthcare and in the 
manufacture, emphasizing to the performance and the best 
way of modeling the system. The aim is to identify any 
related research been Carried out and to examine why 
healthcare supply chain lag behind the manufacture supply 
chain. 
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3- Define supply chain in the healthcare 
The nature of the product in the healthcare is different 
than in the manufacture. It is affecting the human life, 
so assuring the availability in the right time, right 
place, and in the right cost is very essential. So, it is 
very important to identify all the element or players who 
participate of delivering this service to the patient. 
4- Select the Chemistry Lab as an example of healthcare 
supply chain 
Healthcare supply chain system is too complicated with 
many section, department, input, output and different 
parameters; it is beyond any study to model the entire 
healthcare supply chain. Therefore, a Chemistry Lab, 
which contains many healthcare supply chain activities 
and has a key position in supply chain, is considered in 
this study to develop a model to understand activities 
happen in the healthcare supply chain system. The 
Chemistry Lab of King Fisal hospital has been chosen to 
be the case study. 
5- Create performance measures 
A set of performance measures have been identified based 
on the literature review and been selected based on the 
wide rang of capturing the performance activates of all 
supply chain elements. 
6- Define the novel approach of an integrated supply 
chain in healthcare; performance and cost 
The research contributes the available literature in two 
ways. One is the contribution to the modeling and 
analysis of health-care problems within the supply chain 
context by providing a modeling platform. The second is 
to treat the problems encountered in health-care supply 
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chain in an integrated manner by considering both 
relative performance and the cost issues together 
7- Conceptual model 
A conceptual model is developed to describe the general 
functional relationship among all components of the 
healthcare supply chain system. 
The structure for modeling and performance evaluation for 
this type of supply chain through conceptualization is 
done in a hierarchical way, in order to define a detail 
level of the functions (Or activities) in each element. 
8- Select simulation technique 
Healthcare systems are usually too complex to be dealt 
with from an analytical point-of-view, especially when 
processes have characteristics like high variety and low 
quantity need, unexpected events, lack of planning, high 
cost, etc. In such scenarios, simulation comes up as a 
powerful tool for performance analysis and optimization. 
9- Range of scenarios 
In the effort to cover all possible circumstances that 
may effect the functionality of the reference model, 
fifteen different scenarios were designed and clustered 
into three major groups; the Test Demand Fluctuation 
which is affected by patient arrival pattern, Resource 
Reliability which is related to staff and equipment 
availability, and Inventory/ Outsourcing of Supplies, as 
this involves the suppliers as well as hospital logistics 
department. 
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10- Results and analysis 
Finally, analysis of the results found through the 
simulation experimentation is presented, which is based 
on the case study of Chemistry Lab of King Fisal Hospital 
in Saudi Arabia. 
4.6 Supportive Research Tool 
The tool to help building the model will be the 
Simulation. The reason is its ability to deal with very 
complicated models of correspondingly complicated 
systems. The healthcare modeling process is not a 
straightforward work. It takes a lengthy procedure to put 
all the components together and define the parameter 
interactions with each other to formulate what we can 
expect from the Healthcare modeling. So Simulation Model 
would be the best choice to model such complicated 
environment. Further, it is suitable for the dynamic 
model like health care, which frequently changes with the 
time; like number of surgical cases or the needed 
medication to reflect the ongoing activities. It also 
generates very detailed output in comparison to the 
mathematical modeling or other modeling tools such as 
artificial intelligence-based models or algorithmic 
models. 
Another reason for simulation's increasing popularity is 
the obvious improvement in performance /price ratios of 
computer hardware, making it ever more cost effective to 
do what was prohibitively expensive computing just decade 
ago. Finally, advances in simulation software power, 
flexibility, and ease of use have moved the approach from 
the realm of tedious and error-prone low-level 
programming to the arena of quick and valid decision 
making tool. 
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4.6.1 Simulation in the Health Care 
Over the past four decades, simulation has proven to be a 
significant tool in the modeling and analysis of a wide 
variety of health care delivery systems. Over 41 years 
ago, Fetter and Thompson (1965) as well as Robinson, 
Wing, and Davis (1968) applied simulation to patient 
scheduling and other hospital operational problems. These 
simulation modeling efforts have increasingly continued 
to apply in different parts of the healthcare systems and 
a few examples among many more are Jun et al, 1999; 
Weinstein et al, 2003; Issenberg et al, 1999; Wong 2004; 
McLaughlin et al, 2002; Bond and Spillane 2002; Murray et 
al, 2005. 
Several characteristics of simulation make this 
technology uniquely applicable in the health care arena 
and especially for this research. The importance of the 
simulation can be viewed from the following points, which 
provide the basis of selecting simulation as a tool for 
this research: 
1. Computer simulation models conform both to system 
structure and to available system data (Pritsker 
1989). 
Simulation models emphasize the direct 
representation of the structure and logic of a 
system as opposed to abstracting the system into a 
strictly mathematical form. 
The availability of system descriptions and data 
influence the choice of simulation model parameters 
as well as which system objects and which of their 
attributes can be included in the model. 
2. Simulation supports experimentation with systems at 
relatively low cost and at little risk. 
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Alternatives can be assessed without the fear that 
negative consequences will damage day-to-day 
operations, as would be the case if experiments 
were conducted directly on existing, operating 
systems. 
3. Variation matters. 
Variation has to do with the reality that no system 
does the same activity in exactly the same way or 
in the same amount of time always. If every aspect 
of every operation always worked exactly on the 
average, system design and improvement would be 
much easier tasks. 
Variation may be represented by the second central 
moment of a statistical distribution, the variance. 
For example, the times between arrivals to a drop- 
in outpatient clinic near its opening time could be 
exponentially distributed with mean 5 minutes and, 
therefore, variance 25 minutes. Variation may also 
arise from decision rules that change-processing 
procedures based on what a system is currently 
doing or because of the characteristics of the 
patient receiving care. For instance, the 
examination time for a patient needing two sutures 
removed could be 5 minutes and for a patient 
receiving an annual physical could be 30 minutes. 
4. Simulation experiment results conform to unique 
system requirements for information. 
Using simulation, the analyst is free to define and 
compute any performance measure of interest, 
including those unique to a particular system. 
Transient or time varying behaviors can be observed 
by examining individual observations of these 
quantities. Thus, simulation is uniquely able to 
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generate information that leads to a thorough 
understanding of system design and operation. 
5. Simulation is an extremely useful tool for modeling 
uncertainty. 
It is a major characteristic of illness (for 
example), which makes emulation so attractive for 
modeling health care system. It is also easy to 
contain probabilistic (random) components. 
6. Modeling large scale and complex system. 
It is a suitable method for this kind of system. 
Determining in the health care how to allocate and 
schedule all resources can rarely be performed with 
the aid of a simple formula. 
4.6.2 Solution as an Integrated Health Care Supply Chain Model 
An integrated supply chain model is developed in the 
healthcare environment, in particular focusing on the 
Chemistry Laboratory. It focuses on relative performance 
modeling through cost and system performance modeling. It 
is not only giving particular benefit to reduce the cost 
or to improve the quality or to have an overall improved 
system, but a continuous monitoring mechanism is 
developed to measure all of these parameters for 
adjustment as required. Also, it provides a basis to 
know the effect of any change, like manpower or selling 
cost of a material, on the entire system. The developed 
model can be beneficial for other Healthcare services as 
well. 
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4.7 Research Contribution to Health Care Supply Chain 
This research contributes the available literature in two 
ways. One is the contribution to the modeling and 
analysis of health-care problems within the supply chain 
context by providing a modeling platform. The second is 
to treat the problems encountered in health-care supply 
chain in an integrated manner by considering both 
relative performance and the cost issues together as 
described in section 5.5. 
Integrated is referred to the connectivity of all 
elements so the variation in one of the element will 
effect the others instead of studying each element only 
individually. 
In order to explain the complicated relationships between 
the system parameters such as test demands, consumable 
inventories, procurement, suppliers, time and cost, it is 
needed to have a properly built, integrated model, which 
must capture all the detail relationships, dynamics and 
the performance in a more understandable way, to identify 
the problems, and provide correct solutions. For this 
reason, there is a strong need to build a proper supply 
chain model in health-care system. This research seeks to 
fill this gap and answers the research questions posed by 
researchers and practitioners related to the performance 
of the healthcare supply chain system. Therefore, this 
research makes a considerable contribution to healthcare 
supply chain research by providing an integrated and 
detailed model as a basis to do all the needed analysis, 
(See Section 3.5.2 for the baseline discussion). 
Another contribution of this research is in the cost 
calculation method used in healthcare systems. The cost 
calculation is always exaggerated considerably in health- 
care business and most of the time it works against the 
interest of the patients. This research uses an activity- 
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based cost calculation method to calculate the cost in 
health-care, which identifies the cost sources as well as 
level of cost towards forming the overall cost. 
Therefore, it is easy under this scheme to identify where 
all these cost items come from and what their levels are, 
which gives a considerable advantage to the analyst to 
tackle the problem and eliminate or minimize the 
unnecessary factors that contribute the cost. 
This research has consolidated the cost calculation to 
the performance modeling so that it enables to measure 
the system performance along with cost which provides a 
strong basis to the analyst and managers to make better 
decisions in health-care industry considering all the 
relevant parameters. 
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CHAPTER 5 
SIMULATION MODELING OF SUPPLY CHAIN IN HEALTH CARE 
5.1 Introduction 
This chapter presents a detailed description of the 
simulation model created to improve the efficiency of 
health care supply chain, in particular the chemistry Lab. 
Therefore, it is started with the detailed description of 
the chemistry Lab, its inputs, outputs, working mechanics, 
and the modeling with simulation. 
Then the entire simulation model built is presented with a 
step-by-step approach to give the readers an insight into 
how and why the simulation model was created, its 
components, connections and functionalities. Finally, some 
sample output is presented to complete the modeling 
circle. 
5.2 Why Healthcare Simulation Modeling 
As simulation has been proven to be efficient in the 
healthcare setting, which was presented in section (4.6.1) 
in more detail, this section points out the reason of 
selecting simulation modeling for supply chain in 
healthcare? 
Healthcare systems are usually too complex to be dealt 
with from an analytical point-of-view, especially when 
processes have characteristics like high variety and low 
quantity need, unexpected events, lack of planning, high 
cost, etc. In such scenarios, simulation comes up as a 
powerful tool for performance analysis and optimization. 
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The healthcare supply chain in this dissertation is 
following these simulation steps, which can be summarized 
as: 
" Conceptual problem formulation and analysis; 
" Data and information collection; 
" Model building; 
" Verification and validation; 
" Experiment design; 
" Experiment execution and results analysis; 
" Refinement of experiment design; 
" Final results analysis; and 
" Process documentation. 
As we learn from the manufacturing 
simulation has been used at 
applications. Objective varies, but 
simulation is usually related to the 
it most suitable approach for hea 
model: 
system and process, 
several different 
based on past works, 
following which make 
Lthcare supply chain 
" Inventory reduction - setting appropriate levels 
according to the production planning; 
" Performance improvement; 
" Making sure that new processes are tested and approved 
before their actual implementations; 
" Reaching the optimal use of resources (machines, 
production lines, personnel, etc. ); 
" Obtaining better Logistics results within the supply 
chain; 
" Use of a model to foresee the future behavior, that is, 
the effects produced by changes in the system or by new 
operations methods (Pedgen et al, 1990); 
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" Study of capacity usage, inventory levels, control 
logic, integration, sequencing/scheduling, bottlenecks, 
search for better layouts (Lobao & Porto, 1996). 
Most of simulation tools are designed as interactive 
tools to be sued by a human planner not as real time 
decision-making tools, which are directly linked to 
control system to dispatch tasks. Simulation tools aid 
human planner to make a right decision by providing 
information. However, human planner should be able to 
interpret and modify the plan in order to achieve better 
supply chain performances. 
Benefits of supply chain simulation are as follows: 
" It helps to understand the overall supply chain 
processes and characteristics by Graphics/animation. 
" Able to forecast; using probability distribution, user 
can model unexpected events in certain areas and 
understand the impact of these events on the supply 
chain. 
" It could dramatically minimize the risk of changes in 
planning process: By what-if simulation, user can test 
various alternatives before changing plan. 
5.3 Conceptual supply chain model in health care 
A conceptual model is described as the general functional 
relationship among components of a system (Felix, 2003). 
As defined by Ching (2001), the traditional Logistics 
chain is composed by six layers: suppliers' suppliers 
(sources), suppliers, processors (manufacturers), 
distributors (or wholesalers), retailers and consumers. 
The Healthcare SC structure mainly for chemistry Lab 
considered in this research has four elements based on the 
literature recommendations and the author expertness in 
the healthcare supply chain setting. (as reviewed in 
3.5.2): Suppliers, Logistics Department, Chemistry Lab, 
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and Patients. There are two main objectives in the 
development of a conceptual model in this thesis: 1) to 
create a platform for the analysis and study the 
performance of SC network and 2) to create a mechanism to 
calculate the cost of activities happen in a supply chain. 
The goal of the conceptual model is to define all the 
involving elements, their functionalities, their 
interactions with the other system elements and generate a 
platform to create a software-based model, such as 
simulation or mathematical models. 
The expected benefits from these modeling efforts are to 
have a way to reduce lead times, forecasting errors, 
inventory levels and cost and increase in service levels. 
Figure 5.1 illustrates the structure of the proposed 
conceptual model of the SCM-HC of a chemistry lab. It is a 
hierarchical way structure in order to define a detail 
level of the functions (Or activities) in each element. 
This is to aid in having an accurate performance measure 
during the software simulation modeling presented in 
chapter 6. 
There are four hierarchical levels in the structure of the 
conceptual model as shown in figure 5.1, these are: 
Level 1: Represent the main element of the SCM-HC of the 
chemistry lab as defined above. The integration 
of this level is achieved in two ways. First, 
the information flows from patient to the rest 
of the supply chain. The Second is the flow of 
material from the supplier to the rest of the 
supply chain. The mechanism to organize such the 
flow of information and the order of the supply 
is presented in section 5.5.4 and figure 5.1. 
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Level 2: The second hierarchical level represents each 
element of SCM-HC which performs as intermediate 
modeling of each. Each element has its own 
structure (details of it will be in the level 
3). It indicates the workflow among all sub- 
models and the requirements of each. It 
represents more detail than the first hierarchy. 
Level 3: Detailed modeling of specific functions (intra- 
company) is designed at this level. A sub-model 
of each element has been structured. For patient 
arrival there is tests ordered represented as a 
demand and test's result represented as 
receiving detail explanation in section 5.5.4.1 
The second element is the lab which is 
considered is the heart of the model consist of 
two areas, the first is performing the tests 
which have different structure of each test. The 
other area is storage of the components witch it 
has its own structure; this can be seen in 
section 5.5.4.2. Third element is Logistic which 
is responsible of ordering the supplies needed 
to perform the needed tests, also to receive 
them in the arrival component sub-module, the 
third sub-model is the storage of the components 
which considered as the main storage area. 
Section 5.5.4.3 has more detail. The fourth 
element is the suppliers, which has the 
structure of all suppliers in terms of providing 
the needed supplies as requested by the logistic 
of the hospital. The structure and explanation 
of this sub-model can be seen in figure 5.2 and 
section 5.4.4.4. 
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Level 4: This level represents the order and storage 
mechanism of the components for two of the 
supply chain elements, the Lab and the Logistic. 
It provides the information of all supplies 
(components) utilized by the lab. 
In order to understand the proposed conceptual model the 
following paragraphs present a typical walk through 
scenario in a chemistry lab and it interactions with the 
supply chain. It is considered the Lab test results as 
tangible products that are performed (manufacture) in the 
Chemistry Lab. The patient is the consumer who request 
particular Lab test. In order to perform the test, 
supplies have to be available within the reach of lab; 
otherwise, no results could be given to the patient who is 
the primary client. So, the summary of the order flow is 
described below following the conceptual model's 
hierarchical steps. 
Patient arrival, each patient has a demand pattern and 
there are different demand behaviors based on number of 
needed tests. Patient arrives to the Lab are assumed to 
follow an exponentially distributed inter-arrival pattern, 
which is believed to reflect the actual pattern. 
Once the Lab receives the specimen, first the lab will 
make sure the availability of needed components to perform 
the test are all available, and the test is performed in 
its own sequence. The specimen is held at the beginning 
of the test in case of any needed component is missing, 
until the component arrives to the Lab storage. 
Logistics on the other hand, will check if required 
quantity is available in their inventory, it will send the 
needed items immediately to the Lab. Otherwise, the 
Logistics sends whatever available and issue an order of 
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the out of stock component by Procurement section to a 
particular supplier. 
Supplier receives order for a component or item from the 
Hospital Logistics. If the supplier has enough inventories 
of required items it immediately dispatches ordered 
component to the Hospital. If the supplier does not have 
the quantity needed in stock (warehouse), a request of 
required component or item to manufacturers will take 
place. Once the components are ready, then they will be 
delivered to the Hospital. 
Therefore, the proposed conceptual model structure follows 
the principle of pull system. 
SC performance measures are mainly related to meeting 
demand (service levels), both at each stage and at the 
whole supply chain level. 
The inventory control policy adopted, at this time, simply 
follows the following routine: when an inventory level is 
below the safety level, an order for the material to be 
purchased is placed. The optimum order size (quantity) and 
the safety inventory levels are calculated by the 
inventory policy adopted and ordered following the number 
of orders and order times. 
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5.4 Chemistry Laboratory 
The following sub-section present the terminology 
used with the operation of the lab, the 
responsibilities of the staff working at the lab, 
the inventory policy adopted, and supplies 
requisition mechanism. 
5.4.1 Definitions of supply chain terms in the Lab 
Chemistry Laboratory is one of the most dynamic 
environments in health care. To better understand some 
terms used in communication with the other party in the 
Supply Chain the following section of the different used 
in the model: 
1. Special Purchase Request (SPR): The mechanism by which 
items are stored by the warehouse may be obtained. 
2. Signatory Authority Levels: Authorization levels are 
based on the total value of special purchase request 
(SPR). 
3. Non-Stock Items: Items and supplies that do not meet 
the criteria for stock items. Purchase of these items 
shall be through the special purchase request (SPR). 
4. Stock Items: Shall mean products for which a 
continuous need has been demonstrated and is approved for 
inclusion in the Materials Managements stock items 
catalogue set by the Product Evaluation & Standardization 
Committee and kept in the warehouse for immediate issue 
and use. 
5. Supplies: Shall mean items, excluding equipment, which 
are required to perform Laboratory testing, i. e., testing 
reagents and calibrators, controllers and other 
consumables. 
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Appendix A shows all variables been used in the model 
with definitions. 
5.4.2 Responsibilities 
The four elements of supply chain representing the whole 
model (refer to 5.4.4), each element is a part of a 
department and has responsibilities to be distributed 
among the staff as follows: 
1. Laboratory, which the primary function is to, 
performed the assigned test. 
Section Heads and Supervisors (or designees) are 
responsible for maintaining an adequate inventory of 
required supplies to provide uninterrupted testing 
services at all times. 
Laboratory Administration is responsible for rapid 
authorization of SPR's and to assist with the expediting 
process when the section has been unsuccessful. 
Laboratory Supply Staff are responsible for the receipt 
and delivery of all supplies and interaction with the 
Materials Management and Purchasing Departments to 
troubleshoot delivery problems in a timely manner. 
2. Logistics which is the function is to provide the 
needed supply equipment which it is underneath; 
Purchasing, Receiving and Inventory Controller. 
The Purchasing Department is responsible for negotiating, 
awarding, and generating Purchase Order (P0). 
- Buyer, buy the needed supply 
- Material Controller, maintain the inventory 
- General Section, transferring the items section 
separately. 
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5.4.3 Inventory Policies Adopted 
All Laboratory sections (i. e. Section Head and 
Supervisor) are responsible for developing an effective 
inventory system to ensure an adequate quantity of 
supplies is available to provide uninterrupted service at 
all times. The system utilized shall include the 
following elements: 
"A list of all required supplies 
" Minimum and maximum supply levels to be maintained. 
Consideration is to be given to the order processing 
and expected delivery times when defining the minimum 
and maximum levels 
"A requirement for periodic physical inventory to 
ensure accuracy of calculated inventory levels 
"A method for obtaining the necessary stock items 
"A process for initiating SPR's for non-stock items 
"A system to track, monitor and follow-up the status of 
SPR orders and P0's 
Supply inventory should be rotated to prevent any 
unnecessary outdating of supplies. 
The inventory control policy: when an inventory level gets 
lower safety inventory level an order for the material 
(component) purchase (or manufacturing) is placed. The 
optimum order size (quantity) and the safety inventory 
levels are given by the decision-maker. At The Chemistry 
Lab, two types of orders exist: purchase Orders for the 
purchasing of components from Logistics and suppliers, and 
Test Order (production orders), to perform the test 
(different TEST types are considered, and each TEST is 
made of different combination of components). 
Regarding the patient request, each patient has demand 
patterns. The information been gathered for one year, 
according to actual data. 
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A supplier receives orders for a component from the 
Logistics. if it has enough inventories, it immediately 
dispatches the ordered components to them. If the supplier 
does not have the quantity needed in stock (warehouse), it 
will then manufacturer the component and then delivers it 
to the hospital. In this case, the supply chain service 
level and cycle time will be deteriorated. 
If the Chemistry Lab has enough component the test will be 
performed and send to the patient file, so the order will 
be closed. On the contrary, the order remains open until 
the Lab performs the test and sends it to the patient. 
When the Lab does not have enough inventory of the needed 
component to meet the needed demand the Lab will dispatch 
appropriate orders to Logistics, which they will check 
their inventory whether the items available to be send 
directly to the Lab or not, than an order initiated to a 
proper supplier to provide the components. As soon as the 
Chemistry Lab receives all of the needed components from 
the Logistics, a signal is sent to initiate production. 
The test then will be performed and sent to the file. 
Therefore, the proposed simulation structure follows the 
principle of pull production, however. SC performance 
measured are mainly related to meeting demand (service 
levels), how quickly this is done (cycle times), and 
inventory levels, both for at a stage and at the whole 
supply chain. 
5.4.4 Supplies Requisition Mechanisms 
Any supply needed the equipment to be used in the 
Chemistry Laboratory should go through a certain path as 
shown in the Figure 5.2. 
Once the request takes place by the originated section in 
the Laboratory, it will go to Logistics with 
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identification code whether the items needed is a stock 
or non-stock items. 
If it is a stock item, it will be ordered internally 
" Supplies are obtained from the warehouse and delivered 
to the Lab sections by the Laboratory supply staff with a 
copy of the list of items requested/delivered. 
" Section staff must check the items received against 
the list to confirm accuracy of the delivery. 
If it is non-stock items if requires a special purchase 
request (SPR) (external requisition). 
" Determine if the required item is currently in the 
Purchasing database. If not the item must be standardized 
by completing a request for Standardization form. The 
Standardization form must be signed by the Supervisor and 
initialed by the Section Head. 
" Submit the completed Standardization form to 
Laboratory Supply staff for processing. 
" Enter the order in the Oracle system and include 
information, i. e. item code, quantity, required delivery 
dates (if it is to be a standing order), etc. 
" Forward the order for the required approval 
signatures. 
" Periodically check the status of the SPR and expedite 
if necessary using Expedite Form. 
" Prior to signing for receipt of supplies from the 
Receiving Section of Materials Management, the user must 
check the goods received against the attached copy of the 
Purchase Order to verify the accuracy of the order and 
whether the items are received in full or partial 
delivery. Any discrepancy should be reported immediately 
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to the Receiving Section of Materials Management prior to 
signing for receipt. Fig 5.3 gives a general relationship 
between purchasing, receiving, vendors, and the chemistry 
Lab. 
" Any request, revision, adjustment or cancellation, in 
an existing SPR or P0, must be in the form of a speed 
letter or memo. Justification for the change must be 
included. The speed letter or memo must be signed by the 
Supervisor, initialed by the Section Head, and 
transmitted to the Laboratory Administrator (or designee) 
for signature. The completed speed letter, or memo, is 
returned to the originating section for forwarding to the 
applicable department for necessary action. 
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beside the Lab finance and they will pay to the supplier 
(vendors) according to the purchase ordered by Logistics 
97 
and accepting trom the ena-user wnicn in cnis case is cne 
Laboratory. It also indicates the needed information 
between Logistics and Laboratory. 
Present Supply Chain in the Labo tort' (Sippiies) 
Laboratory 
RnixrsaTat 
To Vendor 
Phle orry 
Test Request 
Irtegrahed Giriical 
Ir om-abon Sye, 
Stoffes Request 
"4 ty 
" Desxipbon 
" Needed by (tine) 
" Estimated Price 
" vendors (more than rne) 
Fixiiies 
L. Cgsbcs 
ReceJ Ang 
SuPPies 
Fnarioe ý--ý Logistics R. rdia§ng 
Figure 5.4 
The relationship among all parties concerning equipment and 
supplies 
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5.5 The Simulation of the Healthcare Supply Chain Model 
The following is the detailed description of the 
simulation model built for the health-care. Supply chain, 
which is centered on a chemistry Laboratory. Flow chart 
(Fig. 5.5) gives a description path of the test and 
component, once requested until log out. As suggested in 
section 4.6.1 and 5.2. 
5.5.1 Simulation Modeling Assumptions 
In order to eliminate any possible misunderstanding or 
unrealized expectations, a list of all modeling 
assumptions are provided as follows: 
5.5.1.1 General Assumption 
1- The patient arrival rate is modeled as random 
exponential as it formed the best representing the 
actual pattern of patient around the Lab that is 
working 24 hours a day servicing out/in patients. 
2- The duration of the simulation is 365 days in one- 
year? 
3- The Lab modeled as a pull and push system. in pull 
system, entity by demand generated by downstream 
processes in the Lab case once the patient enter the 
Lab the Phlebotomist take the specimen as requesting a 
certain test, on the other hand, the push system is 
conducted is regard to the component availability. 
4- Expenses data in the model are based on how the 
average for staffing, in order to ensure that the 
yearly salaries remain consistent regardless of the 
simulated time, the cash flow portion of the model 
user date converted into hourly averages instead of 
basing them by case. However, resources like equipment 
are identified by cases, as busy or ideal. 
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5.5.1.2 Patient Arrivals: 
5- Inter arrival times are assumed Exponential with mean 1 
arrival per minute. 
6- Upon arrival of the order, test type decided before the 
patient arrives the reception. 
5.5.1.3 Lab: 
7- Each specimen is treated separately, one after the 
other. 
8- Test type has its own line. Two tests of two types are 
not done in one process, although they may share some 
resources. 
9- Unit of component is a quantity enough for one use 
only. That is one test for reagents, one control process 
or one calibrations process. 
10- First component called reagent, one reagent process is 
performed every test 
11- Second component called control, One control process 
is performed every 10 tests? 
12- Third component called calibrator, One calibration 
process is performed every 20 tests? 
13- it is assumed that a technologist does not wait a 
process if it takes more than 15 minutes long. Instead he 
puts the specimen (a process that takes 5% of the original 
process) and leaves it until it's ready. He then transfers 
it to the next process (a process that takes 5% of the 
original process). 
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14- It is assumed that inventory control in the Lab is a 
process that is run separately from analysis and in 
parallel with it. However, inventory and chemical analysis 
both interact and affect each other directly. 
15- It is assumed that when order 
order is issued until receiving 
response from the supplier. 
5.5.1.4 Logistics 
is issued, no other 
the old order or no 
16- If the Lab orders a certain material that is not 
available in the Logistics, the Logistics sends whatever 
available and issues an order to the supplier. Otherwise, 
an order is issued if it is found that inventory is below 
safety level during a periodic check 
17- The purchasing department decides which component to 
order from which supplier. 
5.5.1.5 Suppliers 
18- There are only 8 suppliers 
19- A supplier is assigned 2 Reagents, 2 Controls, and 2 
Calibrators 
20 -A supplier can provide any quantity of any component 
it is assigned (except in the unreliable supplier's 
scenario) 
21- The internal system of suppliers is not of interest to 
this model. So it is represented by the resulted delay. 
5.5.2 Data Collection 
Data collected over a period of one (1) year by Lab 
Technologist and Administrators interview of the clinical 
information system, these data mainly consisted of 
patient arrival time, specimen process, test results 
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process, component process, from the need to be 
purchased. An interview with the staff manager provided 
the standard staff scheduling time and requirements. Data 
collection and the Lab based on 432523 specimens per year 
and all requirements from staff, suppliers, utilities, 
etc. This information was gathered form the Chemistry 
Laboratory of King Fisal Hospital, as it is the case 
study of the research. 
5.5.3 Arena Simulation Environment 
The simulation language, Arena, was used to model the Lab. 
Arena is a Windows-based platform that is popular and 
widely used to its tremendous flexibility and ease of use. 
Arena has been used to model everything from manufacturing 
work cells to complex interactions in an emergency room. 
Furthermore, Arena's Input and Output Analyzers provide 
excellent tools to fit input probability distributions 
based on actual data and analyze of the clinic provides a 
visual representation of the Lab, and analyze the results 
format. As discussed in 4.6.1. 
One of the major contribution of using Arena is the 
capability of continues calculating the accumulated cost 
for each test as can be seen in the scenario based 
analysis section under the cost of test. 
Arena is a development of the special-purpose simulation 
language SIMAN, which is a powerful, general-purpose 
simulation language written for modeling discrete, 
continuous or combined systems. The Arena simulation 
package is an extension of SIMAN in that it supports 
hierarchical modeling. Thus, Arena combines the ease of 
use found in high-level simulators with the flexibility of 
special-purpose simulation languages. Arena is also 
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compatible with general-purpose procedural languages like 
Microsoft Visual Basic, FORTRAN and C. 
Arena provides a wide range of modules that can be 
combined into a flowchart to build a variety of simulation 
models. Arena is arranged in the familiar Microsoft 
Windows format, with drop down menus, toolbars and icons. 
The system under study can be considered as containing 
physical elements such as machines, workers, transporters, 
storage and part flow. Each of these physical elements can 
be represented by a module icon, which can be selected, 
dragged and dropped onto the model window. When linked, 
these modules form the system model. In some cases the 
system will have logic flow, which is connected in a 
similar manner. Models are combined with an experimental 
component that specifies the experimental conditions such 
as initial conditions, length of run, and type of 
statistics to be gathered and part routes (Kelton et al, 
2004). 
As the simulation runs, Arena keeps track of the response 
of the system. Arena provides a reporting system that 
compiles simple output summary report and is capable of 
producing high-level table and graphs of user defined 
system data. Statistics can also be automatically reported 
in other file formats, including HTML, Word and Excel. 
5.5.4 Structure of Simulation Model 
For the modeling of the proposed structure in the 
simulation software ARENA, a set of global variables needs 
to be defined as exemplified at Appendix A. 
The ARENA tool has been used to simulate the SCM-HC of the 
chemistry lab covering its main elements namely suppliers, 
Logistics, chemistry lab, patients arrival 
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This model covers four elements of the health-care chain 
system, namely suppliers, hospital Logistics department, 
chemistry department, patients. 
The following is the step-by-step hierarchy of the supply 
chain-working mechanic, which is reflected in the 
simulation model built. The explanation will be provided 
for individual component of the model along with its 
functionality as well as its integration with the other 
elements of the simulation model. Figure S. S. 
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Order issued from 
hospital REFER TO 5.5.4.1 
department 
Sample (blood, 
urine) amval to 
lab 
A Code assigned 
to the order 
request material 
supply availability 
YES 
Prepare the 
sample and 
needed supplies 
Perform the test 
Verified by 
L pathologist 
- REFER TO 5.5.4.1 
REFER TO 5.5.4.2 REFER TO 5.5.4.3 
Figure 5.5; Flow chart representing the path 
of test and needed components. 
-NO 
Logistics NO 
supplies availabili 
YES Fund available NO 
Send to lab Return to 
requestor 
YES 
Purchase from 
supplier 
REFER TO 5.5.4.4 
, 
Supplier 
NO Manufacture to 
pplies availabili prepare supplies 
YES 
Send to patient file Send to logistics 
105 
To illustrate how the model works the following: Section 
including the figures, which been taken directly from the 
simulation program, it shows how its hierarchical from the 
simulation program, it shows how its hierarchical levels 
were implemented, through the use of sub-models, as well 
as the interlink and specific and managerial functions of 
Suppliers, Lab, Logistics and patient Figure 5.6 presents 
its model for the first hierarchical level. 
Figure 5.6 First hierarchical level of the Model 
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it shows all four blocks connected by lines with arrows, 
the right to left arrows, indicates order signals and left 
to right arrows components or test results delivery. On 
the entry points are represented by little squares on the 
left side of the rectangles, while, exit points are 
triangles on its right side for the sub-model rectangle. 
In the case of Lab, sub-model two pairs of entry-exit 
points exist, the upper pair regards orders from the 
patient and result of the requested test related to 
patient block while the bottom pair representing orders to 
Logistics for components then to be received to the Lab 
once available, as well as its order from Logistics to its 
supplier and getting the components from all supplier to 
the Hospital Logistics. 
The following is the detail structure of healthcare supply 
chain model's element: 
5.5.4.1 First element: Patient Arrival, Tests Request 
The input of the module is the results of the tests; they 
are stores in the Hold block, "Keep in Record" to avoid 
losing cost data while, disposing entities, to be stored 
in the electronic patient record, called; Hospital 
Information System, Physician can have access to it at any 
time also, to compare it with the previous tests. 
The output of this module is the start of the whole model; 
it represents arrival of the patient to the Lab which 
inter-arrival exponentially distributed with mean 1 
arrival per minute. 
Each patient is assigned a test types as requested by his 
physician, at the Reception, Phlebotomists take the blood 
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and send it to the specific Lab section. The entity is 
assigned a new type; a specific test name. The 
distributions of tests based on the actual data have been 
gathered for one year. 
Lab is capable of doing different tests, to meet the 
different departments' demands. More than 100 different 
types of tests are done in the Lab but 16 different types 
of tests are considered in this study. 
The requests (orders) come to the Lab randomly following 
an exponential distribution with an average of 1 minute. 
The tests are varies in term of arrival, it follows a 
certain percentage from the total number of test which is 
432523 according to the Table 5.1. It is also represent 
the total number of each kind of test. 
When a tests request arrives to the Lab, the request is 
assigned a unique order number or code until it is 
processed, reported and delivered to the requesting 
department, then the case is closed and archived. 
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Table 5.1 Represent all Tests with the percentage of arrival 
And the number of tests 
S/N TEST 
PERCENTAGE 
OF EACH TEST 
NUMBER OF 
TESTS 
1 Core C. Glucose 29.5 127594 
2 Core C. Ketone 1.4 6055 
3 Core C. Osmo 4.3 18598 
4 
Core C. Urine 
Protein 
13.47 
58260 
5 RIA 1.25 Vitamin D 2.28 9861 
6 RIA BHCG 0.3 1297 
7 RIA Folate 3 12975 
8 RIA Homocytine 0.6 2595 
9 Special c. AAT 1 4325 
10 Special c. G6PD 0.4 1730 
11 Special c. HBAIC 21.5 92992 
12 Special c. VMA 0.25 1081 
13 TDM CARE 5 21626 
14 TDM FK506 16 69203 
15 TDM MTX 0.3 1297 
16 TDM Opiates 0.7 3027 
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5.5.4.2 Second Element: The Chemistry Lab 
Consist of two parts: (1) performing tests (2) storage of 
components 
1) Performing Test 
The input consists of two; one from reception, which is a 
specimen, comes from the patient module and the needed 
components from the Logistics Department. On the other 
hand, the output is the results of Lab test which to be 
kept in the patient records, also another output to 
Logistics as components orders. 
The specimen arrives from reception then distributed to 
their test lines. When a specimen enters the particular 
test line, then this is giving the path of all tests, 
also, the storage control in the Lab; it is representing 
the second hierarchical level of its supply chain 
structure. The system in the beginning makes sure the 
needed component to perform the tests is available, then 
that test to be performed in its own sequence. 
The specimens are held at the beginning of the test if any 
of the needed components is not available, till it arrives 
to the Lab storage. if all components are available one 
unit of reagent (Re) is removed from the Lab storage, and 
a counter is increased by one. It is known by a default 
to do control (Co) every 10 tests, and a calibration (Ca) 
every 20 tests. 
After the test is done the results are reviewed and 
verified to be sent to its patients records. Some results 
need a Pathologist or senior to review them to make sure 
of correct results, and analyze the result comparing with 
the patient file and offer advice; they are indicated in 
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the model by a certain percentages taken from the Hospital 
history. The 3rd hierarchical level (Figure 5.1) will be 
presented below showing all kind of tests has been 
performed. 
The Chemistry Lab is a major Section in the Department of 
Pathology Laboratory Medicine. Its value is the 
measurement and analysis of blood and urine Chemistry. All 
tests description with Arena Graph can be seen in Appendix 
B. 
a) Core Chemistry Section: It is measuring General 
Chemistry assays, Renal Profile, Hepatic Profile, Lipid 
Profile, Cardiac Profile, Osmolalities, and Urine 
Chemistry. 
1- Glucose Assays 1/20: Checking for glucose level for 
diabetic and non-diabetic patient. 
2- Ketonel/l: It is one of the glucose derivatives 
used for diabetic patient and newborn babies. 
3- Osmo 1/1: It is used as an indicator for 
hypertension and measuring osmolality after 
dialysis. 
4-Urine Protein 1/7: It is used as an indicator for 
kidney function. 
b) Radio Immunoassay Section (RIA) : It is testing 
Hormones, Tumour Markers, Radio-isotopic assays, Cardiac 
markers and Anemia markers. 
1- BHCG1/14: Tumour marker and to determine pregnancy. 
2- Folate 1/1 (Red Cell): Anemia marker. 
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3- 1.25 vitamin D 1/.: bone development marker. 
4- Homocystine 1/1: Cardiac risk marker. 
c) Special Chemistry Section: It is measuring Special 
Proteins, HbA1C, Caffeine, Sweat chlorides, and Extensive 
menu of miscellaneous manual assays. 
1- Alpha-l-antitrypsin: This assay is useful for work- 
up of individuals with suspected disorders such as 
familial chronic lung disease. 
2- HBAIC: Useful in evaluating the long-term control 
of blood glucose concentrations in diabetic patients. 
3- VMA (Vanillylmandelic Acid): Useful for screening 
fro vascular tumour. 
4- G6PD: G6PD deficiency is the most inborn error or 
metabolism, effecting over 100 million people with 
varying degrees of hemolytic disease. 
d) TDM Section: It is measuring Therapeutic Drug and 
Monitoring Drugs of Abuse. 
1- Carbamazepine (Carb): 1/11: Anti-convulsant marker 
2- FK506 1/1: Immuno- suppression for liver and kidney 
transplant. 
3- Methotrexate (MTX) %: Inhibit the development of 
neoplasms cells, which is related to cancer. 
4- Opiates 1/7: Drugs of abuse for psychiatric 
patients. 
2) Storage Control in the Lab 
The Chemistry Lab stores small quantities of the 16 
Reagents, 16 Control and 14 Calibrators. It is made to 
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make the needed components instantaneously ready to use 
for the tests. The system in a periodically manner, check 
the level of inventory for each component, and issue an 
order to the Logistics of the needed components (that is 
to set the entity type, order size, and component type and 
set X ordered to 1), when the new shipments arrive, the 
Lab storage system store these components in Lab storage 
(that is to add the order size to x Lab storage and set x 
ordered to 0. 
5.5.4.3 Third Element: The Logistics 
The inputs of the Logistics modules are two: the first 
one, the orders from Lab storage system, the second are 
the component arriving from the suppliers. 
There are two major inputs for the Logistics module, 
these are, x, and y. 
The works in Logistics is consisting of two parts: 
1. Order Processing 
Once the order arrives from the Lab the system checks if 
required quantity is available in Logistics inventory, it 
is available, it will immediately send to the Lab. 
Otherwise, the Logistics send whatever available and 
issue an order of stock component (that is set entity 
type to component code, set order size and set Log 
ordered x variable to 1), to Purchasing Department to 
purchase the needed component. It is consist of two sub- 
models: 
I- Component Availability 
A) Reagent, Controller, and Calibrator control in 
Logistics 
Identifying all reagents, differentiate which available 
to be sent to the Lab, out of stock reagent will make 
sure ordering to purchasing. If there is a quantity 
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which less than the order for the Lab, it will be send to 
the Lab in the same time make a request to Purchasing 
Department. 
B) Periodic Check 
Logistics periodically check the inventory level of each 
component, and issues an order of Purchasing if the level 
is below safety level the order issued in the Logistics 
storage is assigned a type and send to the Purchasing 
Department. 
II- Purchasing Department 
Every request enters this department take the following 
processes: 
If the component needed is standard (it have been order 
before which is approved to be used in the Hospital), it 
will go to renewal block. Otherwise, it is standardized 
and then sends to removal. From renewal it goes to 
generate an SPR, which stand for Special Purchase Request 
then to approve staff according to the approval 
authority, then to be check if there is enough fund for 
this order. If there is no fund, the request will be 
sent back to the SPR generator, but if the fund is 
available it will be decided from which supplier to order 
the component from, then finally, the order go to 
Procurement which will issues the purchase order and send 
it to corresponding supplier. 
2. Component arrival and storing 
When the Logistics receive a shipment from the supplier 
it will directly stored according to the type of the 
item, Reagent, Control, and Calibrations in log storage. 
The cost of the storage item is displayed, and the 
inventories of all components are displayed also. 
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5.5.4.4 Fourth Element: The Suppliers 
This module has eight suppliers, which supply 46 
different types of components to the Chemistry Lab 
through the Logistics Department. 
When orders reach the suppliers block, it is decided to 
which supplier should be sent to, according to the user 
(Hospital) defined entity attribute call "My Supplier". 
As there is no manufacture in Saudi Arabia for this 
component the supplier imports the items once is not 
available. Manufacturing time plus transporting the items 
to the supplier then to the requestors, which is the 
Hospital, take a long time, so it will delay the whole 
process 
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CHAPTER 6 
ANALYSIS OF HEALTHCARE SUPPLY CHAIN 
6.1 Introduction 
The aim of this chapter is to analyze the results found 
through the simulation experimentation, which is based on 
the case study of Chemistry Lab of King Fisal Hospital in 
Saudi Arabia, concentrating on 16 different kinds of 
tests (Table 5.1) as explained in section 5.5.4.1. The 
experimentation was carried out through a number of 
designated scenarios, each targeting a specific problem 
within the healthcare supply chain, like shortage of 
supplies, unexpected breakdown of equipments, and 
instability of patient arrival rate. The scenarios are 
run for a one-year period to observe all the variations 
as well as developments within the system so that any 
potential problem related to run-time especially for 
short period runs would be eliminated. 
The analysis is based on two sets of performance 
criteria. The first set of criteria, called Primary 
Performance Criteria (As defined in section 4.2 which is 
the aim of this research), consists of lead-time, 
throughput, WIP, inventory status, material flow time, 
and cost of test. The cost analysis of each test and for 
each scenario covers all resources participated in 
performing the tests. The second set of criteria, which 
is called Secondary Performance Criteria, consists of 
equipment utilization, staff utilization, queue size, and 
material order size. 
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The healthcare simulation model will be utilized in two 
ways. The first, as a reference model which is assumed to 
have an ideal environment, and the second, to be exposed 
to different set of scenarios to extract the result and 
compare them with reference model's results to analyze 
the output and come up with suitable recommendations to 
enhance the efficiency of healthcare supply chain. 
6.2 Reference Model 
Based on the conceptual model (section 5.3) a simulation 
model for the supply chain in the healthcare 
concentrating on the chemistry lab been created as a 
reference model which is the first stage of simulation 
based on ideal criteria's. All elements of healthcare 
supply chain are covered, starting from patient arrivals, 
Chemistry Lab, Logistic, and the suppliers, as stipulated 
in Figure 5.1. This is the so-called standard model, 
which assumes all the components of the healthcare supply 
chain system behave perfectly in Chemistry lab. It is 
assumed that there is no problem experienced in material 
or information flow. 
This model is somewhat of an idealistic model and no 
short-term variations occur. For example, when an order 
is received by the Lab, it was assumed that all the 
requested materials, consumables equipment and staff are 
available. There may be a moderate level of queue at 
times that demand is high, in case of any missing 
material or shortage of consumables. 
Then inventory department keep enough stock so that the 
required material or consumable was supplied in a 
reasonable timeframe to perform the task. It is assumed 
that there was no equipment breakdown, staff or inventory 
shortages, so that all the functions were performed 
normally within a reasonable period. 
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The performance of this base model is measured using 
primary and secondary performance metrics and is used as 
a reference to compare all the scenarios based model's 
output to measure the effects of different variations on 
the supply chain behavior. 
6.3 Scenarios of the supply chain 
The scenarios that have been simulated are designed to 
capture the dynamics of supply chain activities centered 
on a Chemical Lab within a large local hospital. In the 
effort to cover all possible circumstances that may 
affect the functionality of the reference model, fifteen 
different scenarios were designed and clustered into 
three major groups which are representing the most 
important factors affecting the efficiency of the supply 
chain, according to the literature recommendation and the 
healthcare supply chain experience of the author. Each 
group has different scenarios to cover all possible 
future problems and demand and to see how the Chemistry 
Lab will react accordingly. The first group is the Test 
Demand Fluctuation which is affected by patient arrival 
pattern, Resource Reliability is the second which is 
related to staff and equipment availability, and the 
third is the Inventory/Outsourcing of Supplies, as this 
involves the suppliers as well as hospital logistics 
department. 
The clustered scenarios listed as below: 
Group A: Test Demand Fluctuation 
" Low customers 
High customers 
  High demand 
  Some tests are lower 
  Some tests are higher 
  Longer lead time 
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  Special line for emergency cases 
Group B: Resource Reliability 
  Unreliable equipment 
  Unreliable supplier 
" Shortage of staff 
  Repair is longer 
Group C: Inventory/Outsourcing of Supplies 
  Continuous review 
  Imax policy 
  Batches policy in purchasing 
  No funding 
6.4 The Framework for the Analysis 
The analysis of the simulation data has two dimensions. 
The first dimension is scenario-based and the findings 
from the scenarios are compared with the Reference Model 
findings and are presented in the following section. The 
second dimension is the comparisons of scenarios findings 
with alternative scenarios based on primary and secondary 
performance criteria. The aim of these comparisons is to 
analyze the output generated by different scenarios and 
come up with suitable recommendations to enhance the 
efficiency of healthcare supply chain. As stated in 
Section 6.1 it will help identifying the weakness and 
bottleneck in each element of supply chain, which would 
negatively affect the overall system performance, 
measured through primary and secondary performance 
metrics. The results are extracted from each of the 
simulation runs and presented in a table format for each 
performance measure. An analysis has been conducted for 
all fifteen scenarios but three scenario's results are 
demonstrated in this chapter as they are most 
representing each group, while the remaining twelve 
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scenario's results and analysis can be found in Appendix 
C. 
6.5 Performance Measures of the Reference Model 
The performance measures of the reference model as well 
the scenario based models are done through primary and 
secondary performance metrics. The analysis of reference 
model and scenario-based models will provide a real basis 
for the decision making needed in supply chain system. 
Further, it will give all the indications whether the 
supply chain is efficient or not. It also indicates the 
potential problem areas and possible solutions. The 
following sub-section present the simulations of the 
performance measuring metrics based on the Reference 
Model. The simulation's results are presented in tables 
that are going to be used to compare them to the results 
of the 15 scenarios presented in this chapter and in 
Appendix C. 
6.5.1 Primary Performance Measures for the Reference 
Model 
As stated previously the primary performance metrics are 
lead-time, material flow time, throughput, inventory 
status, WIP, and cost of test. The data in the following 
tables for the reference and the scenarios model are the 
result of the simulation model, extracted from Arena 
software and stipulated in a table format for easy 
analysis and comparison, the following analysis is based 
on the above performance metrics. Each of the following 
sub-sections will present first an explanation of the 
data in the table, secondly; shows how significant the 
data to the healthcare supply chain and the third will be 
the relationship with other performance metrics to come 
up with a unique conclusion, an example of Glucose test 
will be presented in each performance metric. 
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6.5.1.1 Lead Time for the Reference Model 
The lead time is the time measured once the test order 
take place until is delivered to the customer, which in 
this case; once the Chemistry Lab receive the test order 
through performing the test until posting the result in 
the hospital information system. The model assigns a 
unique identity and a start time for each order, which is 
the start time for lead-time measure as illustrated in 
Table 6.1. The unit of measure is hour. 
The Table 6.1 is consisting of three columns, the first 
which indicate all the tests. The second is the minimum 
value for each particular test, the third is indicating 
the average value for each one, and the last column shows 
the maximum value. The average lead-time values in the 
third column are the base number for the comparison. The 
minimum number of the average lead time is 41.8 hours and 
the maximum value is 109 hours. It can be easily realized 
that the variation from mean value is between 41.8 hours 
and 109 hours. This indicates that the lead-time follows 
a narrow/wider bond. This can be explained with the 16 
different types of the tests. Although these 16 tests 
mostly sharing some of the same resources using different 
consumables and materials each takes a different time to 
accomplish according to the length of performing the test 
and availability supplies and other resources. 
The longest time taken to do a required test is for Test 
# 16 (TDM Opiates). It is understood that because the 
test is performed manually without using the analyzer, 
the results take a longer time to complete. The 
information gathered from Table 6.1 will be used as basis 
to compare with other scenario. 
The lead time providing a very useful information to 
analyze the healthcare supply chain system, it is a first 
step to know the existent of the problem in the supply 
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chain or not, if there is a problem as along lead time 
the other performance metric like throughput, material 
flow time, or staff and equipment utilization can narrow 
the reason and identify the bottlenecks. 
The Chemistry Lab is performing 432523 tests per year for 
the 16 test. Glucose as an example is the highest 
percentage with 127594 tests per year (according to Table 
5.1). In average the test takes 102 hours to produce the 
result and to be appeared in the patient's file, it needs 
component to start with as in Table 6.2,3,4 in section 
6.5.1.4. The time to perform the test is only one hour, 
this is the result of subtract the lead time in Table 6.1 
and the queue size in Table 6.12 which indicate the 
waiting time for each test. This information lead to an 
average of waiting time 101 hour for the Glucose test, 
the reason for that can be unavailability of resources 
like equipment and staff or mishandling the supplies, 
resulting unavailability of needed components. By 
reviewing the sections 6.5.2.1 and 6.5.2.2 which are 
equipment and staff utilization, it appears the low 
utilization in both resources 12.33 % for staff and 2.3 
for equipment. The resources as above are adequate to 
handle the entire load without delay, so the only reason 
of the long waiting time is the mishandling the supplies, 
on the other hand according to the section 6.5.1.3 the 
throughput for the Glucose tests is 29.1 test per hour 
this can be also examine with the different scenarios in 
section 6.6. 
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Table 6.1 
LEAD TIME FOR EACH TEST (hour) 
TEST MIN AVR MAX 
GLUCOSE 0.4 102 733 
KETONE 0.24 57.5 248 
OSMO 0.29 61 249 
URINE 0.41 100 725 
VITAMIN D 2.4 85.5 383 
BHCG 0.47 74 369.5 
FOLATE 1.5 73.7 380.3 
HOMOCYSTINE 1.13 73 355 
AAT 0.39 61.6 258 
G6PD 0.42 64 268 
HBAIC 0.52 73 399.8 
VMA 0.64 61.5 266.4 
CARB 0.48 69 280 
FK506 0.46 41.8 175.2 
MTX 0.37 69.9 219.3 
OPIATES 0.23 109 
, 
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6.5.1.2 Material Flow Time for the Reference Model 
The Material flow time (MFT) is the time elapse in hour 
unit between the points at which material enters the 
supply chain to the point it utilized. For this model MFT 
is counting the time for the component once received by 
the Chemistry Lab from Logistic until utilized by 
performing the test. The Arena software is providing this 
data as an indication of the relationship between the 
Logistic and the Lab concerning the availability of the 
supplies and how fast can the Logistic provide it to the 
Lab. It is important information to understand the two 
elements of the healthcare supply chain. 
The Tables 6.2,6.3, and 6.4 below consist of all 
materials (components) needed to perform the 16 tests. 
They are categories as: Reagents, Controllers, and 
Calibrators, as explained in section (5.5.1.3). Each 
table has three columns, the first shows all the tests 
while the second indicates the material flow time, the 
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third is providing the total inventory in the lab and 
logistic of each concern item. The two tests VMA and 
FK506 do not have calibrators because they are manually 
preformed. 
The faster material flow time the good indication of 
delivering the needed items on time. This indicator 
provides how the relationship between the chemistry lab 
and the logistic, in particular forward the material's 
requests and backward the needed components. As an 
example; The MFT of Glucose is 62 for reagent and 
calibrator, while MFT for the controller is 11 hours, 
these values are proportional with availability of the 
supplies and will be compared with the fifteen scenarios 
to monitor the relationship between the logistic and Lab 
in scenario based analyses section. 
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Table 6.2 `l', -tbl&: i, .i 
REAGENT TABLE Calibrator. Table 
TEST 
MFT 
(Hour) INV. 
GLUCOSE 62 5518 
KETONE 104 772 
OSMO 43 8045 
URINE 62 1688 
VITAMIN D 57 2817 
BHCG 68 1081 
FOLATE 55 54196 
OMOCYSTINE 81 804 
T 29 14193 
6PD 26 31410 
BAIC 126 1074 
VMA 60 1963 
CARB 83 81096 
FK506 32 36331 
TX 54 12447 
OPIATES 13 353 
TEST 
MFT 
(Hour) INV. 
GLUCOSE 62 2101 
KETONE 58 286 
SMO 11 3028 
URINE 14 613 
VITAMIN D 14 1012 
BHCG 56 377 
FOLATE 55 
2009 
1 
OMOCYSTINE 10 254 
T 68 4763 
6PD 239 
1633 
1 
BAIC 1 234 
MA N/A N/A 
CARB 12 
2546 
9 
FK506 N/A N/A 
TX 16 4498 
OPIATES 2 655 
Table 6.4 
CONTROLLER TABLE 
TEST 
MFT 
(Hour) INV. 
GLUCOSE 11 2203 
KETONE 542 2433 
SMO 53 2559 
URINE 13 571 
VITAMIN D 12 941 
BHCG 11 382 
FOLATE 11 20107 
OMOCYSTINE 13 238 
T 10 4637 
6PD 306 17221 
BAIC 197 316 
MA 13 392 
CARB 12 21692 
FK506 12 14687 
TX 11 4089 
PIATES 8 805 
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6.5.1.3 Throughput for the Reference Model 
Throughput is the rate (test per hour) at which the 
result of the lab tests is filed in the patient's chart. 
So it is number of total tests been performed divided by 
material flow time. The result is presented in Table 6.5. 
As increasing of the throughput as an indication of high 
efficacy the chemistry lab is. The comparison will be 
between the same kinds of test with different scenario. 
Table 6.5 
THROUGHPUT OF EACH TEST (rate of test/hour) 
TEST THROUGHPUT 
GLUCOSE 29.118036 
KETONE 1.3828767 
OSMO 4.1858447 
URINE 5.3260273 
VITAMIN D 2.2187214 
BHCG 0.2979452 
FOLATE 2.9504566 
HOMOCYSTINE 0.5760273 
AAT 0.9703196 
G6PD 0.4077625 
HBAIC 21.281735 
VMA 0.2605022 
CARE 4.9803652 
FK506 1.6050228 
MTX 0.0821917 
OPIATES 0.7038812 
Table 6.5 shows all the throughput of the tests according 
to the available starting inventory. It appears that 
glucose is the highest among all tests at 29 hours, while 
MTX is 0.08, indicating a low demand. 
On the other hand, the throughput of all components as 
illustrated in Table 6.2,3,4 indicates a big variation, 
which needs to be studied with the scenarios. 
As the lead time in section 6.5.1.1 provides information 
about the whole element of supply chain, and MFT gives 
the relationship between the Chemistry Lab and Logistic, 
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the throughput is examining the efficiency of the 
Chemistry Lab 
6.5.1.4 Inventory Status for the Reference Model 
The cost of inventory is most of the times is hidden 
because the finance in the hospital are considering the 
value of the supply without taking into account the cost 
of inventory including staff and storage facility. 
Table 6.6 represents the level of inventory in the 
Laboratory and in Logistics, as the quantity of 
components should be enough for all tests the Lab 
performed. The quantity of materials ordered is depended 
on the Chemistry lab forecast. The organization has to 
take the necessary steps to reduce the level of inventory 
to an optimum level to sustain as well as not to 
interrupt its activities. Further, the Hospital must be 
careful not to lose control of inventory, which could 
cause costs spiral out of control. This is why it is 
important to monitor the level of inventory for all the 
supplies not only to replenish the items once it's below 
the safety level but also to watch the expiry and damaged 
items. The available components for Glucose tests as an 
example (Table 6.6) are stored in two areas; in the 
Chemistry Lab and in the Logistic. The values for the 
components are to start with, the quantity in Logistic is 
more as the space in the lab can not accommodate high 
level of quantity. The table is also indicate unbalanced 
of quantities of components with the number of tests as 
can be seen in Carb's test, which contains 62020 of 
reagent while the test is less than Gulocose which has 
4036 of the reagent. This indicates lack of proper 
forecasting. 
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Table 6.6 
LAB STORAGE TABLE 
(number of components) 
REAGENT CALIBRATOR CONTROLLER 
TEST VALUE 
LABRE1 1482 
LABRE2 195 
LABRE3 1918 
LABRE4 394 
LABRE5 640 
LABRE6 248 
LABRE? 13663 
LABRE8 284 
LABRE9 3258 
LABRE10 10988 
LABREII 242 
LABRE12 442 
LABRE13 19076 
LABRE14 9125 
LABRE15 2893 
LABRE16 55 
TEST VALUE 
LABCAI 91 
LABCA2 12 
LABCA3 120 
LABCA4 23 
LABCA5 37 
LABCA6 15 
LABCA7 766 
LABCAB 10 
LABCA9 183 
LABCA10 671 
LABCA11 184 
LABCA12 N/A 
LABCA13 989 
LABCA14 N/A 
LABCA15 167 
LABCA16 38 
TEST VALUE 
LABCO1 142 
LABC02 142 
LABC03 183 
LABC04 39 
LABC05 64 
LABC06 24 
LABC07 1448 
LABCOB 15 
LABC09 335 
LABCO10 28 
LABCO11 3 
LABC012 34 
LABC013 1680 
LABC014 875 
LABC015 267 
LABC016 39 
LOG STORAGE TABLE 
(number of components) 
_ 
REAGENT CALIBRATOR CONTROLLER I 
TEST VALUE 
LOGRE1 4036 
LOGRE2 577 
LOGRE3 6127 
LOGRE4 1294 
LOGRE5 2177 
LOGRE6 833 
LOGRE7 40534 
LOGRE8 520 
LOGRE9 10935 
LOGRE10 20422 
LOGREIZ 832 
LOGRE12 1521 
LOGRE13 62020 
LOGRE14 27206 
LOGRE15 9608 
ILOGRE16 
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TEST VALUE 
LOGCAI 
LOGCA2 
2010 
274 
LOGCA3 2908 
LOGCA4 590 
LOGCAS 975 
LOGCA6 362 
LOGCA7 19325 
LOGCAS 244 
LOGCA9 4580 
LOGCA10 15660 
LOGCAII 50 
LOGCA12 N/A 
LOGCA13 24480 
LOGCA14 N/A 
LOGCA15 4331 
LOGCA16 617 
TEST VALUE 
LOGCO1 2061 
LOGCO2 2291 
LOGCO3 2376 
LOGCO4 532 
LOGCO5 877 
LOGCO6 358 
LOGCO7 18659 
LOGCOB 223 
LOGCO9 4302 
LOGCO10 17193 
LOGCO11 313 
LOGCO12 358 
LOGCO13 20012 
LOGCO14 13812 
LOGCO15 3822 
LOGCO16 766 
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6.5.1.5 Work In Process (WIP) for the Reference Model 
All Chemistry Lab tests that have been ordered but not 
completed yet will be presented in Table 6.7. WIP is 
defined in the manufacture setting as inventory after the 
first step in manufacturing and before the last (Conway 
et al, 1987), WIP should stay small because the 
components used to perform the test are utilized without 
any outcome of reported result, so the components can be 
considered as a waste. Other reason can be the high in- 
process inventories increase cycle times and decrease 
responsiveness to patients. The table shows WIP for each 
test. It indicates the variation in WIP level from 3398 
of FKS06 to the minimum of 8 for VMA. There are several 
different reasons why the WIP level is so high and 
varies. One of them is availability of component, but 
insufficient staff. There will be an analysis for each of 
WIP levels in the scenario section. 
Table 6.7 
WIP (number of unfinished tests) 
TEST WIP 
GLUCOSE 1487 
KETONE 39 
OSMO 127 
URINE 2208 
VITAMIN D 94 
BHCG 11 
FOLATE 108 
HOMOCYSTINE 21 
AAT 29 
G6PD 13 
HBAIC 776 
VMA 8 
CARB 161 
FK506 3398 
MTX 499 
, OPIATES 38 
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6.5.1.6 Cost of Test for the Reference Model 
According to the Lab process and the utilization of 
resources, the accumulated costs are represented in the 
Table 6.8. The table is consist of four column, the first is 
the list of all tests, the second the value of average cost 
of each test which will be used as the base number for the 
comparison with other scenarios in section 6.6 scenario 
based analyses, the third column is the minimum value, the 
last is the maximum value. The cost of each test in the 
table is representing the resources wither staff or 
equipment participating by certain time in performing the 
needed test. As example the cost of Glucose test is 1.9 
Pound. It is accumulated of the time of Medical technology 
core chemistry staff and Roche Hitachi P modular auto 
analyzer equipment and the cost of the supplies (reagent, 
controller, and calibrator) and the cost of handling the 
supplies wither in purchasing or storage facility. The Table 
6.8 indicates the highest cost in Vitamin D with the value 
of 6.7, while the lowest is MTX with a value of 1.4. The 
scenarios presented in the next section will present the 
causes the organization faces for this level of cost for 
each of the item used in the Lab. Whereas, changing level of 
demand, at the same time would be the determining factor for 
the variation of the cost. 
Table 6.8 
COST OF EACH TEST (in sterling Pound) 
TEST AVE MIN MAX 
GLUCOSE 
KETONE 
1.909 
1.7877 
1.3069 
1.2774 
2.9198 
2.6887 
OSMO 2.0059 1.4676 2.9917 
URINE 2.0554 1.5012 3.0116 
VITAMIN D 6.7123 5.028 1442.09 
BHCG 2.5506 1.9726 3.409 
FOLATE 6.0894 4.8963 7.6853 
HOMOCYSTINE 4.2361 3.487 5.3294 
AAT 2.146 1.5995 3.0629 
G6PD 1.9706 1.4252 2.9165 
HBAIC 4.1247 3.0526 11.6439 
VMA 3.2474 2.4026 4.1936 
CARB 1.6824 1.1864 2.6089 
FK506 1.8503 1.3458 2.7603 
MTX 1.4458 0.9949 2.1895 
OPIATES 2.5481 2.1464 3.3417 
6.5.2 Secondary Performance Measures for the Reference Model 
Under the secondary performance metrics, there are 
criteria to look at the different aspects of the Lab 
performance within the supply chain to understand the 
dynamics of the behavior further. These criteria will 
help us to understand the individual parameters' effects 
on the system performance and possible interactions 
between the parameters as well, which will eventually 
help to evaluate overall performance. The following is 
the detailed analysis of the healthcare supply chain 
centered again on the chemistry Lab using the secondary 
performance metrics. 
The metrics are equipment utilization, staff utilization, 
queue size and material order size. 
6.5.2.1 Equipment Utilization for the Reference Model 
Most of the works in Health Care, especially in the 
Chemistry Lab are dependent on the equipment. Utilizing 
the equipment as intended provide cost reduction and more 
throughputs. Also any breakdown of the equipment will 
effect negatively on the lead-time. 
Table 6.9 indicates the different utilization rate for 
each test. The capability of the equipment is by far 
higher than the load; the equipment can be used for other 
tests. The information from the Table 6.9 is mainly for 
the intended test; this data will be useful more once 
identifying the reason of the delay of supply chain and 
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how the equipment usage and reliability will affect that. 
The results show that generally the lab equipment is 
under utilized, as can be seen from the data; as example, 
the Glucose test is using the analyzer with a percentage 
of 2.4%. The reason of the low utilization can be the 
fear of the manager of possibility of receiving high load 
in a short period of time, so they purchase bigger 
equipment for something may not need it. 
Table 6.9 
EOUIPMENT UTILIZATION (percentage %) 
EQUIPMENT UTILIZATION 
ABBOTT TDXFLX 0.1 
BIORAD VARIANT II 4.2 
CORNING CHLORIDE 925 ANALYZER 3.6 
DADE BEHRING BNII 0.1 
DADE BEHRING DIMENSION RXL 0.4 
DADE BEHRING VIVA TWIN 1.7 
ROCHE HITACHI E MODULAR AUTO ANALYSER 1.94 
ROCHE HITACHI P MODULAR AUTO ANALYSER 
(for: Glucose test) 2.4 
6.5.2.2 Staff Utilization for the Reference Model 
Staffs in the Lab are sharing the responsibility among 
them for each test groups (Core Chemistry, Special 
Chemistry, RIA, and TDM). To eliminate any delay or 
bottleneck of performing the Lab tests, the management 
must take the necessary steps to make sure that the 
staffs in Chemistry lab are fully utilized. 
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Table 6.10 
TAP TTTTT, TRATTOM (nercentaae %) 
UTILIZAT 
STAFF ION 
BUYER 01 1.13 
MEDICAL TECHNOLOGIST CORE CHEMISTRY 
(Glucose, Ketone, Osmo, and Ur. Protein) 12.3 
_ 
MEDICAL TECHNOLOGIST RIA 
(Vitamin D, BHCG, Folate, Homocytine) 23.5 
MEDICAL TECHNOLOGIST SPECIAL CHEMISTRY 
(AAT, G6PD, HBAIC, VMA) 49.2 
MEDICAL TECHNOLOGIST TDM 
(Carb, FK506, MTX, Opiates) 1.8 
PHLEBOTOMIST 54.8 
The results in Table 6.10 represent the percentage of the 
time utilized by the staff, as 100 will be the maximum, 
which utilizes the whole available time. It appears that 
the staff utilization level is very low, especially for 
the case of the buyer and medical technologist TDM. This 
does not mean that the staffs are not working, but the 
contributions of staffs are not related to the function 
of the Lab's normal activities particularly to the 
intended tests. 
It indicates that the utilization of all staff is very 
poor. The level of variation is high and this issue needs 
serious review and commitment from the managerial level 
to understand what causes this low level of staff 
utilization. 
6.5.2.3 Material Order Size for the Reference Model 
Among other resources, the material order size (Table 
6.11) provides us with information of the component used 
to perform the tests. As the outcome of the model has a 
high number, the expectation is to have higher ordering 
of all components as well. The variation of the value 
among the material depends on the frequency of use. This 
performance measure will confer how the relationship 
among the Lab, Logistic and the supplier. In particular, 
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how the logistic react to the need of the Lab and issuing 
purchase orders accordingly. 
Table 6.11 
MATERIAL ORDER SIZE 
NAME OF COMPONENT'S ORDER NUMBER OF ORDERS 
CONTROL 393 
CALIBRATOR 182 
REAGENT 532 
6.5.2.4 Queue Size for the Reference Model 
One of the important issues of Health Care providers is 
how to reduce the queue size. Queuing to see a physician 
is only part of long chain as the physician waiting for 
the lab or radiology result the other department like 
Chemistry Lab are waiting for there parts and supplies to 
complete there work. In the Table 6.12 providing the 
average value of waiting time by hours to complete the 
tests and save the result in the patient's file. The 
reasons of having queues for performing tests are 
different. One of them is the availability of components. 
The comparison of the result would identify the reasons 
of delay. The delay can reach up to 276 hours for the 
protein urine analysis, which is very high. 
Table 6.12 
QUEUE SIZE(hour) 
TEST AVER 
GLUCOSE 101 
KETONE 57 
OSMO 60 
URINE 276 
VITAMIN D 82 
BHCG 73 
FOLATE 72 
HOMOCYSTINE 71 
AAT 61 
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G6PD 63 
HBAIC 72 
VMA 60 
CARB 64 
FK506 41 
MTX 69 
OPIATES 108 
6.6 Scenario-Based Analysis 
This section of the analysis focuses on the output 
selected through scenario-based experimentation. Each 
scenario targets a specific case in the supply chain. 
While keeping the rest of the parameters fixed one 
parameter is changed according to a possible variation in 
the operation of the supply chain. For example, depending 
on the season or extra-ordinary development such as 
outbreak of certain diseases, demand for certain tests 
for a certain time period. Since this is not usual 
operation of the system, the supply chain will react upon 
this new situation in a different way in comparison to 
normal situation of system operation. 
Although this is dependent on occurrence of certain 
outside factors, this is not an unusual circumstance and 
may happen in any Healthcare Supply Chain frequently. The 
research question here is to understand whether this new 
case will affect the overall system performance adversely 
or not. In other words, how all these variations in 
demand would affect the rest of the parameters and 
different performance measures? 
The primary and secondary performance metrics are again 
used to understand the behavior of the system. The 
following is the detailed analysis of this metrics and 
all measures are used against the Reference Model created 
and analyzed in the beginning of this chapter (from 
section 6.4 to 6.6) 
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6.6.1 Scenario one: Low Customer Arrival Rate 
The patient arrival module has been changed to: 
exponential distribution with mean 10 arrivals per hour, 
which is comparably very low. 
In some seasons, especially during holidays, low patients 
affect the hospital performance. The Chemistry Lab is 
fully staffed and has all the resources but a low number 
of tests are requested. How the Lab will handle this 
situation is the question to be answered with this 
scenario. The expectation of the output of this scenario 
is to have low inventory matching with decrease of the 
patient rate. This is an important issue for supply chain 
as the excessive material will raise the cost and 
reducing it in an unplanned way would affect the quality 
of care. 
6.6.1.1 Primary Performance Measures 
6.6.1.1.1 Lead Time 
The lead time as shown in the Table and Graph 6.13 
dropped in comparison to the reference model. This is a 
predicted decrease as the low rate of patient requesting 
fewer tests. The average lead time for Glucose for 
example has reduced by 82.6%. The data show a 
consistency, some are higher drop like RIA section which 
consists of BHCG, Vitamin D, Folate, and Homocystine. it 
is acceptable as RIA section has the low number of tests. 
Also the results indicate the availability of resources 
to do all tests without shortage of delivering the 
supplies. 
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Table and Graph 6.13 
LEAD TIME COMPARISON TO REFERENCE MODEL (hour) 
SCENARIO: REFERENCE MODEL 
TEST MIN AVR MAX MIN AVR MAX 
GLUCOSE 0.37 21 167 0.4 102 733 
KETONE 0.24 20 148 0.24 57.5 248 
OSMO 0.28 22 224 0.29 61 249 
URINE 0.39 21 166 0.41 100 725 
VITAMIN D 2.49 2.6 2.82 2.4 85.5 383 
BHCG 0.21 1.1 83 0.47 74 369.5 
FOLATE 1.6 1.6 172 1.5 73.7 380.3 
HOMOCYSTINE 0.31 1.2 133 1.13 73 355 
AAT 0.38 24 164 0.39 61.6 258 
G6PD 0.414 20 149 0.42 64 268 
HBAIC 0.516 24 169 0.52 73 399.8 
VMA 0.633 24 145 0.64 61.5 266.4 
CARB 0.469 22 168 0.48 69 280 
FK506 0.459 20 192 0.46 41.8 175.2 
MTX 0.379 26 166 0.37 69.9 219.3 
OPIATES 0.229 18 15B 0.23 109 899 
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6.6.1.1.2 Material flow time 
More than 70% of all tests are not affected by the low 
demand. This result is shown in Table and Graph 6.14 
which consists of reagent, calibrator, and controller. 
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Accordingly, the level of inventory has dropped slightly 
as less material is ordered with less frequently because 
of the number of tests conducted. Seven tests like 
GLUCOSE and VMA indicate that they have less flow time 
and the other eight tests like KETONE and HBAIC have 
increased level of flow time. 
Table and Graph 6.14 
REAGENT TABLE COMPARISON 
SCENARIO REFERENCE MODEL 
TEST MFT(hour) INV MFT(hour) INV 
GLUCOSE 33 5974 62 5518 
KETONE 191 842 104 772 
OSMO 30 7874 43 8045 
URINE 43 1673 62 1688 
VITAMIN D 186 2463 57 2817 
BHCG 193 1077 68 1081 
FOLATE 31 55632 55 54196 
HOMOCYSTINE 230 704 81 804 
AAT 28 13061 29 14193 
G6PD 147 34194 26 31410 
HBAIC 218 818 126 1074 
VMA 37 1914 60 1963 
CARB 24 76567 83 81096 
FK506 36 39602 32 36331 
MTX 134 10554 54 12447 
OPIATES 61 1863 13 353 
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CONTROLLER COMPARISON TABLE 
SCENARIO REFERENCE 
TEST MFT(hour) INV MFT (hour) INV 
GLUCOSE 146 2517 11 2203 
KETONE 506 2192 542 2433 
OSMO 23 3499 53 2559 
URINE 35 709 13 571 
VITAMIN D 36 1166 12 941 
BHCG 271 429 11 382 
FOLATE 31 24998 11 20107 
HOMOCYSTINE 43 299 13 238 
AAT 177 5340 10 4637 
G6PD 55 18383 306 17221 
HBAIC 34 366 197 316 
VMA 41 603 13 392 
CARB 13 28802 12 21692 
FK506 13 13901 12 14687 
MTX 161 4659 11 4089 
10PIATES 3.6 1507 8 805 
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CALIBRATOR TABLE 
SCENARIO REFERENCE MODEL 
TEST MFT(hour) INV MFT(hour) INV 
GLUCOSE 37 25817 62 2101 
KETONE 339 319 58 286 
OSMO 194 3130 11 3028 
URINE 236 621 14 613 
VITAMIN D 39 1125 14 1012 
BHCG 305 425 56 377 
FOLATE 36 24210 55 20091 
HOMOCYSTINE 31 284 10 254 
AAT 300 5401 68 4763 
G6PD 35 18078 239 16331 
HBAIC 789 511 0 234 
VMA N/A N/A N/A N/A 
CARE 14 28712 12 25469 
FK506 N/A N/A N/A N/A 
MTX 53 5006 16 4498 
OPIATES 0.45 953 2 655 
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6.6.1.1.3 Throughput 
Throughput of the test as indicated in the Table and 
Graph 6.15 was effected negatively by decreasing the 
demand. In fact, this result is a natural outcome of the 
low demand and the number of completed tests is now less 
parallel to the number of requested tests. 
Table and Graph 6.15 
THROUGHPUT COMPARISON(rate of test/hour) 
SCENARIO REFERENCE 
TEST THROUGHPUT THROUGHPUT 
GLUCOSE 1.7 29.118036 
KETONE 0.0889 1.3828767 
OSMO 0.251 4.1858447 
URINE 0.8018 5.3260273 
VITAMIN D 0.14 2.2187214 
BHCG 0.0163 0.2979452 
FOLATE 0.1807 2.9504566 
HOMOCYSTINE 0.0347 0.5760273 
AAT 0.0611 0.9703196 
G6PD 0.0218 0.4077625 
HBAIC 1.268 21.281735 
VMA 0.0138 0.2605022 
CARB 0.2913 4.9803652 
FK506 0.8025 1.6050228 
MTX 0.0194 0.0821917 
OPIATES 0.04509 0.7038812 
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6.6.1.1.4 Inventory Status 
Inventory status is a very important metric to indicate 
the performance of the supply chain. It indicates the 
responsiveness of the Chemistry Lab to any change. 
According to Table 6.16, there is a little change in the 
inventory of all components either in the Lab or 
Logistics in comparison to the Reference Model except 
test number 16 TDM Opate which has increased tremendously 
without any planned increase in usage. This unexpected 
increase in this specific material usage could be 
explained as a random nature of the simulation model. All 
the tests maintain the same inventory level with a little 
variation. This does not match with the decreasing level 
of the patient demand. As a result, there will be unused 
supplies which are subject to destruction, if the expire 
dates are passed, which is likely to happen in this case. 
A proper forecasting with reliable data is needed to 
prevent this situation from occurring, or to seek another 
alternative of managing the supplies as discussed in 
2.4.2.2 and 3.3.1. 
Table 6.16 
STORAGE COMPARISON TABLE (number of components) 
LAB STORAGE TABLE 
I 
REAGENT CALIBRATOR CONTROLLER 
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SCENARIO REFERENCE SCENARIO REFERENCE SCENARIO REFERENCE 
TEST VALUE VALUE TEST VALUE VALUE TEST VALUE VALUE 
LABRE1 1497 1482 LABCAl 88 91 LABCOI 150 142 
LABRE2 191 195 LABCA2 11 12 LABC02 143 142 
LABRE3 1974 1918 LABCA3 115 120 LABC03 197 183 
LABRE4 380 394 LABCA4 23 23 LABC04 38 39 
LABRE5 622 640 LABCA5 38 37 LABC05 61 64 
LABRE6 262 248 LABCA6 16 15 LABC06 26 24 
LABRE7 13961 13663 LABCA7 833 766 LABC07 1448 1448 
LABRE8 165 284 LABCA8 9 10 LABC08 17 15 
LABRE9 3283 3258 LABCA9 194 183 LABC09 328 335 
LABRE10 10480 10988 LABCA10 620 671 LABC010 297 28 
LABRE11 196 242 LABCA11 169 184 LABCO11 20 3 
LABRE12 444 442 LABCA12 N/A N/A LABC012 44 34 
LABRE13 19201 19076 LABCA13 1071 989 LABC013 1728 1680 
LABRE14 11139 9125 LABCA14 N/A N/A LABC014 699 875 
LABRE15 2763 2893 LABCA15 167 167 
] 
LABC015 283 267 
ILABRE16 
536 55 LABCA16 72 38 
_ 
IL C016 54 39 
LOG STORAGE TABLE 
I 
REAGENT CALIBRATOR CONTROLLER 
I 
SCENARIO REFERENCE 
TEST VALUE VALUE 
LOGRE1 4477 4036 
LOGRE2 651 577 
LOGRES 5900 6127 
LOGRE4 1293 1294 
LOGRE5 1841 2177 
LOGRE6 815 833 
LOGRE7 41671 40533 
LOGRES 539 520 
LOGRES 9778 10935 
LOGRE10 23714 20422 
LOGRE11 622 832 
LOGRE12 1470 1521 
LOGRE13 57366 62020 
LOGRE14 28463 27206 
LOGRE15 7791 9608 
LOGRE16 1327 298 
SCENARIO REFERENCE 
TEST VALUE VALUE 
LOGCA1 2493 2010 
LOGCA2 308 274 
LOGCA3 3015 2908 
LOGCA4 598 590 
LOGCA5 1087 975 
LOGCA6 409 362 
LOGCA7 23377 19325 
LOGCAR 275 244 
LOGCA9 5207 4580 
LOGCA10 17458 15660 
LOGCA11 315 50 
LOGCA12 N/A N/A 
LOGCA13 27641 24480 
LOGCA14 N/A N/A 
LOGCA15 4839 4331 
LOGCA16 881 617 
SCENARIO REFERENCE 
TEST VALUE VALUE 
LOGCO1 2367 2061 
LOGCO2 2049 2291 
LOGCO3 3302 2376 
LOGCO4 671 532 
LOGCO5 1105 877 
LOGCO6 403 358 
LOGCO7 23550 18659 
LOGCO8 282 223 
LOGCO9 5012 4302 
LOGCO10 18086 17193 
LOGCO11 346 313 
LOGCO12 559 35 
LOGCO13 27074 20012 
LOGCO14 13202 13812 
LOGCO15 4376 3822 
LOGCO16 1453 766 
6.6.1.1.5 WIP 
Table and Graph 6.17 indicates work in process, which are 
comparably very low. This again can be explained with a 
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low demand rate. Since the Lab has no due date pressure 
and has more time to do the tests the work done is more 
quickly, reducing the WIP level considerably. 
Table and Graph 6.17 
WIP COMPARISON(number of unfinished tests) 
TEST SCENARIO REFERENCE MODEL 
GLUCOSE 142 1487 
KETONE 7 39 
OSMO 11 127 
URINE 59 2208 
VITAMIN D 8.9 94 
BHCG 0.48 11 
FOLATE 12 108 
HOMOCYSTINE 4 21 
AAT 5 29 
G6PD 1 13 
HBAIC 106 776 
VMA 0.1 8 
CARE 24 161 
FK506 55 3398 
MTX 3 499 
OPIATES 3 38 
WIP COMPARISON 
3500 
2000 
1000 
o - - 
O 
J 
0 
0 
O 
Z 
< 
H 
O 
~Q U 
co 
2 
Co 
< 
U 
2 
ý"SC IO ý' 
L0 REFERENCE 
6.6.1.1.6 Cost of Test 
The cost of each test is not much different than the 
Reference Model Table and Graph 6.18 because the staff 
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and resources are still included. The minor difference 
mainly comes from the reduced mean flow time for each 
test process. This means that the time spent for each 
test operation is less in comparison to the Reference 
Model and the direct Labor cost is slightly less than 
the normal level. 
Table and Graph 6.18(in sterling Pound) 
COST COMPARISON OF EACH TEST 
SCENARIO REFERENCE MODEL 
TEST AVE MIN MAX AVE MIN MAX 
GLUCOSE 1.9 1.3 2.8 1.909 1.3069 2.9198 
KETONE 1.7 1.3 2.5 1.7877 1.2774 2.6887 
OSMO 2 1.4 2.9 2.0059 1.4676 2.9917 
URINE 2 1.4 2.9 2.0554 1.5012 3.0116 
VITAMIN D 7 6.6 7.2 6.7123 5.028 1442.09 
BHCG N/A N/A N/A 2.5506 1.9726 3.409 
FOLATE 3.8 3.2 4.2 6.0894 4.8963 7.6853 
HOMOCYSTINE N/A N/A N/A 4.2361 3.487 5.3294 
AAT 2.14 1.6 2.89 2.146 1.5995 3.0629 
G6PD 1.9 1.4 2.68 1.9706 1.4252 2.9165 
HBAIC 4.1 3.1 10.89 4.1247 3.0526 11.6439 
VMA 3.2 2.5 4.2 3.2474 2 . 4026 4.1936 
CARB 1.6 1.2 2.5 1.6824 1.1864 2.6089 
FK506 1.8 1.3 2.7 1.8503 1.3458 2.7603 
MTX 1.4 1.01 2.22 1.4458 0.9949 2.1895 
OPIATES 2.5 2.1 3.1 2.5481 2.1464 3.3417 
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6.6.1.2 Secondary Performance Measures 
6.6.1.2.1 Equipment Utilization 
The utilization level has dropped matching the patient 
reduction. This is an expected result as reducing the 
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demand. Maximum was the Biorad Vaviant II Analyzer (Table 
and Graph 6.19) . 
Table and Graph 6.19 
Rl1TTTPMF. NT TTTTT, TRATTÖN CÖMPARTSQN (nerceritaae %) 
SCENARIO 
REFERENCE 
MODEL 
EQUIPMENT UTILIZATION UTILIZATION 
ABBOTT TDXFLX 0.03 0.1 
BIORAD VARIANT II 0.5 4.2 
CORNING CHLORIDE 925 
ANALYZER 0.4 3.6 
DADE BEHRING BNII 0.01 0.1 
DADE BEHRING DIMENSION RXL 0.4 0.4 
DADE BEHRING VIVA TWIN 0.2 1.7 
ROCHE HITACHI E MODULAR 
AUTO ANALYSER 0.0006 1.94 
ROCHE HITACHI P MODULAR 
AUTO ANALYSER 0. 2.4 
SCENARIO 
0.2835 
0.0257 
0.000574 0.501 
0.193 
0.353 
0.386 
0.0078 
  ABBOTT TDXFLX 
" BIORAD VARIANT II 
O CORNING CHLORIDE 925 
ANALYZER 
D DADE BEI-RING BNII 
  DADE BEI-RING DIM ENSION 
RXL 
MDADEBEI-RINGVIVA TWIN 
  ROCHE HITACHI EM ODULAF 
AUTO ANALYSER 
13 ROCHE HITACHI PM ODULAF 
AUTO ANALYSER 
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6.6.1.2.2 Staff Utilization 
The staff utilization is lower than the reference model 
(Table and Graph 6.20) . The staffs have now more unused 
time because of less demand. The unit cost of staff will 
now be higher than other cases and management must come 
up with a solution for this situation, otherwise the cost 
is inflated without any justification. This is valid 
except the Medical Technology RIA, which has increased to 
the maximum, showing the unbalance of staff distribution. 
Table and Graph 6.20 
STAFF UTILIZATION COMPARISON (Aercentaae %) 
SCENARIO REFERENCE MODEL 
STAFF UTILIZATION UTILIZATION 
BUYER 01 0.7038 1.129484 
MEDICAL TECHNOLOGIST CORE CHEMISTRY 
(Glucose, Ketone, Osmo, and Ur. 
Protein) 1.885 12.33 
MEDICAL TECHNOLOGIST RIA 
(Vitamin D, BHCG, Folate, 
Homocytine) 99.79 23.51 
MEDICAL TECHNOLOGIST SPECIAL 
CHEMISTRY 
(AAT, G6PD, HBAIC, VMA) 5.86 49.2 
MEDICAL TECHNOLOGIST TDM 
(Carb, FK506, MTX, Opiates) 0.56 1.831827 
PHLEBOTOMIST 6.593 54.85 
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6.6.1.2.3 Material Order Size 
The material orders (Table 6.21) have been dropped by 
different percentage according to the components used. 
Matching the low demand with the low lot size and less 
frequent number of orders for the Chemistry Lab, it is 
expected that there should be a decrease in the inventory 
level as well; however, this is not reflected in the 
inventory level. This indicates a lack of proper 
communication between the Lab and Logistic in the 
ordering mechanism. 
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Table 6.21 
MATERIAL ORDER SIZE COMPARISON 
SCENARIO REFERENCE MODEL 
NAME OF ORDER 
NUMBER OF 
ORDERS NUMBER OF ORDERS 
LAB CONTROL 129 393 
LAB CALIBRATOR 65 182 
REAGENT 70 532 
6.6.1.2.4 Queue size 
As discussed in the lead time, similarly the queue size 
(Table and Graph 6.22) has been reduced tremendously for 
some test because of no due date pressure and less test 
requests. 
Table and Graph 6.22 
OUEUE SIZE COMPARISON (hour) 
SCENARIO REFERENCE MODEL 
TEST AVER AVER 
GLUCOSE 21 101 
KETONE 20 57 
OSMO 22 60 
URINE 20 276 
VITAMIN D 0.01 82 
BHCG 1 73 
FOLATE 0.01 72 
HOMOCYSTINE 1.1 71 
AAT 23 61 
G6PD 19 63 
HBAIC 23 
1 172 
VMA 23 60 
CARE 21 64 
FK506 19 41 
MTX 25 69 
OPIATES 17 108 
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6.6.1.3 Conclusion 
From all the tables and graphs, the low flow of patients 
can affect positively to the level of waiting time, lead 
time, queue size, inventory status, material order size 
but negatively effect the utilization of equipment and 
staff. The summary of output of this scenario is as 
follows: 
  Lead time is reduced tremendously 
  Staff utilization has dropped matching with the low 
demand 
  Throughput for the test became low 
  Inventory for all component are the same with 
slight change in some materials. This does not 
match 100% with the low number of patients. This is 
an indication of poor forecasting. 
  The cost is reduced in a small rate because of 
other factors like staff and resources are the same 
despite low demand. 
  Number of orders reduced equivalent to the dropped 
of patient from the Chemistry Lab. But this does 
not affect the actual inventory level which remains 
the same as the reference model. 
As a result; the management should look for alternative 
ways of handling the purchase and controlling the supply 
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inventory. As discussed in section 2.4.2.2 and 3.3.1, 
Just In Time (JIT) may be the good choice. 
6.6.2. Scenario two: Unreliable Suppliers 
in this scenario, suppliers are considered as the source 
of problem in the supply chain. Improving the performance 
of the suppliers would enhance the flow of material 
throughout the chain. Problems in the suppliers' site 
will be directly and indirectly affect the patient who is 
the real beneficiary of the whole supply chain. 
Unreliable suppliers provide hospitals with needed 
medical items with an inconsistent pattern causing a lot 
of interruptions or other problems which affect the 
efficiency of the Chemistry Lab negatively. The aim of 
this scenario is to understand what kind of impact the 
unreliable supplier can have on the overall system 
performance and what measures need to be taken by the 
supply chain to overcome this problem. The output 
gathered for this scenario will be examined in the 
following sections. 
6.6.2.1 Primary Performance Measures 
6.6.2.1.1 Lead Time 
Eight different tests in Table and Graph 6.23 show the 
increased lead time while the other eight tests have 
dropped by 10 to 20 percent. The suppliers in this 
scenario show varying performance in responding to the 
hospital request for needed items. The delay from the 
supplier side has reflected as a longer lead time for the 
tests in the lab as they can be observed in the table. 
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Table and Graph 6.23 
LEAD TIME COMPARISON TO REFERENCE MODEL(hour) 
SCENARIO: REFERENCE MODEL 
TEST MIN AVR MAX MIN AVR MAX 
GLUCOSE 0.3844 81.7226 373.14 0.4 102 733 
KETONE 0.2423 64.7832 288.99 0.24 57.5 248 
OSMO 0.295 66.2047 293.27 0.29 61 249 
URINE 0.4084 234.48 5128.98 0.41 100 725 
VITAMIN D 2.4366 77.4657 314.31 2.4 85.5 383 
BHCG 0.4829 55.9244 199.37 0.47 74 369.5 
FOLATE 1.5183 68.8743 300.41 1.5 73.7 380.3 
HOMOCYSTINE 1.142 61.0659 234.18 1.13 73 355 
AAT 0.3868 67.2051 238.42 0.39 61.6 258 
G6PD 0.4312 72.4026 317.55 0.42 64 268 
HBAIC 0.5265 78.2133 455.64 0.52 73 399.8 
VMA 0.6203 67.4101 224.45 0.64 61.5 266.4 
CARB 0.4733 67.0685 207.93 0.48 69 280 
FK506 0.4654 20.1582 94.7537 0.46 41.8 175.2 
MTX 0.378 56.6607 190.22 0.37 69.9 219.3 
OPIATES 0.236 147.74 712.42 0.23 109 899 
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6.6.2.1.2 Material Flow time 
The effect of the suppliers on the material flow is 
different from reagent to controller and calibrator. It 
mainly follows the demand and inventory level as 
illustrated in Table and Graph 6.24 which consist of 
reagent, calibrator, and controller. As we have each test 
need at least three components, these materials are 
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purchased from different vendors. If one of the vendors 
refuses to deliver the test will not be performed. 
Table and Graph 6.24 
REAGENT TABLE COMPARISON 
SCENARIO REFERENCE MODEL 
EST FT (hour) INV FT(hour) INV 
1 36.96 5625 62 5518 
2 90.7 893 104 772 
3 79.65 7729 43 8045 
4 66.69 2504 62 1688 
5 38.4 3656 57 2817 
6 22.32 1162 68 1081 
7 36.84 55435 55 54196 
8 152.78 775 81 804 
9 34.167 23579 29 14193 
10 24.3399 11830 26 31410 
11 41.72 1765 126 1074 
12 54.29 58367 60 1963 
13 78.1 45459 83 81096 
14 20.887 19346 32 36331 
P 
15 25.61 3104 54 12447 
16 13 264 13 353 
REAGB4T MFT COMPARISON 
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CONTROLLER COMPARISON TABLE 
SCENARIO REFERENCE 
EST FT(hour) INV FT(hour) INV 
1 12.38 2177 11 2203 
2 299.87 1995 542 2433 
3 10.256 2814 53 2559 
4 47 500 13 571 
5 48.76 863 12 941 
6 63.168 337 11 382 
7 12.855 20085 11 20107 
8 12.922 240 13 238 
9 14.854 4682 10 4637 
10 358.31 16620 306 17221 
11 219.8 315 197 316 
12 13.6 294 13 392 
13 7.99 24161 12 21692 
14 13.9244 13392 12 1468711 
15 10.8 4097 11 4089 
16 6.609 811 8 805 
CONTROLLER MFT COMPARISON 
  SCENARIO 1 
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Calibrator comparison Table 
SCENARIO REFERENCE MODEL 
TEST FT(hour) INV FT(hour) INV 
1 61.335 2096 62 2101 
2 206.7 5 58 286 
3 48.42 2768 11 3028 
4 12.92 605 14 613 
5 55.78 938 14 1012 
6 56.15 377 56 377 
7 10.414 21319 55 20091 
8 54.12 231 10 254 
9 14.29 5086 68 4763 
10 190.12 16127 239 16331 
11 81.9 523 0 234 
12 /A /A /A /A 
13 12.42 25677 12 25469 
14 /A /A /A /A 
15 13.714 4523 16 4498 
16 6 544 2 655 
CALIBRATOR MFT COMPARISON 
  SCENARIO 
" REFERENCE 
6.6.2.1.3 Throughput 
Throughput of the test as indicated in the Table and 
Graph 6.25 was effected negatively by the supplier's poor 
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commitment of delivering the items. Although the hospital 
tries to control the business within the premises, the 
effect of unreliable suppliers can have a huge role on 
the performance of delivering the services timely, as it 
is the case in this scenario. The throughput of the lab 
is affected negatively because of unreliable suppliers, 
so the different policies to purchase the needed items 
should be introduced such as prime vendors, as discussed 
in section 2.4.2.2.2. 
Table and Graph 6.25 
THROUGHPUT COMPARISON 
(rate of test/hour) 
SCENARIO REFERENCE 
EST THROUGHPUT THROUGHPUT 
GLUCOSE 14.63047945 29.118036 
KETONE 0.698059361 1.3828767 
SMO 2.096803653 4.1858447 
URINE 3.264383562 5.3260273 
VITAMIN D 1.130251142 2.2187214 
BHCG 0.068607306 0.2979452 
FOLATE 1.48413242 2.9504566 
OMOCYSTINE 0.289840183 0.5760273 
A. AT 0.488013699 0.9703196 
6PD 0.2 0.4077625 
BAIC 10.5869863 21.281735 
VMA 0.123858447 0.2605022 
CARE 2.454908676 4.9803652 
FK506 0.802511416 1.6050228 
TX 0.04109589 0.0821917 
PIATES 0.352283105 0.7038812 
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6.6.2.1.4 Inventory Status 
According to Table 6.26, there is not much change in the 
inventory of all components whether in the Lab or 
Logistics in comparison to the Reference Model. The 
hospital gets use to the delays caused by suppliers, so 
they tend to store more items once the requested shipment 
is not delivered on time. This way of managing the 
important medical material does not only inflate the cost 
but also manipulates and risks the patient health. 
Table 6.26 
STORAGE COMPARISON (number of components) 
LAB STORAGE TABLE 
REAGENT CALIBRATOR CONTROLLER 
SCENARIO REFERE 
COMPON VALUE VALUE 
LABRE1 1464 1482 
LABRE2 165 195 
LABRE3 1998 1918 
LABRE4 435 394 
LABRES 583 640 
LABRE6 251 248 
LABRE7 13724 13663 
LABRE8 275 284 
SCENARIO REFER 
COMPON VALUE VALUE 
LABCAI 91 91 
LABCA2 3 12 
LABCA3 120 120 
LABCA4 23 23 
LABCAS 36 37 
LABCA6 15 15 
LABCA7 782 766 
LABCA8 9 10 
SCENARIO REFER 
COMPON VALUE VALUE 
LABCOI 137 142 
LABC02 148 142 
LABC03 180 183 
LABC04 38 39 
LABCO5 63 64 
LABC06 25 24 
LABC07 1,296 1448 
LABC08 17 115 
158 
LABRE9 3201 3258 
LABRE10 10951 10988 
LABRE11 242 242 
LABRE12 440 442 
LABRE13 19071 19076 
LABRE14 9226 9125 
LABREIS 2872 2893 
LABRE16 38 55 
LABCA9 184 183 LABC09 304 335 
LABCA10 673 671 LABC010 _! 28 28 
LABCA11 184 184 LABCO11 3 3 
LABCA12 N/A N/A LABC012 28 34 
LABCA13 976 989 LABC013 1,818 1680 
LABCA14 N/A N/A LABC014 817 875 
LABCA15 169 167 LABC015 265 267 
LABCA16 42 38 LABC016 40 39 
LOG STORAGE TABLE 
IREAGENT ICALIBRATOR I ICONTROLLER 
SCENARIO REFER 
COMPON VALUE VALUE 
LOGRE1 4161 4036 
LOGRE2 727 577 
LOGRE3 5730 6127 
LOGRE4 2069 1294 
LOGRES 3072 2177 
LOGRE6 910 833 
LOGRE? 41710 40533 
LOGRE8 499 520 
LOGRES 20378 10935 
LOGRE10 879 20422 
LOGREIZ 1522 832 
LOGRE12 57926 1521 
LOGRE13 26388 62020 
LOGRE14 10120 27206 
LOGREIS 231 9608 
LOGRE16 226 298 
SCENARIO REFER 
COMPON VALUE VALUE 
LOGCA1 2004 2010 
LOGCA2 2 274 
LOGCA3 2648 2908 
LOGCA4 581 590 
LOGCA5 901 975 
LOGCA6 362 362 
LOGCA7 20536 19325 
LOGCAR 221 244 
LOGCA9 4901 4580 
LOGCA10 15454 15660 
LOGCAll 338 50 
LOGCA12 N/A N/A 
LOGCA13 24701 24480 
LOGCA14 N/A N/A 
LOGCAI5 4354 4331 
LOGCA16 501 617 
SCENARIO REFER 
COMPON VALUE VALUE 
LOGCO1 2040 2061 
LOGCO2 1847 2291 
LOGCO3 2633 2376 
LOGCO4 461 532 
LOGCO5 800 877 
LOGCO6 31 358 
LOGCO7 18788 18659 
LOGCO8 223 223 
LOGCO9 4378 4302 
LOGCO10 16592 17193 
LOGC011 312 313 
LOGCO12 266 358 
LOGCO13 22343 20012 
LOGCO14 12575 13812 
LOGCO15 3832 3822 
LOGCO16 771 766 
6.6.2.1.5 WIP 
Table and Graph 6.27 indicates the level of work in 
process. The number of tests that are in progress has 
increased reflecting and correlated to the delay of the 
items that should be delivered on certain times. The 
effect of the supplier commitment to deliver on time is 
high causing high level of WIP. One of the possible ways 
of overcoming of this problem is to buy on consignment 
base as discussed in section (2.4.2.2.3). So, the 
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inventory and accumulated cost can be shifted to the 
suppliers. 
Table and Graph 6.27 
WIP COMPARISON(number of unfinished tests) 
SCENARIO REFERENCE MODEL 
TEST AVERAGE AVERAGE 
GLUCOSE 7542 1487 
KETONE 3576 39 
SMO 10741 127 
URINE 3206 2208 
VITAMIN D 5831 94 
HCG 766 11 
FOLATE 7603 108 
OMOCYSTINE 1498 21 
T 2509 29 
6PD 1045 13 
BAIC 5465 776 
VMA. 641 8 
CARB 1261 161 
FK506 4069 3398 
TX 733 499 
PIATES 1801 3 
WIP COMPARISON 
  SCENARIO 
IN REFERENCE 
6.6.2.1.6 Cost of Test 
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The costs of each test are not much different than the 
Reference Model (Table and Graph 6.28) because of the 
staff and resources are still included as a part total 
value. 
Table and Graph 6.28 
COST COMPARISON OF EACH TEST(in sterling Pound) 
SCENARIO REFERENCE MODEL 
TEST VE IN MAX VE IN MAX 
GLUCOSE 1.91 1.29 2.92 1.909 1.3069 2.9198 
KETONE 1.79 1.31 2.76 1.7877 1.2774 2.6887 
SMO 2.01 1.44 2.91 2.0059 1.4676 2.9917 
URINE 2.06 1.49 3.02 2.0554 1.5012 3.0116 
VITAMIN D 5.05 4.34 6.12 6.7123 5.028 1442.09 
HCG 2.56 1.98 3.58 2.5506 1.9726 3.409 
FOLATE 3.52 2.88 4.60 6.0894 4.8963 7.6853 
OMOCYSTINE 4.23 3.51 5.40 4.2361 3.487 5.3294 
T 2.15 1.59 3.13 2.146 1.5995 3.0629 
6PD 1.97 1.42 2.87 1.9706 1.4252 2.9165 
BAIC 4.13 3.07 12.81 4.1247 3.0526 11.6439 
VMA 3.26 2.45 4.38 3.2474 2.4026 4.1936 
CARB 1.68 1.18 2.62 1.6824 1.1864 2.6089 
FK506 1.85 1.35 0.00 1.3388 2.6976 2.7603 
TX 1.44 0.90 2.17 1.4458 0.9949 2.1895 
OPIATES 2.54 2.17 3.40 3.3204 2.1464 3.3417 
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6.6.2.2 Secondary Performance Measures 
6.6.2.2.1 Equipment Utilization 
The utilization is more or less the same as the Reference 
Model for all items, since the system is assumed to be 
working normal conditions except some occasional 
interruptions in material supply (Table and Graph 6.29). 
Table and Graph 6.29 
EQUIPMENT UTILIZATION COMPARISON (percentage %) 
SCENARIO REFERENCE 
EQUIPMENT UTILIZATION UTILIZATION 
BOTT TDXFLX 0.1 0.1 
BIORAD VARIANT II 4.2 4.2 
CORNING CHLORIDE 925 ANALYZER 3.6 3.6 
ADE BEHRING BNII 0.1 0.1 
ADE BEHRING DIMENSION RXL 0.4 0.4 
ADE BEHRING VIVA TWIN 1.6 1.7 
OCHE HITACHI E MODULAR AUTO ANALYSER 1.94 1.94 
OCHE HITACHI P MODULAR AUTO ANALYSER 2.4 2.4 
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6.6.2.2.2 Staff Utilization 
The utilization remained the same as the Reference Model 
with the exception of the buyer which was slightly 
increased reflecting the increase of the number of 
orders. Also the RIA Medical Technologist dropped by 50 
percent, indicating of less number of requests for this 
particular group (Table and Graph 6.30). 
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Table and Graph 6.30 
Staff Utilization (percentage %) 
SCENARIO REFERENCE 
STAFF UTILIZATION UTILIZATION 
BUYER 01 2.19 1.129484 
MEDICAL TECHNOLOGIST CORE CHEMISTRY 
(Glucose, Ketone, Osmo, and Ur. Protein) 12.87 12.33 
MEDICAL TECHNOLOGIST RIA 
(Vitamin D, BHCG, Folate, Homocytine) 13.48 23.51 
MEDICAL TECHNOLOGIST SPECIAL CHEMISTRY 
(AAT, G6PD, HBAIC, VMA) 48.97 49.2 
EDICAL TECHNOLOGIST TDM 
(Carb, FK506, MTX, Opiates) 1.824 1.831827 
PHLEBOTOMIST 54.37 54.85 
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6.6.2.2.3 Material Order Size 
The material orders (Table 6.31) increased for all 
components by more than 100% for the calibrator and 5% 
for the reagent and the controller. As a reflection of 
not receiving the items on time that are requested. The 
lab requests more materials in high quantity to cover the 
supplier delay, which results of high quantity without 
usage. 
Table 6.31 
MATERIAL ORDER SIZE COMPARISON 
SCENARIO REFERENCE MODEL 
NAME OF ORDER NUMBER OF ORDERS NUMBER OF ORDERS 
CONTROL 415 393 
CALIBRATOR 459,182 
REAGENT 574 532 
6.6.2.2.4 Queue Size 
As discussed in the lead time, similarly the queue size 
(Table and Graph 6.32) fluctuated according to the 
availability of supplies. As it can be observed from the 
table, the queue size has increased for the materials 
used in certain tests and remained the same or decreased 
slightly for the materials that are available for some 
other tests. 
Table and Graph 6.32 
QUEUE SIZE COMPARISON(hour) 
SCENARIO REFERENCE MOD EL 
TEST AVER AVER 
GLUCOSE 81 101 
KETONE 64 57 
SMO 65 60 
URINE 234 276 
VITAMIN D 74 82 
BHCG 55 73 
FOLATE 67 72 
OMOCYSTINE 59 71 
T 66 61 
6PD 71 63 
BAIC 77 72 
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CARB 66 64 
FK506 19 41 
TX 56 69 
OPIATES 147 108 
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6.6.2.3 Conclusion 
Suppliers are the essential part of the supply chain 
system and any problem with supply process, the whole 
chain would be affected. As we went through the 
performance metrics of this scenario, the throughput of 
the chemistry lab is relatively low. Therefore, there 
should be a safety stock for all the components used once 
needed by the patients. But as mention before this is not 
a cheap solution. The hospital management should seek 
help of the manufacturing tools and techniques, as 
discussed in the previous sections (2.4.2.2 and 3.3) to 
find alternative solutions which may be applicable to the 
health care industry to fill the gab between the hospital 
and the vendor or supplier. 
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6.6.3. Scenario Three: I, Ax Inventory Policy 
I,, x is an inventory policy, which orders a maximum 
quantity once the stock levels dropped to the re-order 
point. Some would argue making the inventory always full 
is a guarantee of material availability, but this comes 
with an expense and would increase the over-all costs. 
6.6.3.1 Primary Performance Measures 
6.6.3.1.1 Lead Time 
The lead time as shown in Table and Graph 6.33 dropped by 
50 to 90% except the Opiates and Urine test has increased 
tremendously (no explanation available for this 
increase) 
. The 
VITAMIN D, BHCG, FOLATE, and HOMOCYSTINE 
drop to the minimum which would not appear in the Arena. 
These decrease of the tests apparently a natural outcome 
of stock availability of supplies, which eliminates the 
short-of-stock and any interruptions so the delays are 
eliminated which in turn reduced the lead time 
considerably. 
Table and Graph 6.33 
LEAD TIME COMPARISON TO REFERENCE MODEL(hour) 
SCENARIO: REFERENCE MODEL 
TEST MIN AVR MAX MIN AVR MAX 
GLUCOSE 0.3869 13.6517 1.39.04 0.4 102 733 
KETONE 0.2411 22.3404 245.51 0.24 57.5 248 
OSMO 0.2872 29.013 246.96 0.29 61 249 
URINE 0.4128 339.491 5939.58 0.41 100 725 
VITAMIN D N/A N/A N/A 2.4 85.5 383 
BHCG N/A N/A N/A 0.47 74 369.5 
FOLATE N/A N/A N/A 1.5 73.7 380.3 
HOMOCYSTINE N/A N/A N/A 1.13 73 355 
AAT 0.3873 30.6455 204.17 0.39 61.6 258 
G6PD 0.4353 40.1356 200.22 0.42 64 268 
HBAIC 0.5216 36.6455 319.5 0.52 73 399.8 
VMA 0.6365 43.4815 189.3 0.64 61.5 266.4 
CARE 0.4822 29.4835 187.12 0.48 69 
_ 
280 
FK506 0.4617 41.3743 194.38 0.46 41.8 175.2 
MTX 0.3654 37.3901 186.44 0.37 69.9 21.9.3 
OPIATES 0.2338 287.601 6427.96 0.23 108 899 
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LEAD TIME COMPARISON 
6.6.3.1.2 Material Flow time 
More than 70% of all tests are affected by increasing the 
MFT while the other decreased as illustrated in Table and 
Graph 6.34 which consist of reagent, calibrator, and 
controller. One of the reason is the logistic can not cup 
with high quantity of supplies like the increase of 
inventory of Homocystine from 804 to 43812. Material with 
short shelf lives have increased by making sure that all 
the stock is always available most of time up to its 
maximum level. Therefore, when we include the shelf life 
into calculation of material flow time from procurement 
point to the consuming it, this gives rather a long flow 
time like GLUCOSE. However, when we start the flow time 
from the point of delivering it to the lab for any 
processing, this has dropped slightly as a result of less 
interruption and less idleness. 
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Table and Graph 6.34 
REAGENT TABLE COMPARISON 
SCENARIO REFERENCE MODEL 
TEST MFT(hour) INV MFT(hour) INV 
GLUCOSE 202.95 6597 62 5518 
KETONE 161.8 953 104 772 
OSMO 132.95 9371 43 8045 
URINE 26.39 1403 62 1688 
VITAMIN D 173.56 3228 57 2817 
BHCG 69.34 1168 68 1081 
FOLATE 76.96 25673 55 54196 
HOMOCYSTINE 16.51 43812 81 804 
AAT 43.422 14472 29 14193 
G6PD 36.99 43498 26 31410 
HBAIC 52 897 126 1074 
VMA 204.86 2131 60 1963 
CARB 272.86 183896 83 81096 
FK506 202.96 36897 32 36331 
MTX 31.7 14445 54 12447 
OPIATES 14.53 67 13 353 
REAGENT MFT COMPARISON 
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CONTROLLER COMPARISON TABLE 
SCENARIO REFERENCE 
TEST MFT(hours) INV MFT(hours) INV 
GLUCOSE 15.2 38835 11 2203 
KETONE 16 13290 542 2433 
OSMO 20.8 16979 53 2559 
URINE 16.96 2742 13 571 
VITAMIN D 15.5 9111 12 941 
BHCG 16.6 5831 11 382 
FOLATE 15.5 109850 11 20107 
HOMOCYSTINE 17 1466 13 238 
AAT 15.7 51823 10 4637 
G6PD 311.7 9824 306 17221 
HBAIC 494.14 2623 197 316 
VMA 14.418 2 13 392 
CARB 14.22 296176 12 21692 
FK506 24.26 2984 12 14687 
MTX 19.72 36754 11 4089 
OPIATES 29.06 912 8 805 
CONTROLLER MFT COMPARISON 
  SCENARIO 
  REFERENCE 
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CALIBRATOR TABLE 
SCENARIO REFERENCE MODEL 
TEST MFT(hour) INV MFT(hour) INV 
GLUCOSE 292.6 636.45 62 2101 
KETONE 261.6 36.28 58 286 
OSMO 240.2 705.38 11 3028 
URINE 249.7 110.58 14 613 
VITAMIN D 78.1 187.09 14 1012 
BHCG 501.6 66.91 56 377 
FOLATE 263.4 6,120.73 55 20091 
HOMOCYSTINE 465.2 46.05 10 254 
AAT 311.1 1,323.46 68 4763 
G6PD 447.4 4,064.01 239 16331 
HBAIC 782.4 221.29 0 234 
VMA N/A N/A N/A N/A 
CARB 25.81 6,835.44 12 25469 
FK506 N/A N/A N/A N/A 
MTX 450 901.78 16 4498 
OPIATES 7.2 656.02 2 655 
CALIBRATOR MFT COMPARISON 
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6.6.3.1.3 Throughput 
Throughput of the test as indicated in Table and Graph 
6.35 was effected positively in the most of the tests. 
This is a result of availability of the supplies. 
Table and Graph 6.35 
The Throughput (rate of test/hour) 
SCENARIO REFERENCE 
TEST THROUGHPUT THROUGHPUT 
GLUCOSE 39.07 29.118036 
KETONE 1.68 1.3828767 
OSMO 5.25 4.1858447 
URINE 2.43 5.3260273 
VITAMIN D 2.31 2.2187214 
BHCG 0.04 0.2979452 
FOLATE 2.85 2.9504566 
HOMOCYSTINE 1.06 0.5760273 
AAT 1.1 0.9703196 
G6PD 1.05 0.4077625 
HBAIC 22.49 21.281735 
VMA 0.34 0.2605022 
CARE 5.51 4.9803652 
FK506 2.40 1.6050228 
MTX 1.05 0.0821917 
OPIATES 1.11 h 0.7038812 
THROUGHPUT COMPARISON 
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6.6.3.1.4 Inventory Status 
According to Table 6.36, there is a serious amount of 
change in the inventory of all components whether in the 
Lab or Logistics in comparison to the Reference Model; it 
172 
appears this is the worst scenario of handling the 
materials. This, in fact, expected results since the 
working mechanics of the adopted inventory policy 
concerns the maximum availability of the stock. Whenever 
any material stock level drops down to reorder level, the 
policy adopted immediately orders the item up to its 
maximum level ignoring the economic order quantity 
policy, which unnecessarily increase the level of stock 
mist of the time. This in turn causes a considerable 
amount of cost to the hospital. Some of the component 
like reagent (LABRE16) is less than the reference which 
may indicate to wrong calculation of safety threshold 
level. 
Table 6.36 
STORAGE COMPARISON (number of components) 
LAB STORAGE TABLE 
IREAGENT 
CALIBRATOR 
11CONTROLLER -1 
SCENARIO REFER 
COMPON VALUE VALUE 
LABRE1 2373 1482 
LABRE2 377 195 
LABRE3 4814 1918 
LABRE4 350 394 
LABRE5 1345 640 
LABRE6 500 248 
LABRE? 24923 13663 
LABRE8 227 284 
LABRE9 5959 3258 
LABRE10 13918 10988 
LABREII 291 242 
LABRE12 868 442 
LABRE13 145308 19076 
LABRE14 15219 9125 
LABRE15 6577 2893 
LABRE16 37 55 
SCENARIO REFER 
COMPON VALUE VALUE 
LABCAI 342 91 
LABCA2 14 12 
LABCA3 311 120 
LABCA4 23 23 
LABCA5 35 3 
LABCA6 15 1 
LABCA7 3337 76 
LABCA8 12 10 
LABCA9 662 183 
LABCA10 2290 671 
LABCAII 180 184 
LABCA12 N/A N/A 
LABCA13 2466 989 
LABCA14 N/A N/A 
LABCA15 351 167 
LABCA16 156 38 
SCENARIO REFER 
COMPON VALUE VALUE 
LABC01 37156 142 
LABC02 13189 142 
LABC03 14997 183 
LABC04 2702 39 
LABC05 9046 64 
LABC06 5781 24 
LABC07 108769 1448 
LABCOB 1436 15 
LABC09 51414 335 
LABCO10 267 28 
LABCOII 242 3 
LABC012 1 34 
LABC013 295387 1680 
LABC014 901 875 
LABC015 33971 267 
LABC016 194 39 
LOG STORAGE TABLE 
REAGENT CALIBRATOR CONTROLLER 
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SCENARIO REFER 
COMPON VALUE VALUE 
LOGRE1 4223 4036 
LOGRE2 575 577 
LOGRE3 4557 6127 
LOGRE4 1053 1294 
LOGRE5 1883 2177 
LOGRE6 667 833 
LOGRE? 750 40533 
LOGRES 43584 520 
LOGRES 8513 10935 
LOGRE10 29579 20422 
LOGREIZ 606 832 
LOGRE12 1263 1521 
LOGRE13 3588 62020 
LOGRE14 21678 27206 
LOGRE15 7867 9608 
LOGRE16 30 298 
SCENARIO REFER 
COMPON VALUE VALUE 
LOGCA1 293.76 2010 
LOGCA2 22.1 274 
LOGCA3 393.61 2908 
LOGCA4 87.1008 590 
LOGCA5 151.23 975 
LOGCA6 51.5157 362 
LOGCA7 2,783.0 19325 
LOGCAR 33.5154 244 
LOGCA9 661.44 4580 
LOGCA10 1,773.1 15660 
LOGCA11 41.2702 50 
LOGCA12 N/A 
LOGCA13 4,369.0 24480 
LOGCA14 N/A 
LOGCA15 550.02 4331 
LOGCA16 500.01 617 
SCENARIO REFER 
COMPON VALUE VALUE 
LOCCOI 1679 2061 
LOGCO2 101 2291 
LOGCO3 1982 2376 
LOGCO4 40 532 
LOGCOS 65 877 
LOGCO6 50 358 
LOGCO7 1081 18659 
LOGCO8 30 223 
LOGCO9 409 4302 
LOGCO10 9556 17193 
LOGCO11 2381 313 
LOGCO12 1 358 
LOGCO13 789 20012 
LOGCO14 2082 13812 
LOGCO15 2783 3822 
LOGCO16 717 766 
6.6.3.1.5 WIP 
Table and Graph 6.37 indicates work in process. The 
materials used in tests have fluctuated increased items 
and decreasing other considerably; as a result of the Im, x 
policy, which appears to be not applicable to healthcare 
because it do not proved a solution to the inventory 
rather increasing the work in process for some of the 
tests. However, this policy may be used for the strategic 
items, which shortage of them may cause serious 
consequences such as human life or serious illnesses. 
Table and Graph 6.37 
WIP COMPARISON(number of unfinished tests) 
SCENARIO REFERENCE MODEL 
TEST AVERAGE AVERAGE 
GLUCOSE 873 1487 
KETONE 3544 39 
OSMO 58 127 
URINE 2112 2208 
VITAMIN D 46 94 
BHCG 759 11 
FOLATE 7728 108 
HOMOCYSTINE 14 21 
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AAT 24 29 
G6PD 46 13 
HBAIC 4934 776 
VMA 0.3 8 
CARB 1284 161 
FK506 4085 3398 
MTX 736 499 
OPIATES 1701 38 
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6.6.3.1.6 Cost of Test 
The costs of each test are higher than the Reference 
Model (Table and Graph 6.38) because of the Imax policy 
is very costly, need more staff and resources to monitor 
and order the needed quantity. All recourses are included 
in the test value calculation. RIA Section cost did not 
appear. 
Table and Graph 6.38 
COST COMPARISON OF EACH TEST(in sterlina Pound) 
SCENARIO REFERENCE MODEL 
TEST AVE MIN MAX AVE MIN MAX 
GLUCOSE 1.91 1.34 2.86 1.909 1.3069 2.9198 
KETONE 2.70 1.28 2.76 1.7877 1.2774 2.6887 
OSMO 2.51 1.44 2.95 2.0059 1.4676 2.9917 
URINE 2.06 1.48 3.07 2.0554 1.50121 
_ 
3.0116 
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VITAMIN D N/A N/A N/A 6.7123 5.028 1442.09 
BHCG N/A N/A N/A 2.5506 1.9726 3.409 
FOLATE N/A N/A N/A 6.0894 4.8963 7.6853 
HOMOCYSTINE N/A N/A N/A 4.2361 3.487 5.3294 
AAT 2.86 1.64 3.07 2.146 1.5995 3.0629 
G6PD 2.09 1.44 2.83 1.9706 1.4252 2.9165 
HBAIC 6.12 3.15 11.75 4.1247 3.0526 11.6439 
VMA 4.24 2.46 4.41 3.2474 2.4026 4.1936 
CARE 1.68 1.19 2.56 1.6824 1.1864 2.6089 
FK506 2.35 1.34 2.81 1.8503 1.3458 2.7603 
MTX 1.44 1.00 2.12 1.4458 0.9949 2.1895 
OPIATES 3.15 2.13 3.24 3.3204 2.1464 3.3417 
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6.6.3.2 Secondary Performance Measures 
6.6.3.2.1 Equipment Utilization 
The equipment utilization is increased as the supplies 
and staffs are available. The maximum was the Biorad 
Vaviant II Analyzer (Table and Graph 6.39) 
Table and Graph 6.39 
EOUIPMENT UTILIZATION COMPARISON (nercentaae %) 
SCENARIO REFERENCE MODEL 
EQUIPMENT UTILIZATION UTILIZATION 
ABBOTT TDXFLX 4.1 0.1 
BIORAD VARIANT II 10.98 4.2 
CORNING CHLORIDE 925 ANALYZER 10.9 3.6 
DADE BEHRING BNII 1.01 0.1 
DADE BEHRING DIMENSION RXL 1.1 0.4 
DADE BEHRING VIVA TWIN 3.34 1.7 
ROCHE HITACHI E MODULAR AUTO ANALYSER 0.9 1.94 
IROCHE HITACHI P MODULAR AUTO ANALYSER 4.1 2.4 
SENARIO 
  ABBOTT TDXFLX 
" BIORAD VARIANT II 
4.06328 4 0742 
0.9000328 o CORNING CHLORIDE 925 
ANALYZER 
3.34 
O DADE BEHRING BNII 
1.06 
10.98C U DADE BEHRING DIM ENSION 
1.01299 RXL 
0 DADE BEHRING VIVA TWIN 
" ROCHE HITACHI E 
10.90201 M ODULAR AUTO 
ANALYSER 
G ROCHE HITACHI P 
M ODULAR AUTO 
ANALYSER 
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6.6.3.2.2 Staff Utilization 
The staff utilization is higher than the Reference Model 
(Table and Graph 6.40). The staff is reflecting the 
availability of supplies as well as high demand, 
especially the Medical Technology RIA which increased to 
the maximum in the lab, while Medical Technologist 
special chemistry to the minimum. It shows the unbalance 
of staffing distribution. 
Table and Graph 6.40 
STAFF UTILIZATION COMPARISON (Dercentaae %) 
SCENARIO REFERENCE MODEL 
STAFF UTILIZATION UTILIZATION 
BUYER 01 3.4007 1.129484 
MEDICAL TECHNOLOGIST CORE 
CHEMISTRY (Glucose, Ketone, 
Osmo, and Ur. Protein) 33.4327 12.33 
MEDICAL TECHNOLOGIST RIA 
(Vitamin D, BHCG, Folate, 
Homocytine) 99.98 23.51 
MEDICAL TECHNOLOGIST SPECIAL 
CHEMISTRY 
(AAT, G6PD, HBAIC, VMA) 11.49 49.2 
MEDICAL TECHNOLOGIST TDM 
(Carb, FK506, MTX, Opiates) 13.586 1.831827 
PHLEBOTOMIST 74.38 54.85 
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6.6.3.2.3 Material Order Size 
The material orders are (Table 6.41) fluctuated, the 
controller increased from 393 to 3494 which is a huge 
increase, the calibrator dropped by more than 70% and the 
reagent reduced by 5%. The number of orders does not 
indicate the quantity of each. The Imax policy requests 
the maximum quantity which may reduce the number of 
orders according to reorder level of each item. 
179 
Table 6.41 
MATRRTAT, nRnRR RTRR MMPARTRON 
SCENARIO REFERENCE MODEL 
NAME OF ORDER NUMBER OF ORDERS NUMBER OF ORDERS 
CONTROL 3,494 393 
CALIBRATOR 29 182 
REAGENT 511 532 
6.6.3.2.4 Queue Size 
As discussed in the lead time, similarly the queue size 
(Table and Graph 6.42) been reduced by 50 to 90% except 
the Opiates test which increased tremendously. The 
VITAMIN D, BHCG, FOLATE, and HOMOCYTINE tests are dropped 
to the minimum. 
Table and Graph 6.42 
QUEUE SIZE COMPARISON(hour) 
SCENARIO REFERENCE MODEL 
TEST AVER AVER 
GLUCOSE 13 101 
KETONE 22 57 
OSMO 28 60 
URINE 339 276 
VITAMIN D N/A 82 
BHCG N/A 73 
FOLATE N/A 72 
HOMOCYSTINE N/A 71 
AAT 30 61 
G6PD 39 63 
HBAIC 36 72 
VMA 42 60 
CARE 28 64 
FK506 40 41 
MTX 36 6 
OPIATES 287 108 
180 
QUEUE SIZE COMPARISON 
250 
150 
100 
50 
LU oow __`ý`ý! U fl 00zQQU co 0 QX Ö=0 
  SCENARIO 
i  REFERENCE 
6.6.3.3 Conclusion 
The lead time dropped tremendously except the Opiates 
tests. Inventory of component is very high in the reagent 
and calibration but controller is depleted. The cost of 
the inventory is very high, but on the other hand, the 
throughput is better than the Reference Model, WIP is 
fluctuated because the ratio of the available components 
and the material shelf life. Utilization of equipment and 
staff are increased representing the availability of 
supplies and other resources. This scenario show two 
important points, the first is the compatibility of the 
lab with the changes, as can be seen more component 
result of better throughput and short lead and queue 
times. But the other point need to be indicated is that 
the increase in the inventory level to the maximum. As a 
result of maximum inventory, more items are disposed 
because of expired item lives. The solution could be 
shifting the inventory toward the supplier to manage it 
by sharing some of the cost, so that the total cost would 
be reduced. 
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Chapter 7 
Discussion of the Results 
7.1 Introduction 
In this chapter the work on both the modeling and 
research experiments are discussed in order to allow a 
set of conclusions to be reached in chapter 8. The 
comments are made on the effectiveness of the 
experimental software. The competitive elements of the 
results produced in the research experiments reported in 
chapter 6 are further assessed. 
7.2 Modeling of Health Care Supply Chain 
Supply Chain concept was introduced in the manufacture 
industry in late 1950's. Over the time the concept has 
been implemented and improved to be as we know today, 
integrated supply chain with the help of the advances in 
information technology. On the other hand, healthcare 
supply chain has been extremely slow of adapting the 
concept, resulting in poor planning and increasing the 
overall cost. 
The first step in health care supply chain management is 
to identify the potential problems within the system. The 
literature in this field as reviewed in section 3.3 is 
relatively very poor. The available ones mainly point out 
the problems like high cost, supply waste, high inventory 
and inventory cost, poor response level, long waiting 
lists, nowadays; it became a routine to hear that patient 
lives have been under jeopardy because of unavailability 
of supplies or poor management of the assets. 
Health care setting is very complicated and dynamic. To 
model the health care supply chain system, there is a 
strong need for a deeper study of all the processes and 
relationships of all parties. However, modeling the 
system at this scale is difficult, challenging and the 
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data needed is beyond a PhD study. Therefore, this study 
covers a portion of the overall health care supply chain 
system and is centered on a chemistry lab in a local 
hospital considering all the relationships with the wider 
supply chain system. A case study in chemistry lab of 
King Faisal Specialist Hospital and Research Centre has 
been chosen. Several extensive interviews and close 
monitoring of the Lab took place to establish the true 
relationships with the other units of the hospital as 
well as other components of the health care supply chain 
system. A structure of the Lab has been developed 
involving all resources like staff, equipment, materials 
(See Section 5.5.4.2). This study concentrates on 16 
tests that represent the major activities and possible 
variations of them in the chemistry Lab. 
The broad aim of this study is to improve the efficiency 
of healthcare supply chain while reducing the escalated 
cost. To measure the system performance a set of metrics 
have been identified. Based on the Literature 
recommendations as it is introduced in section 3.5 and 
the author experience a selection of these performance 
metrics have been done, the motivation for is to observe 
the system performance within the organization as 
individual and interacting activities, so that a better 
picture could be obtained in understanding the system 
behavior. The classification of the performance metrics 
is based on the level of explanation about the system 
behavior they could provide. The first set of metrics is 
used to measure the direct relationships of activities 
such as throughput, lead time, flow time and WIP with the 
factors such as supply level and quality, inventory 
level, and demand pattern that affect the quality and 
dimension of aforementioned activities. The second set of 
metrics are used to measure the secondary activities such 
as staff and equipment utilization, queue size and supply 
order size with the general supply chain factors that 
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influence the overall system performance. These metrics 
are needed to get a better picture about the system 
behavior as well as to understand the interactions 
between the different elements of the processes to 
recommend a better solution. The followings are the two 
categories of these metrics used in this thesis: 
1) Primary performance measures, which consist of lead 
time, material flow time, throughput for component and 
test, inventory status, work-in-process (WIP), and cost 
of each test. 
2) Secondary performance measures are: equipment 
utilization, staff utilization, material order size and 
queue size. 
As this is the first large scale simulation model 
centered around the chemistry Lab, which connects all 
participants of healthcare supply chain, its general goal 
is to understand the working mechanics of this very 
complicated network, identify the possible problem areas, 
measure the dimension and effect of these areas and to 
recommend a suitable solution to these possible problems 
and improve the overall efficiency of the healthcare 
supply chain in general. 
For this scale study a model, which brings all the major 
elements of the health care supply chain has been 
created. However, this model has been built with an 
integrated structure, so all the performance of 
individual elements can be identified but at the same 
time, their interactions with each other could be 
observed using the performance metrics explained above. 
The integration among all elements is achieved in two 
ways. First, the information flows from patient to the 
rest of the supply chain. The Second is the flow of 
material from the supplier to the rest of the supply 
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chain. The mechanism to organize such the flow of 
information and the order of the supply is presented in 
section 5.5.4 and figure 5.2. 
It is worth noting that the past studies (see section 
3.5) in this field have severely limited focusing only on 
one element of the supply chain such as purchasing, 
inventory or cost without connecting all the 
participating supply chain elements together. 
On reflection it is considered that the model developed 
in this study (section 5.3) is more effective than any 
other approaches traced in the current literature (see 
section 3.4.3 for literature review on health care). 
There are many authors (such ab Jun et al, 1999; 
Weinstein et al, 2003; Issenberg et al, 1999; Wong 2004; 
McLaughlin et al, 2002; Bond and Spillane 2002; Murray et 
al, 2005) that have produced partial solutions, some 
analytical, some using simulation modeling, but none of 
them has embraced the whole issue of health care supply 
chain system as the work reported in this thesis. 
The professionals that try to solve health care problems, 
most of the time, are not equipped with the right tools 
and techniques as operations research or operations 
management practitioners do. They may be experts in 
health care but, health care system does not produce its 
own solution tools and techniques such as performance 
modeling, optimization, inventory control or supply chain 
management, and these must be borrowed from operations 
management / industrial engineering disciplines. This 
study uses one of these proven tools and techniques that 
have been used by the aforementioned disciplines in 
manufacturing or service sectors for a long time, which 
is the simulation technique. 
The issue must be pointed out that the model created is 
based on a number of scenario-based models (See Chapter 
6) each of one of which is regarded as a certain aspect 
of the supply chain system as discussed in section 6.4. 
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However, in practice there may be much more different 
problems and these may be experienced in a different way, 
even the same problem that is covered in this model, 
would generate different output. Therefore, these models, 
in practice, may need some certain degree of 
modifications to accommodate the operational guidelines 
required by a particular supply chain system for adequate 
operation. 
7.2.1 Software 
This research models the system performance along with 
cost performance. Simulation has initially been chosen 
because of modeling the details of complex systems such 
as health care supply chain, better than any other 
modeling tools such as analytical or artificial 
intelligent-based modeling tools, the need to interface 
the performance modeling to cost modeling was an obstacle 
whether simulation should be chosen as sole modeling tool 
or not (See Chapter 5 for detailed discussion). However, 
the cost modeling ability of the commercially available 
simulation software, Arena, has provided a powerful 
reason why this software tool needed to be chosen. Indeed 
the software used in modeling of health care supply chain 
has made a tremendous contribution to modeling effort 
spent to create this study by providing an excellent 
platform to model both the system performance and cost 
together so that tiresome interfacing different software 
systems and further coding are eliminated. Further, the 
cost of any activity take place within the system could 
be modeled separately as well as modeling the integrated 
parameters of the system give the facility to identify 
isolated or integrated cost of the actions taken in the 
system as part of the supply chain activities. 
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7.3 Comparative Assessment of Scenarios 
The work on scenarios has been reported in Chapter 6. A 
reference model has been created initially assuming that 
the entire supply chain system including the lab which is 
considered as a place where some core supply chain 
activities take place runs smoothly without any 
interruptions which may affect the system performance in 
a negative way. This has been needed to compare and 
understand the system performance under possible 
different operational obstacles which each may represents 
a specific problem experienced by the system occasionally 
or frequently. 
Each scenario targets a specific case in the supply chain 
operation. While keeping the rest of the parameters fixed 
one parameter is changed according to a possible 
variation in the operation of the supply chain. For 
example, depending on the season or extra-ordinary 
development such as outbreak of certain diseases, demand 
for certain tests for a certain time period may increase. 
Since this is not usual way of operating of the system, 
the supply chain would react to this new situation in a 
different way in comparison to normal way of operation of 
the system. Every new case is treated as an opportunity 
to understand the behavior of the supply chain system and 
is included into analysis. 
The reference model was run for twelve months and all the 
statistics collected are tabulated or graphically 
displayed using the primary or secondary performance 
metrics. 
The scenarios are designed to answer the research 
questions whether each new case would affect the overall 
system performance adversely or not. In another words, 
how all these variations in operation of the system would 
affect the rest of the parameters and different 
performance measures. 
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The primary and secondary performance metrics are used to 
understand the behavior of the system. The following is 
the detailed analysis of these metrics based on the 
different scenarios measurements comparing with the 
reference model. 
These scenarios are grouped as follows: 
A) Test demand fluctuation 
  Low customers 
" High customers 
  High demand 
  Some tests are lower 
  Some tests are higher 
  Longer lead time 
  Special line for emergency cases 
B) Resource Reliability 
" Unreliable equipment 
  Unreliable supplier 
  Short of staff 
  Repair is longer 
C) Inventory/Purchasing of supplies 
  Periodic review 
  Continuous review 
  Imax policy 
  Batches policy in purchasing 
  No funding 
7.3.1 Comparisons of Scenarios 
The First scenario is designed to see the system reaction 
to low flow of patients, as it would happen in long 
holidays. Apparently, this would cause underutilization 
of the equipment, staff and the available materials. 
Since some of the materials used in health care have a 
very short shelf life, some of the items in stock would 
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become obsolete, which in turn caused some extra cost to 
the system. System had to cancel some of the regular 
orders from several suppliers, which are based on some 
certain level of patient flow level expectations. 
Although it is not considered here, if there is contract 
between suppliers and the health care system for 
cancelled or unfulfilled deliveries, it would bring extra 
cost to the health care system. Therefore, it would be 
advisable that the system should sign more flexible 
contracts with its suppliers not face this kind of extra 
costs. 
All the system performance such as lead time, WIP and 
mean flow time have improved. This is simply because 
there is not pressure on the system now and all the 
required tests, which are comparably less, can now be 
done more quickly without any delay. 
The Second scenario was designed to measure the effects 
of unreliable suppliers on the system performance. As it 
would be expected the system has been affected from the 
irregular deliveries and long lead times in a negative 
way generating long lead times, longer queues, longer 
mean flow times, low throughput and very irregular stock 
movements in the organization. The late deliveries have 
interrupted some of the routine activities because of 
stock outs. The organization must ensure that the ordered 
materials arrive to the system within the promised time 
window. Otherwise, as it was experienced in the system 
the performance would suffer from these late or irregular 
deliveries. The solution would be working with dedicated 
suppliers for the critical materials. This may bring an 
extra cost to the system but system must calculate the 
cost of interruptions and cancellations as well as delays 
and must find out an acceptable threshold for the 
critical materials. 
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Third scenario is designed to analyze the system 
performance under a different inventory policy, which is 
I. I,, Ax is concerned setting the reorder point at maximum 
inventory level so that end of the determined inventory 
period placing an order is guaranteed. This policy, 
similar to the previous inventory policy, has guaranteed 
the material availability, which in turn affected some of 
the system performance metrics positively. One may wonder 
why inventory policies that guarantee the stock 
availability have been picked as inventory policies in 
this study. The justification comes from the strategic 
role of the health care systems and one of the very major 
parameters needs to be considered here is in fact a human 
life. Since there is no compensation for human life, 
these systems are forced to implement costly inventory 
policies to maximize the material availability. I has 
also improved the throughput by guaranteeing an 
uninterrupted material flow, but as it happened in 
continuous inventory policy it came with a cost. When 
this policy is compared to continuous policy it is 
realized that I,, m is more costly because of forced 
maximum stock availability. This also generated high 
equipment and staff utilization. The lead time and WIP 
have not changed much due to keeping the system 
operational conditions the same with the reference model. 
Another scenario presented below showing the inventory 
policy which can be implemented in the healthcare setting 
are selected with the above scenarios as it is important 
to see the feasibility of adapting it. The rest of 
scenarios are presented in the Appendix C. 
Scenario number thirteen is designed to analyze the 
system performance under continuous inventory policy. The 
continuous inventory policy makes sure that company 
monitors the inventory level continuously and whenever 
the inventory level drops down to reorder level or below. 
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This policy makes sure that the materials needed are 
always available. However, because of the special 
circumstances of the health care system, this must be 
guaranteed through a contract with the suppliers. 
Otherwise, suppliers are forced to keep continuous 
inventory as well, which many suppliers would not be 
willing to do so. Material availability certainly 
improved some of the system performance such as 
throughput, staff and equipment utilization. However, 
this uninterrupted lab activities come with a cost and 
the overall cost has increased dramatically because of 
high inventory carrying cost as well as more frequently 
ordering the needed items. The company must strike a 
balance between the guaranteed availability of the 
materials and the cost of carrying such load all the 
time. This is a crucial point from the cost aspect and 
probably some further study is needed to determine the 
optimum level of inventory for the hospital items which 
are more delicate and strategic in comparison to 
industrial items. 
7.4 Final Overview 
The work reported in this thesis falls into two 
subsections. The first is the introduction of a 
simulation modeling, which is being implemented in 
experimental software and has been shown to be a powerful 
aid to health care supply chain analysis. However, of 
course this does not attempt to cover all the issues in 
health care supply chain systems but does offer a major 
experimental study in which over 250 instances have been 
computed in order to develop a basis for understanding 
the performance of individual health care supply chain 
operational problems and their relative merits. 
The modeling method will be more effective if it is 
enhanced to include higher levels of supply chain 
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activities take place in other part of the supply chain 
network. 
The work on the use of scenarios has shown that a clear 
position can be taken on the relative value of a 
particular operational strategy in the health care supply 
chain system. 
It is thought possible to take the work beyond the point 
reached in this thesis in the development of these 
fifteen scenarios and in particular it is thought it 
might be possible to blend these scenarios together to 
produce a definitive and highly economic solution for the 
management of supply chain for the health care system. 
The following are the overview notes and recommendations 
" Any minor changing in any part of the supply chain 
network, this case in a chemistry lab, can be seen 
in remote parts of the network. The healthcare 
supply chain is very sensitive to all kind of 
effect wither is a malfunction of one of the 
component in the system or sudden fluctuation of 
the usage of cretin supply, which may create 
different reactions at different levels in 
different part of the network system. Therefore, 
it is strongly recommended that the supply chain 
parameters should be considered in a holistic 
manner when any action is taken within the system, 
which forces all the players of the supply chain 
to work closely or consult each other not to cause 
any serious outcome in any part of the system. 
  The suppliers, especially, play a crucial role in 
the network and their timeliness is absolutely 
important for the success of the entire network. 
Since the issue is a human life here, any 
interruption in the flow of materials, if the 
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system is not supported with a healthy stock 
policy, may end up with a disastrous result. 
" The supply chain network must secure the smooth 
flow of materials. This could be secured in two 
ways. One is to work with a set of dedicated 
suppliers by guaranteeing the purchases from them. 
This would force them to keep a certain level of 
inventory which takes the stock burden from the 
hospital but comes with a cost since bargaining is 
eliminated through elimination of alternatives. 
The second way is to keep a safety stock for the 
items that have longer shelf lives. However, these 
items are limited in health care and the company 
must generate a kind of pipeline-like supply 
system not to face any interruptions in its 
everyday operations and eliminate the excessive 
stock for many items. However, this needs a very 
careful planning and control and hospitals must 
create a separate unit to look after this vital 
issue. 
" The hospital system should always keep some extra 
suppliers that are quicker in supplying the 
requested materials. This, apparently a costly 
operation, however, it is necessary. Another 
solution for the hospitals would be to develop an 
emergency plan and identify the supplies shelf 
lives and order the items according to the 
importance of these items and their shelf lives. A 
simple ABC inventory plan could be a starting 
point to classify the stored items and more 
sophisticated solutions can be obtained following 
the inventory optimization models for perishable 
items. 
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" The health care system should make necessary 
arrangements such as timely supply of the material 
considering the shelf lives, or these short-shelf- 
life items should be ordered in small lots 
probably more frequently, with its suppliers not 
to face this kind of costs. 
" The healthcare supply chain system should consider 
all scenario cases and a proper plan to overcome 
any unexpected situation. For example of low 
inventory of the supplies is to find alternative 
suppliers or keep certain amount of safety stock 
depending on the shelf lives of these items. 
Another solution would be to force the suppliers 
to keep these items in their stock to respond 
quickly when requested by guaranteeing periodic 
purchases. But, since there is no guarantee that 
the demand for these items would be same all the 
time, the health care system and the suppliers 
should share the risk. 
" The availability of the equipment is absolutely 
vital for the timely activities within the system 
such as tests that use delicate chemical 
materials. 
" Therefore, as it was stressed in unreliable 
equipment scenario, the organization would keep a 
regular maintenance team to look after all the 
equipment periodically especially during the low 
season not to interrupt the system's activities to 
keep the equipment alive. 
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Chapter 8 
Conclusions 
Two major innovations are reported. The first concerns 
the use of a comprehensive simulation based model to 
support scenario-oriented operational policies. The 
results of the experiments based on this approach have 
produced a significant step forward the formal 
understanding of supply chain in health care systems. The 
second major step has been the inclusion of the 
simultaneous cost calculation using ABC model (see 
Section 3.6.2) alongside performance modeling efforts. 
The study of HCSCS, up to supplier level, is feasible and 
a comprehensive understanding of the system modeling can 
be achieved. It is also possible to achieve considerable 
economic benefits for supply chain operation through this 
work especially by identifying the possible inventory and 
supplier problems (see Chapter 6). Nevertheless, in order 
to gain the best results it is important that future work 
should be extended to include all the parameters that 
consider total health care supply chain systems. 
8.1 Contribution of this study to the health care research 
The conclusions drawn from the simulation model created 
are listed below: 
" Understand the supply chain management in 
manufacture and adapt it to the healthcare. 
Healthcare is suffering of the un-efficient 
mechanism of controlling the supplies. The needs 
to learn from the experience of manufacture how to 
best organize and optimize the supplies. By 
understanding the manufacturing process, it can be 
adapted to be used in the healthcare setting. 
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o Most of the problems experienced in health care 
systems are very similar to manufacturing 
problems. 
The manufacturing systems have been using some 
tools, techniques and methods that have been 
proven to be very efficient and effective in 
solving such problems. Therefore, the health care 
sector specialists should be trained to use these 
proven tools and techniques to solve their own 
problems and learn the best practices in 
manufacturing. This would definitely improve the 
efficiency of the problem solving techniques used 
in today's health care industry. 
o Inventory plays a vital role within the Healthcare 
supply chain system. Unlike manufacturing. 
Although it is very costly to keep inventory for 
thousands of items used in the system, two issues 
force the health care institutions to plan their 
inventory policies more carefully than any other 
organization in manufacturing. The first one is 
the sensitivity of dealing with human life and the 
second issue is the delicacy of the items that 
need to be stocked. The health organizations must 
find a balance to keep inventory for the short- 
life supplies and not affecting the healthcare 
provided to patients with reduced cost. Inventory 
optimization techniques can play crucial roles 
here to find this delicate balance. 
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o it is certainly possible to have a smoothly run 
health care organization in terms of system 
performance and cost. 
This needs an extensive coordination between all 
the major players of the health care supply chain 
network and unlike manufacturing supply chain the 
interruption in information and material flow 
cause vital consequences. 
" Supply chain is complicated need a model to 
capture all activities 
Healthcare systems are complex to be dealt with 
from an analytical point-of-view, especially when 
processes have characteristics like high variety 
and low quantity need, unexpected events, lack of 
planning, high cost, etc. In such scenarios, 
simulation comes up as a powerful tool for 
performance analysis and optimization. 
" Solution as an Integrated Health Care Supply Chain 
Model is needed to streamline the process and the 
environment of healthcare supply system. 
An integrated supply chain model is developed in 
the healthcare environment, in particular focusing 
on the Chemistry Laboratory. It focuses on 
relative performance modeling through cost and 
system performance modeling. It is not only giving 
particular benefit to reduce the cost or to 
improve the quality or to have an overall improved 
system, but a continuous monitoring mechanism is 
developed to measure all of these parameters for 
adjustment as required. Also, it provides a basis 
to know the effect of any change, like manpower or 
selling cost of a material, on the entire system. 
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The developed model can be beneficial for other 
Healthcare services as well. 
8.2 Further work 
This study has based on the activities take place in the 
chemistry lab within a large hospital and coordinated the 
supply chain activities according to its own priorities. 
From this point of view, even this study can be counted 
as a limited study at the health care supply chain scale. 
o The further work should include some more 
activities take place in a health care organization 
such as all the logistical activities, all the 
stock movements and all the supplier and 
manufacturers activities so that a better and 
holistic picture can be created to understand the 
further problems and generate better solutions to 
improve the system performance overall. 
o Since the stock keeping is very costly and very 
sensitive because of the delicacy of both materials 
and the consequence, the health care systems should 
ask experts to come up with a secure inventory 
policy probably using some analytical techniques 
such as operations research or industrial 
engineering methods and integrate it to its supply 
chain activities. 
o The cost calculation has been kept limited with 
including only the major cost items in this study, 
therefore, the cost found here, although they give 
an idea about the possible cost figure, is not 
precise cost figure. A further study is needed to 
identify the actual cost figures including all the 
activities, activity drivers, materials, labor and 
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non-operational activities such as support and 
utility work as well as detailed overhead including 
equipment and premises depreciation. 
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APPENDIX A: Notation and Variables 
When and Initial or Variable Type & It Represents why is it Affected by default name size 
used value 
a factor that 
represents This 
the variable is 
percentage of used to set 
Calibrator initial The value of 
usage in storage and this variable 
fixed comparison to order size is entered Ca 
value 
Reagents. of manually and 0.06 Multiplier (1) 
i. e. if a Calibrators is not later 
calibrator is by changed 
used one multiplying during real fourth the it by the 
reagents Reagent 
then: Ca demand in a 
Multiplier = year 
0.25 
CaLabOrder 
j This variable 
is only 
affected by 
This is itself. It 
used to updates 
Accumlative calculate 
itself every 
costs of 
the time an 
Calibrator fixed purchased purchasing 
entity passes 
value costs. This by the Costs 0 sCosts Calibrators. . (1) 
(Money paid variable 
is of new 
used by the arrivals Ca to buy) Purchased Assign 
Components module. 
Costs. (CalibratorsC 
osts+(Calibra 
torsPrice*Ord 
erSize)) 
The price of This is 
one used to The value of Calibrator calculate this variable 
fixed unit. That is the is entered Calibrator the amount of purchasing 
sPrice value Calibrator costs This 
manually and 0.25 
(1) 
enough for 
. 
variable is 
is not later 
changed one used by the during real calibration Calibrators 
only. Costs. 
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Co 
Multiplier 
fixed 
value 
(1) 
a tact-or that 
represents 
the 
percentage of 
Control usage 
in comparison 
to Reagents. 
i. e. if a 
Control is 
used one 
fourth the 
reagents 
then: Co 
Multiplier = 
0.25 
This 
variable is 
used to set 
initial 
storage and 
order size 
of Controls 
by 
multiplying 
it by the 
Reagent 
demand in a 
year 
The value of 
this variable 
is entered 
manually and 
is not later 
changed 
during real 
0.1 
It is set to Its value is 
1 if an order It is being altered by an 
has been altered Assign module 
issued. And when an when the 
when the order of order is 
Ca#Ordered 01 order arrives Calibrator# issued and 0 value it is set is issued, when the 
back to 0. # by lab or stock arrives 
is by and stored, 
1,2.. 11,13,15 logistics. during the 
or 16. simulation. 
Its value is It is set to 
altered by an 1 if an order It is being Assign module has been altered 
issued. And when an when 
the 
0,1 when the order of 
order is 
Co#Ordered issued and 0 value order arrives Control# is 
when the it is set issued, by 
back to 0. # lab or by stock arrives 
is 1,2.. or logistics. and stored, during the 16. 
simulation. 
` rder 
This variable 
is only 
This is affected by 
used to itself. It 
Accumulative calculate updates 
costs of 
the itself every 
ControlsCo fixed purchased purchasing 
time an 
sts value Controls costs. This entity passes 0 (1) 
(Money paid variable 
is by the Costs 
to buy) used by the of new 
PurchasedCo arrivals Co 
mponentsCos Assign 
ts. module. 
(ControlrsCos 
is+(Controlrs 
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Price*OrderSi 
ze)) 
The price of 
This is 
used to one Control calculate 
The value of 
unit. That is the this variable 
ControlsPr the amount of purchasing 
is entered 
ice 
Control 
costs. This 
manually and 0.15 
enough for variable is 
is not later 
one control used by the changed 
operation ControlsCos during real 
only. ts. 
These 
variable It is 
are used affected by (being 
the analysis adjusted) 
over a 
being 
Represents 
ll 
t processed, as 
LabCa#Stor Real the Lab s imulation 
these 
age value storage of to indicate 
analysis 
(1) component the withdraw Calibrator #. 
variability 
these 
of the components 
amounts of 
from Lab 
Storage to be 
components performed. in this 
storage 
These 
variable 
are used 
It is 
affected by (being 
the analysis adjusted) being 
Represents all over the processed, as 
LabColStor Real the Lab simulation these 
age value storage of to indicate analysis (1) component the withdraw 
Control #. 
ariability v 
these 
of the components 
amounts of 
from Lab 
components 
Storage to be 
in this performed. 
storage 
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LabRelStor 
age 
Real 
value 
(1) 
Represents 
the Lab 
storage of 
component 
Reagent #" 
These 
variable 
are used 
(being 
adjusted) 
all over 
t 
simulation 
to indicate 
the 
variability 
of the 
amounts of 
components 
in this 
storage 
It is 
affected by 
the analysis 
being 
processed, as 
these 
analysis 
withdraw 
these 
components 
from Lab 
Storage to be 
performed. 
These 
variables 
are used 
(being 
adjusted) 
during the Its value is 
simulation only changed 
Represents when 
the 
logistics when the 
LogCal6Sto Real the Logistics deliver 
logistics 
rage value storage of components 
respond to a 
(1) component to the lab, 
lab order or 
Calibrator 
or when when a new 
they issue stock 
arrives. a 
purchasing 
ordered to 
refill 
their 
stora e. 
These 
variables 
are used 
(being 
adjusted) Its value is 
during the only changed 
Represents simulation when the 
LogColStor Real the Logistics when the 
logistics 
value storage of logistics respond to a age (1) component deliver lab order or 
Control #. components when a new 
to the lab, stock 
or when arrives. 
they issue 
a 
purchasing 
ordered to 
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refill 
their 
storage. 
These 
variables 
are used 
(being 
adjusted) 
during the Its value is simulation only changed 
Represents when the logistics when the 
LogRelStor Real the Logistics deliver 
logistics 
age value storage of components 
respond to a 
(1) component to the lab, 
lab order or 
Reagent or when when a new 
they issue stock 
arrives. a 
purchasing 
ordered to 
refill 
their 
storage. 
It is set to Its value is 
1 if an order It is being altered by an 
has been altered Assign module 
issued. And when an when the 
when the order of order is LogOrdered 0,1 
order arrives Calibrator# issued and 0 Cal value it is set is issued, when the 
back to 0. # by lab or stock arrives 
Is by and stored, 
1,2.. 11,13,15 logistics. during the 
or 16. simulation. 
It is set to 
Its value is 
1 if an order It is being 
altered by an 
has been altered 
Assign module 
issued. And when an when 
the 
LogOrdered 0,1 when the order of order 
is 
and issued 0 Col value order arrives Control# is when the it is set issued, by stock arrives back to 0. # lab or by and stored, is 1,2.. or logistics. during the 16. 
simulation. 
It is set to It is being its value is 
1 if an order altered altered by an 
Logordered 0,1 has been when an Assign module issued. And order of when the 0 Rel value when the Reagent # order is 
order arrives is issued, issued and 
it is set by lab or when the 
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back to 0. # by stock arrives 
is 1,2.. 15 or logistics. and stored, 
16. during the 
simulation. 
it is used as 
counter, so 
it increases 
itself by one 
A counter to it is used with each 
determine if in Assign test, and 
enough number module when 
the 
Order Real of tests have called 
targeted 
Calibrator value passed and it "control # 
value is 0 
(1) is time to application reached the 
apply counter" in variable 
Calibration every test resets 
itself 
now line. 
to zero and 
starts 
counting 
again for 
next 
calibration 
It is used as 
counter, so 
it increases 
itself by one 
It is used with each A counter to in Assign test, and determine if 
module when the 
Real enough number called 
targeted 
Order 
value of 
tests have "control # value is control 1 (lý passed and it application reached the is time to variable 
apply Control counter" 
in 
resets itself 
now every 
test every t 
line. to zero and 
starts 
counting 
again for 
next 
calibration 
It takes 
PurchasedC Real Total money the value 
omponentsC value paid 
to of the 0 
osts (1) purchase expression: 
components "Components 
Costs,,. 
a factor that This The value of 
Re fixed represents variable is this variable 
Multiplier value the used to set is entered 0.1 (1) percentage of initial manually and 
Reagents storage and is not later 
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usage for order size changed 
about two of Reagents during real 
months in by 
comparison to multiplying 
Reagents it by the 
usage for one Reagent 
year. demand in a 
year 
Its value is It is set to It is being altered by an 
1 if an order altered Assign module has been 
when an when the issued. And order of order is 
Re#Ordered 0,1 when the Rea entl# g issued and 0 
value order arrives is issued, when the it is set by lab or stock arrives back to 0. # by and stored, is 1.. 15 or logistics. during the 
16. simulation. 
A given data 
describes the 
fixed number of Reagent 
value analysis demand in 
array performed in a year (16) a year for 
each of the 
16 tests. 
This variable 
is only 
affected by 
This is itself. It 
used to updates 
calculate itself every Accumulative the time an 
fixed costs of purchasing entity passes ReagentsCo 
value purchased costs. This by the Costs 0 
sts (1) Reagents variable is of new (Money paid used by the arrivals Re to buy) PurchasedCo Assign 
mponentsCos module. 
ts. (ReagentsCost 
s+(ReagentsPr 
ice*OrderSize 
This is 
The price of used to The value of 
one Reagent calculate this variable 
unit. That is the is entered ReagentsPr the amount of purchasing manually and 0.1 ice Reagent 
costs. This is not later 
enough for variable is changed 
one test used by the during real 
only. ReagentsCos 
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ts. 
To set The value of 
Defines the safety this variable 
fixed safety level levels, so is entered Safety 
value in Lab, with orders can manually and 0.5 Multiplier (1) respect to be issued is not later 
order size. early changed 
enough. during real 
Safety Multiplier*Re Sets Safety level for 
LabReSafty Multiplier*Reagent demand in Reagents in the Lab 
a year (#, l) 
Re Multiplier*Reagent demand Sets the order size the lab Re Order size in lab in a year (#, l) issues to request a Reagent 
Safety Multiplier*Co Sets Safety level for 
LabCoSafety Multiplier*Reagent demand in Control in the Lab 
a year (#, 1) 
Co order size in lab 
Co Multiplier*Reagent demand Sets the Order size the lab 
in a year (#, 1) issues to request a Control 
Safety Multiplier*Ca Sets Safety level for LabCaSafety Multiplier*Reagent demand in Calibrators in the Lab 
a year (#, 1) 
Multiplier*Reagent demand Ca Ca 
Sets the Order size the lab 
Ca Order size in lab 1) a ear (# 
issues to request a 
y , Calibrator 
Sets the Order size (the 
. 5*Reagent demand in a year 
Logistics issues to request 
ReLogOrder a Reagent from a supplier) (#ý1) 
to 0.5 of the annual 
performed number of tests 
Sets the Order size (the 
. 25*Reagent demand in a year 
Logistics issues to request 
CoLogOrder 
(#ý1) a Control from a supplier) 
to 0.25 of the annual 
performed number of tests 
Sets the Order size (the 
Logistics issues to request 
CaLogOrder . 
25*Reagent demand in a year a Calibrator from a 
(#, 1) supplier) to 0.25 of the 
annual performed number of 
tests 
3*Safety Multiplier*Re Set safety level of the 
Re LogisticsSafety Multiplier*Reagent demand in logistics for the Reagents 
a year (#, 1) to 3 times the safety of the 
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Lab. 
Set safety level of the 3*Safety Multiplier*Re logistics for the Reagents 
Co LogisticsSafty Multiplier*Reagent demand in to 3 times the safety of the 
a year (#, 1) Lab. 
Set safety level of the 3*Safety Multiplier*Re logistics for the Reagents ! Ca LogisticsSafety Multiplier*Reagent demand in to 3 times the safety of the 
a year (#, 1) Lab. 
ReagentsCosts+ControlsCosts+C 
Sums the purchasing costs 
'ComponentsCosts 
alibratorsCosts 
(money paid to buy 
components) 
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APPENDIX B: The Chemistry Lab Tests by ARENA 
The section of Clinical Biochemistry is a major Section in 
the Department of Pathology Laboratory Medicine. Its value 
is the measurement and analysis of blood and urine 
Chemistry, it consist of four sections as follow: 
A) Core Chemistry Section: 
It is measuring General Chemistry assays, Renal Profile, 
Hepatic Profile, Lipid Profile, Cardiac Profile, 
Osmolalities, and Urine Chemistry. 
1. Glucose Assays : 
The function of the test is checking for glucose level 
for diabetic and non-diabetic patient. 
Separate 61 
Core Chemis 
r- GLUCOSE 
0, 
j Comp arrival 
im Chemistry 
QUCr6E 
Decrement 
Qeat work list 
for Q1 E 
;, ý-_ componeNs 13 
application 
counter 
Cý 
Load in the Perform the Tes 
Anatyzer(or QL 
aux 
o° 
Doan load from 
Pathnet for 
QUOOSE 
Reviewthe 
suit from the 
Mayzerfor 
QUOOSE 
use a unit of 
contml13 
ýmponents 13 use 
time? 
use a unit of 
ý° ! Calibrator 13 
0; & mnrtl C\ 
ý Gspose 278 
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2. Ketone: 
It is one of the glucose derivatives used for diabetic 
patient and newborn babies. 
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3.0 smo : 
It is used as an indicator for hypertension and measuring 
osmolality after dialysis. 
Separate 63 
P load in tie 
Core Chemistry 
p 
kalyzerfor 
Decrement 
Rnth 
Qeatwork list for 
0'ý1 forOSMO 
0ý 0 
ponents 15 
me? \ 
J/> 
orb mYia 
Orm Cosa 64 
H 
Peroim the ras 
csmo 
OviewResu 
Mayne on line Pathi 
SM0 forCSMO 
0G 
II 
} Dspose 280 
use a unit of 
control 15 
use a unit of 
Calibrator 15 
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4. Urine Protein : 
It is used as an indicator for kidney function. 
--- , 'ý---- -prepareand Redo rm the uCbte Chemistry ve gnt the Test lJ ¬ 
Separate 64 LR PROTEIN sample for PROTEIN 
oro' Decrement 
ore C hemis 
INE PROTE 
Comp amval Load in the 
ýý ew fbsults 
for Core on Ime P 
Ch 
alhnet Malyzerfor torlldPE emistry NE U try PROTEIN 
components 16 ponenls 18 us aPPli ation lm 
conho 
counter \ 
use a unit of pspose 261 
-\. 118 
o, a. mn, a n 
ora oce. m Luse 
a unit of 
Calibrator 16 
B) Radio Immunoassay Section (RIA): 
It is testing Hormones, Tumor Markers, Radio-isotopic assays, 
Cardiac markers and Anemia markers. 
S. BHCG1: 
The function is Tumor marker and to determine pregnancy. 
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RIABHCG 
Separate 50 PoABItCG , ýýsl heetfor Compamval Decrement BHCG 
Prepare Ne --- 
Specciemn for 
Auto Analyzer Perform the geviewResults 
BI GTest line PaMnetfo 
0 BHCG 
Q0 
Components 2mponents 2 usa applicaboo time? use a unit of counter control2 
orm ým aspoJ267 
OrB ODraa 22 
use a unit of 
Calibraror2 
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6. Folate (Red Cell): Anemia marker. 
rsh 
ing 
Builtlth e Incubatsonfor PeAFoatelest 
worksheet for 
Staf Incubation 
ýýe Fl 
RIA FOLATES FOLATE 
forfloate 
4test 
RIA FOLATE 
ecrement 7 
Incubate for Load in the - 
n? t2aledlhe 
SLA TE Analyzer 
epa2te51 samde 
onoýýýi i'0 90 
Duplicate 
m%3 mponenis 3 us 
l__, 
ication ýý time7 use a unit of 
cýuýaý ýý T contýl3 
Else 
OrdrcGGont 130.10 
OrdeerC tor30.20 
use a unit of 
Calibralor3 
Dispose 268 
0 
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7.1.25 vitamin D: Bone development marker. 
RIA 
25V hA MIN 
Camp amval 
RadPrepanng ýinishRepann 
the Specciemn the Specciemn Sarting finishing 
Extract the Extract the Incubator Incubation 
samlpe 
F, 
h, samlpe 
Build the 
Prepare Me 
A 1.25NTA1111 Specciemn xorkshee(for Eztractthe Separate 49 DDecrement 1.25 NTAMIND 
o, " samlpe 
ow `7 
-'ý use a unit of 
control 1L 
46mponenfs 1 usa 
conloI1 ý\ lime, 
Dispose 266 application 
use a unit of 
Calibrator 1 
omýnra o 
Oftr 
Id 
Dc 
8. Homocystine: Cardiac risk marker. 
Load in the 
RIA RIA Build the Analyzer for HOMOCYSTIN worksheetfor HOMOCYSTIN Run the Anayz HQMOCYSIINEC Decrement HOMOCYSTIN 
ainval 
000 
Stair J52 
useaunitof 
HOMOCY 
Secomponents 4 control 4 test 
application 
4omponents 4 usag 
counter time? 
0 Duplicate 
Load in the 
RIA Build the Analyzer for 
isse 
HOMOCYSTIN worksheet for HOMOCYSTIN RuntheAnayz 
Decrement HOMOCYSTIN 
00 
Starting 
useaunitof 
HOMOCYSTIN 
components 4P co control 4 test 
or application %'omponents 4 usag 
counter time? 
cai 
Else 
ordercoet i4>-1o use aunitof 
Order CalibIM41! 20 Calibrator4 
1 Dispose 269 
Assesses 0 
dad Pedommng 
to lest 
Finishing Ieuiewthe 
Performing the Ibsult from tl 
the Tes test 
F 
kayzer 
Lincubate fort 
second time 
PerbrtnftTest Review Results 
lbr on line Pathnet 
HOMOCYSTIN for 
HOMOCYSTIN 
00 
test 
I 
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C) Special Chemistry Section: 
It is measuring Special Proteins, HbA1C, Caffeine, Sweat 
chlorides, and Extensive menu of miscellaneous manual assays. 
9. Alpha-l-antitrypsin (AAT): 
This assay is useful for work-up of individuals with 
suspected disorders such as familial chronic lung 
disease. 
Special Build the Run the 
Special Chemistry AAT jI Worksheet for Anayzerfor 
CherpcfnAAT Separate 53 pecrent AAT AAT ýý7 Original , 
Coq amVaf 
NP Ica to 
Load in the 
Analyzer for 
AAT 
0 
componena 5 Om ponenls 5 
application 
coupler ý 
Review Results 
an line Pathnet 
i forAAT 
0 
use a unit of 
cord 5 
Else 
Orderconto 5o"t0 
Order Ceh liter5o 20 
use a unit of 
Calibator5 
Dispose 210 
0 
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10. HBAIC: 
It is useful in evaluating the long-term control of blood 
glucose concentrations in diabetic patients. 
Perform the Tes 
ýview%sults o 
Load in the HBeC line Path net for 
H 4c 
Malyierfor FBWC 
RAC 
0 
peel 
"nfoIthßnayz 
Separate 55 Special Chemist Chemistry org. CDacremen Deallist alutionfor 
HBA IC Comp fßNC FBWC 
ýCnticalPesultio 
41 
com n 
Olutionforhßal 
! ". 
ýÖmponený 7 use use a unit of 
ý Gme? T control 7 
b 
0 
0rm 
ri mlroOYta I -W 
l1 .;... 
use a unit of 
Calibrator? 
w 
L'Fepo,, 
Iesolt 
Phone for lß4 
qi Dspose272 4- 
11. VMA (Vanillylmandelic Acid): 
It is useful for screening fro vascular tumor. 
IeviewPosults 
on line Pathnet 
for IßJC 
228 
etbdrVM 
Review Resul Down loa to Special Creatwork list Pathn on line Pathnet 
I 1c 
ChemistrVM forVMA for VMA Special p Decrement 
Chemistry Separate 56 0 
Comp arrival °np'"a' 0 
a, pi ate Prepare the 
Reagent Perform the Tes 
VMAmanually 
components 8 
application 
counter 
omponents 8 uc 
6me? 
Else 
Order control 8>=10 
trderCalibra r8>=20 
conaol8 I II 
Dispose 273 
use a unit of 
Calibrator8 0 
12. G6PD: 
G6PD deficiency is the most inborn error or metabolism, 
affecting over 100 million people with varying degrees of 
hemolytic disease. 
S pecial Load in the 
Chemist Analyzer for 
G6PDry G6PD Perfonnthe 
Decrement Test UP D 
Special 0 
Chem shy 00 
G6PD Comp S eparate 54 L 
Creatwork 
DuDhco. 
Rn 
the 
IistforG51D 
I AGBPDfor 
0 
components 
application 
6 mponý e6 us 
T 
use a unit of 
counter I control 
B 
Order conlrol 6>"10 
Order C. lbr. tor 61.20 
use a unit of 
Calibrator 6 
Review 
Results on 
line P athnet 
forG6PD 
0 
DiN 6po$; 271 
ý0 
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D) TDM Section: 
It is measuring Therapeutic Drug and Monitoring Drugs of 
Abuse. 
13. Carbamazepine (Garb): Anti-convulsion marker. 
Separate 57 
or Tpd CM Decrement 
TDM CARB components 9 
Comp amval 
L 
application 
counter rýý 
14. FK506 : 
Aliquoted into 
cups 
pretreated for 
Clftest 0 
Centrifuged for Perform the 
L Crest Kork list M Test CRAB 
for CARE 
0ý v 
use a unit of 
control 9 
omponents 9 use 
time? 
use a unit of 
B8 Calibrator? 
0rm Cal m 0 da Otrüa 
Dispose 274 
The test Immuno-suppression is for liver and kidney 
transplant. 
230 
TDM FK506 
Decrement 
Separate 58 i, 
Oro ", Aý 
TDM FK506 
Compamval 
components 
10 
application 
counter 
Preheated the 
sam le before Perform the Tes 
anaysis for RG06 
FK506 
CC0 
xý %Jb CSA Dilution to 
FK506 
Oeat work list 
1orFK506 ýI F1,30( 
dfar CSAaýution 
0 roe 
0 
ömponents 10 us 
time? use a unit of 
control 10 
n 
Ord ame 
orm oo-au 102 Luse 
a unit of 
Calibrator 10 
LI 
Qlever FMO6 
results 
aspose275 
15. Methotrexate (MTX): 
Inhibit the development of neoplasm's cells, which is 
related to cancer. 
Decrement 
P 
TOM MTX 
Qeat vork list Li 
for MTX redortn the Tes // 
MTX i hb RLX1 or TD( 
alution 
DM MTX Corn 0 Rd. 
arrival 
-- -- - Ad Gan Dugs 0 Diubon 
Separate 59 
0 
Feve: 
nQ MTX 
results 
use e umt of 
control 11 
components 11 ponents 11 us 
-ý, application time? 
counter 
use a unit of Dispose 278 
11 Calibrator 11 
a, r0 
01 rd 1.10 n. n. M. ýrr rom 
231 
16. Opiates : 
This test is checking of drug abuse for psychiatric 
patients. 
TDM CRATES Prepare the 
----------- 
Decrement forCmat 
work list list sample 
ii J64 
Se0 
Opae 
I components 1 
application 
counter 
1DMOPIATE use aunit of 
Comp amval 
Lusa12 
time? 
ij 
Dispose 277 
0ý 11 0 
form the 1 
CRATES 
manually 
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APPENDIX C: Scenarios from Number Four to Number Fifteen 
The scenarios have been designed as part of the simulation 
modeling of health care supply chain. However, because the size 
of the output, we have put only selected scenarios to the main 
chapter that reports the modeling efforts (Chapter 6), the 
remaining scenarios has been given in this Appendix for the 
further explanation and insight. 
1. Scenario Four: High Customer Level Arrival Rate 
The patient arrival module has been modified to 
exponential with mean 10 arrivals per second. This change 
is representing the arrival of patients in a faster rate 
while maintaining the maximum number of patients. 
Controlling the flow of patients is not possible, but by 
monitoring the patient demands over a period of time the 
fluctuation between high and low can be determined. It 
depends on the seasonal holidays, emergency cases, and 
unpredicted military or environmental situations. From 
Table 6.14 it can be seen that by this changes how the 
Chemistry Lab is affected. 
1.1 Primary Performance Measures 
1.1.1 Lead Time 
Increasing patient by requesting more tests as it is 
shown in Graph 1, the Lab cannot cope up with this sharp 
increase. It appears that longer the lead time some tests 
like BHCG, Vitamin D, Folate, and Homocystime are done 
less because of the staff time. The longer test times 
(lead times) kept the staff busy with relatively few test 
types only and these tests have consumed all the allotted 
time of the staff which in turn resulted with not 
accepting more tests. 
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1.1.2 Material Flow Time 
To perform any test indicated in Graph 5.1, there should 
be three components except for Test 12 & 14, which have 
only 2 components each, material flow time is very 
essential. It affects the level of inventory and the 
throughput. The fluctuation between decreasing and 
increasing affect the outcome of the Lab. 
Graph 2 consists of three parts; one is calibrator to 
indicate maximum difference in the reference in Test # 
11, the special chemistry HBAIC with difference of 635. 
Second is controller; as we can note the similarity with 
the Reference Model. The third is the reagent which 
generally was average. As illustrated in the Table and 
Graphs, the materials that are used in certain tests have 
dramatically increased because of the high number of 
tests done as a result of increasing demand. Apparently, 
these materials need to be ordered either more frequently 
or in bulk, which in turn may cause high inventory cost. 
The inventory section must come up with a plan to answer 
this high demand case not to cause any interruption in 
TESTS 
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the tests, which may be very costly for the organization, 
such as lose of human life. 
Graph 2 
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1.1.3 Throughput 
As it can be observed from Graph 3, the throughput has 
been negatively affected from the high demand rate. One 
major reason for this is the Lab cannot work productively 
under the pressure. Another reason could be the Logistics 
Department is not prepared for this high demand and some 
of the materials used in the tests are not available to 
do the test, which cause a low throughput. In this 
experimentation, we assumed that the inventory level was 
kept at the same level as demand is normal and no special 
purchase was made for the high demanded materials. This, 
in fact should trigger the Logistics Department to act 
immediately and order all the materials used more for the 
new case. 
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1.1.4 Inventory Status 
Most of the component inventory has increased because of 
the high order of some materials with increasing demand, 
but some still have low inventories, while the demand is 
high. This will be discussed at the end of this scenario 
in the conclusion. 
1.1.5 WIP 
Without any doubt, a high percentage of work lagged 
behind, as the Lab could not match with the high demand 
as we can see in Graph 4. There is a very dramatic 
increase in the number of WIP generated by high demand 
level. 
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120000 
100000 
80000 
60000 
20000 
Z 
Ü 
U 
WIP COMPARISON 
LU w 
UQQ 
m 
2=O 
m 
  GLUCOSE 
" KETON E 
DOSMO 
O URINE 
  VITAMIN D 
10 BHCG 
" FOLATE 
O HOMOCYSTIN 
E 
  AAT 
  G6PD 
1.1.6 Cost of Test 
Graph 5 shows that there are only limited number of 
tests, which were effected by high demand, such as 
Vitamin D increased three times, while the other test, 
Folate decreased by half. This, in fact, is a result of 
the high demand for some of the tests. 
Graph 5 
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1.2 Secondary Performance Measures 
1.2.1 Material Order Size 
There are two components have high number of order size, 
the reagent and the controller, while the calibrator 
decreases from 182 to 154. 
1.2.2 Queue Size 
The queue size increased tremendously for all tests 
except the RIA test, which dropped and cannot handle more 
tests, as indicated in Graph 6. In fact, this can be 
observed from the WIP level, which is a major source of 
queue size. 
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Graph 6 
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1.2.3 Equipment Utilization 
There is not much difference in the utilization of 
equipment (Graph 7), only the Roche Auto Analyzer dropped 
from 1.9 to 0.001. 
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1.2.4 Staff Utilization 
From Graph 8, the staff utilization is almost the same 
with the utilization level observed in the Reference 
Model, but Medical Technologist RIA work utilization has 
jumped to 99.97 from 23.51. 
Graph 8 
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1.3 Conclusion 
Ten performance measures have been studied for in case 
number of patient has increased dramatically because of 
any reason. The Chemistry Lab reacted differently as 
stated in the following points: 
  RIA section cannot handle the load, as the number 
of staff allocated for this job is limited. This 
section needs more staff or proper resource sharing 
to handle this much work loads within a reasonable 
time. 
  Most of the problems of the WIP, queue and longer 
lead time come from the improper handling of the 
materials as shown in Tables and Graphs from 6.16 - 
6.19. The system is not prepared for this kind of 
sudden increase in demand and kept the same level 
of inventory as normal times. This caught up the 
system in an unexpected way and the system could 
not react in an agile manner to recover quickly by 
ordering more materials of needed type in a short 
time. Since each material has a certain lead time 
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to deliver, during some period of the time the 
system had to work without any proper supply which 
in turn caused some serious delay in process 
leading long lead times, high WIP and queue levels 
and under utilization of equipment and staff. The 
system may be prepared to keep some amount of 
safety stock for some of the materials that are 
used more frequently to protect itself from these 
kinds of malfunctions. 
2. Scenario Five: High Customer Demand Level 
Patient's arrival module has been changed for this 
scenario to normal (1.5) arrival per minute. It is hard 
to predict patient's arrival, but having more scenarios 
will cover most of the patient arrival pattern. This 
scenario will provide a platform for understanding of 
steady flow of patient, at the same time high percentage 
of test requested, and how the system will react to it. 
2.1 Primary Performance Measures 
2.1.1 Lead Time 
The constant arrival of patients has a big effect to 
lead-time; it is the same as we have low demand with 
exponential arrival. Graph 9 proves this except for 
protein analysis. 
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2.1.2 Material Flow Time 
Material flow time for the three 
calibrator, and controller) have 
increased MFT, with the exception 
expectation was the same as any 
demand flow of material got slower. 
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2.1.3 Throughput 
Throughput of the tests has dropped. Similar to section 
(6.6.1.1.3) one of the reasons for this drop is the staff 
limitation of work under pressure of high demand, also 
the reorder mechanism in the Logistics department and 
unavailability of the items can be the cause of low 
throughput. (Graph 11) 
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2.1.4 Inventory Status 
The information indicates the reagents for all test are 
compensated to match the demand, on the other hand 
calibrator and controller are not affected as expected. 
This gives an indication of poor planning. As demand for 
more tests increase, component inventory should be 
increased. Missing one type of material will stop the 
performance of any related test. 
2.1.5 WIP 
WIP is showing a decrease in all tests, which indicate a 
constant arrival of patient, will yield a decrease of 
work in process. Availability of recourses is one of the 
reasons of this result. (Graph 12) 
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2.1.6 Cost of Test 
The cost of each test is not much different than the 
Reference Model (Graph 13) because of the throughput of 
the tests are less than the Reference Model. As the price 
was expected to be less but the staff and resources are 
still included which raise the cost to be the same as 
Reference Model. Also the RIA test did not appear as an 
indication of not performing the tests. 
Graph 13 
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2.2 Secondary Performance Measures 
2.2.1 Material Order Size 
The material orders have been dropped by more than 20%. 
This indicates the availability of materials is high and 
because of poor planning and less throughput the order of 
material was less. 
2.2.2 Queue Size 
As discussed in the lead-time, similarly the queue size 
(Graph 14) has been reduced to more than a third in some 
test, while RIA section did not produce any result. 
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Graph 14 
2.2.3 Equipment Utilization 
The utilization of the equipment (Graph 15) has been 
dropped. It is not expected to be lower while the demand 
is high, but the increase of WIP and decrease of output 
make the equipment under utilized as intended to be. 
Graph 15 
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2.2.4 Staff Utilization 
The staff utilization is lower than the Reference Model 
(Graph 16) except medical technology RIA which increased 
to the maximum, showing the imbalance of staffing 
distribution. It is expected with high demand to utilize 
the staff to the maximum. Staffing may not be the only 
reason of low outcome, it may be the supplies. 
Graph 16 
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2.3 Conclusion 
With high demand and a steady flow of patient the lead- 
time is becoming lower, but the inventory and WIP are 
higher. It is very unique situation, having a high demand 
for tests, under utilization of staff, and reducing the 
number of materials order. The best explanation of this 
situation is lacking of planning and not preparing for 
extreme situations in the Chemistry Lab. 
3. Scenario Six: Some Tests are Severely Higher than the 
Rest of Tests 
The percentage of test arrival of core chemistry glucose 
test has been changed to 42% of total arrival. Chemistry 
Lab as discussed consists of different sections. Some 
resources are separate, and some are shared, increasing 
demand of one test may affect the performance of other 
departments as well, as indicated in the following 
performance measures: 
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3.1 Primary Performance Measures 
3.1.1 Lead Time 
As shown in Graph 17 the average lead-time is slightly 
higher by S to 10%. The effect of the increasing demand 
of the Glucose test dose not make a major change to rest 
of the tests. It does effect the core chemistry section 
because of the more staff are utilized more to perform 
the Glucose test. However, the other tests were affected 
in a negative way causing longer lead times because of 
the disturbance of the percentage of demand tests. 
Graph 17 
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3.1.2 Material Flow Time 
More than 70% of all tests are positively affected, which 
means less materials move around as result of dropped 
demand, by the Glucose test increase. This is valid for 
the reagent and calibrator. Controller on the other hand 
is less by the same percentage. This is indicated in the 
Graph 18, which consists of reagent, calibrator, and 
controller. 
252 
Graph 18 
CONTROLLER MFT COMPARISON 
  SCENARIO 
  REFERENCE 
CALIBRATOR MFT COMPARISON 
253 
" '3 14 15 16 
3.1.3 Throughput 
Throughput of the test as indicated in the Graph 19 was 
effected negatively; the flow of material was high with 
limited component inventory causing the drop not only in 
the Glucose test but in all of the tests. Availability of 
supplies is the major cause of this problem, better 
planning could prevent it. 
Graph 19 
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3.1.4 Inventory Status 
There is not much change in the inventory of all 
components whether in the Lab or Logistics with the 
Reference Model except test number 16 TDM Opiate which 
increased tremendously without any usage. As indicated in 
the throughput section (6.6.4.1.3) the inventory did not 
match with the change in the test demand, which caused 
the drop of the outcome. 
3.1.5 WIP 
Graph 20 indicates work in process for all tests. As 
expected with high demand and low outcome the specimen 
will be waiting to perform the test in the Lab causing 
the increase of WIP except for one test, the Protein 
Urine Analysis. 
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3.1.6 Cost of Test 
The cost of each test is not much different than the 
Reference Model (Graph 21) because of the staff and 
resources are still included in the test cost 
calculation. Two tests are lower; Vitamin D, and Folate 
which may relate to the mean flow time which less for 
these two tests than the Reference Model. 
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3.2 Secondary performance metrics 
3.2.1 Material Order Size 
The material orders have been the same without any effect 
of the high Glucose test demand related to lacking the 
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proper reorder mechanism for both Chemistry Lab and 
Logistics Department. 
3.2.2 Queue Size 
As discussed in the lead time, similarly the queue size 
(Graph 22) has been increased to more than a third in 
some tests, which prove unavailability of supplies cause 
the delay of performing tests. 
Graph 22 
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3.2.3 Equipment Utilization 
The utilization of the Lab equipment has been the same 
with exception of Roche Hitachi P Modular Auto Analyzer, 
which increased slightly to overcome the 42% increase of 
Glucose test. (Graph 23) 
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3.2.4 Staff Utilization 
The staff utilization is the same as in reference 
(Graph 24) except the Medical Technology RIA that 
decreased by 50% as a result of low outcome. 
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3.3 Conclusion 
The first thing we noticed was the increase of lead-time 
by 20% for glucose testing and in the rest of the tests. 
  Throughput of the tests effected negatively while 
staff utilization did not change except the Medical 
Technologist RIA which showed a slight change. 
  Supplies play a major role of the end result. As we 
can see; short of component which can not match the 
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demand increase causing drop of the number of 
result the Lab can produce. 
  Unavailability of supplies related to reorder 
mechanism in the Chemistry Lab and in the Logistics 
Department show an inefficient system. 
4. Scenario Seven: Some Tests are lower than the rest 
As we did in the previous scenario by increasing the 
demand for Glucose test by 429, with the same test we 
change the percentage of test arrival of core chemistry 
glucose to 10% of the total arrival; this is to see the 
effects on the outcome for the whole Lab. Selection of 
Glucose test as an example (it can be any test). The 
chemistry Lab should be prepared to cope up with these 
kinds of changes and to utilize the resources as 
required. 
4.1 Primary Performance Measures 
4.1.1 Lead Time 
The lead-time as shown in the Graph 25 dropped by 30 to 
50%, showing the reaction of the Lab to low demand even 
from just one test. But two tests react in an opposite 
manner, with an increase in lead time; MTX and Protein 
analysis. Other factors like inventory of the components 
can cause a drop in the lead-time. 
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4.1.2 Material Flow 
Two sections in the Lab are effected, Core Chemistry 
and RIA for the reagent, while the calibrator and 
the controller were not targeting any section but 
rather individual test as illustrated in Graph 26 
which consist of; reagent, calibrator, and controller. 
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4.1.3 Throughput 
Throughput of the test as indicated in the Graph 27 was 
effected negatively by decreasing the 
demand; the flow of 
material was high with limited component 
inventory. This 
result was expected reflecting the low number of 
requesting tests. 
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4.1.4 Inventory Status 
According to the data, there is little change in the 
inventory of all components whether in the Lab or 
Logistics with the Reference Model. In fact, the 
inventory should be less as the demand reduced, but lack 
of coordination between the Chemistry Lab and Logistic 
can be the cause of the overstock. 
4.1.5 WIP 
Graph 28 indicates work in process for all tests have 
been decreased. The demand was less only for Glucose 
tests, but the effect of it was to all tests including 
Glucose for WIP. 
Graph 28 
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4.1.6 Cost of Test 
The cost of each test is not much different than the 
Reference Model (Graph 29) because the staff and 
resources are still included. The WIP is high so the 
staff and other resources are busy maintaining the cost 
constant of the most tests. Except the tow tests of RIA 
section; BHCG and Homocystine which can not calculate the 
cost for them. 
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4.2 Secondary Performance Measures 
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4.2.1 Material Order Size 
The material orders have been increased for control and 
calibrator also dropped by 5% to match the low demand. 
4.2.2 Queue Size 
As discussed in the lead time, similarly the queue size 
(Graph 30) was reduced to more than a third in some 
tests, which is normal to match the low demand. There is 
a particular problem protein analysis, which needs more 
study. 
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Graph 30 
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4.2.3 Equipment Utilization 
The utilization has dropped matching to patient 
reduction. Both Roche Hitachi Analyzer E&P dropped in a 
high percentage as these particular tests have been 
reduced. (Graph 31) 
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4.2.4 Staff Utilization 
The staff utilization is lower than the reference (Graph 
32) except for the Medical Technology RIA which increased 
to the maximum, showing the unbalance of staffing 
distribution. 
Graph 32 
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4.3 Conclusion 
This scenario provide us with an indication of the effect 
one test by decreasing the demand will effect the whole 
chemistry lab. Lead-time which is very important shows a 
decrease by two-thirds in some test like glucose, while 
we have lower lead time; the WIP is lower than the 
Reference Model. As we know, almost the same inventory 
and the throughput are lower for all the tests. 
5. Scenario Eight: Longer Than Usual Lead Time 
Lead time is an essential performance measure. Delaying 
the process of the test will effect the other measures 
outcome. In this scenario we are studying; what is the 
value of the effect and the consequences of having long 
lead time. 
5.1 Primary Performance Measure 
5.1.1 Lead Time 
The lead time as shown in the Graph 33 increased by 20 
to 90%. Other factors like inventory of the components 
can cause a drop in the lead time. RIA section failed to 
report the result. 
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Graph 33 
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5.1.2 Materials Flow time 
More than 60% of all tests are affected by the change 
through increasing the material flow time, as illustrated 
in Graph 34 which consist of reagent, calibrator, and 
controller. 
Graph 34 
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5.1.3 Throughput 
Throughput of the test as indicated in the Graph 35 was 
effected negatively by increasing the lead-time; the flow 
of material was high with a limited component inventory. 
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It is expected by longer the lead-time for some of the 
components used less the number of performed test. 
Graph 35 
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5.1.4 Inventory Status 
There is not much change in 
components whether in the Lab 
Reference Model except for Test 
which decreased tremendously. 7 
were not controlled by logistic 
resulting of over stock. 
STORAGE COMPARISON TABLE 
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5.1.5 WIP 
Graph 36 indicates work in process. All tests have been 
increased to a very high percentage. This had been 
matching with longer lead time as expected. 
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Graph 36 
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5.1.6 Cost of Test 
The cost of each test is not much different than the 
Reference Model (Graph 37) because the staff and 
resources are still included in the calculation. 
Graph 37 
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5.2 Secondary Performance Measure 
5.2.1 Material Order Size 
Orders of the materials have been dropped 5% for the 
calibrator whiles the reagent and controller by 10 to 20 
percent. This is normal of decreasing all components but 
the percentage is not expected, as it should be high with 
the reagent and less with calibrator and controller. 
5.2.2 Queue Size 
As discussed in the lead time, similarly the queue size 
(Graph 38) increased to more than a third in some tests, 
which is normal pattern. 
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5.2.3 Equipment Utilization 
The utilization has been the same. The maximum dropped 
for the Roche Hitachi E Modular Auto Analyzer. (Graph 39) 
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5.2.4 Staff Utilization 
The staff utilization is slightly lower than the 
reference (Graph 40) except for the Medical Technology 
RIA, which increased to the maximum, showing the 
unbalance of staffing distribution. 
Graph 40 
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5.3 Conclusion 
As we increase the lead time for some of the materials 
purchased, all chemistry lab section have reduce there 
outcome Inventory for the Lab and Logistics has 
increased, throughput decreased, utilization of the staff 
remains the same and the flow of component is higher. The 
scenario produces what expected result, which indicates 
to a normal pattern. 
6. Scenario Nine: Special Line for Emergency Cases 
To avoid bottleneck and prepare for emergency cases, 
back-up equipment should be added to perform the needed 
test faster than the normal procedure. But adding 
equipment will not prevent utilizing of staff or other 
resources. The following measures will provide us the 
needed information to have a special line for emergency 
cases. 
6.1 Primary Performance Measures 
6.1.1 Lead Time 
The lead time as shown in the Graph 41 fluctuated. Most 
of the tests of the Core Chemistry section are less while 
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the RIA dropped tremendously. The other sections did not 
changed much, except the Opiates test which increased by 
25%. 
Graph 41 
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6.1.2 Material Flow Time 
More than 50% of all tests are less while the rest were 
higher. This indicates there is no defined pattern for 
the MFT. This is illustrated in Graph 42, which consist 
of reagent, calibrator, and controller. 
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Graph 42 
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6.1.3 Throughput 
Throughput of the test as indicated in Graph 43 
was effected negatively. As may the busy resources 
and the fluctuation of the MFT is the result of 
this drop. Concentrating the recourses including 
staff and equipments to the emergency line will 
delay the routine line of performing the tests. 
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6.1.4 Inventory Status 
There is not much change in the inventory of all components 
whether in the Lab or Logistics with the Reference Model. 
6.1.6 Cost of Test 
The costs of each test are not much different than the 
Reference Model (Graph 44) because of the staff and 
resources are still included of the value calculation. It 
is worth to note, Vitamin D test cost have been increased 
by double, which may indicate an increasing of emergency 
cases. 
Graph 44 
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6.2 Secondary Performance Measures 
6.2.1 Material Order Size 
The material orders for the control component have been 
the same while the reagent and calibrator increased by 10 
percent. 
6.2.2 Queue Size 
As discussed in the lead time, similarly the queue size 
(Graph 45) show's most of the tests of Core Chemistry 
section were less while the RIA dropped tremendously. The 
other sections did not changed much except for the 
Opiates test, which increased by 25 percent. 
281 
Graph 45 
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6.2.3 Equipment Utilization 
The utilization has been the same except for the Roche 
Hitachi E modular Auto Analyzer which decrease to the 
minimum. (Graph 46) 
Graph 46 
Equipment utilization % 
SCENARIO   ABBOTT TDXFLX 
  BIORAD VARIANT 11 
0.0545 
2.368 13 CORNING CHLORIDE 925 
ANALYZER 
0 00106 
014.19 
D DADE BEHRING BNII 
1.656   DADE BEHRING DIMENSION RXL 
  DADE BEHRING VIVA TWIN 
0: 0653 
3.47 
  ROCHE HITACHI E MODULAR 
AUTO ANALYSER 
ROCHE HITACHI P MODULAR 
AUTO ANALYSER 
2500 
1500 
1000 cn 
w 
500 0ä 
0 LAOPP-, g co 
0C 
REFERENCE 
0.054064 
2.359011 
4.203799 
1.941751 
1.659685 
0-*. M J2 3.62309 
6.2.4 Staff Utilization 
The staff utilization is lower than the Reference Model 
(Graph 47) except for the Medical Technology RIA, which 
increased to the maximum, showing the unbalance of 
staffing distribution. 
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6.3 Conclusion 
This scenario is very important for some cases like 
emergency or VIP samples, which need faster process as 
well as quality of work. To have this kind of service 
needs more investment of recourses like new employee and 
new equipment and necessary space. If not one of the 
requirements is available, the service can provide but it 
will hinder the other line of service, which is the 
routine or normal line. The effect of the emergency line 
was longer lead-time as shown in the lead-time table. 
Likewise, WIP is very high while the utilization of staff 
and equipment are the same. It is important to measure 
the outcome before changing the setup of the chemistry 
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Lab, because the effect is not only to a certain test path 
but it will effect the entire lab operation as showing in 
the previous performance measures. 
7. Scenario Ten: Unreliable Equipment 
Equipments in the Chemistry lab are the essential 
resources, can not function properly without them. 
Therefore any effect to them will change the outcome of 
the Lab in general. This scenario is unpredicted in the 
lab; the possibility of happening is high parallel with 
the heavy usage of the equipments. 
7.1 Primary Performance Measures 
7.1.1 Lead Time 
The lead time as shown in the Graph 48 had been increased 
by 50 to 90 percent. The effect of the equipment's 
reliability is covering all tests. It is very noticeable 
the effect of the equipment failure rate. Having a proper 
system to maintain the function of all equipments is an 
essential to prevent or to minimize equipment failure. 
Graph 48 
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7.1.2 Material Flow time 
All tests are affected by the unreliability of equipment. 
Half of them increased while the other decreased, it is 
according to the equipment utilization of the materials, 
as the equipment breakdown the flow of material were 
delayed comparing with other equipment which working 
normally the flow of materials will be faster. As 
illustrated in Graph 49, which consist of reagent, 
calibrator, and controller. 
Graph 49 
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7.1.3 Throughput 
Throughput of the test as indicated in the Graph 50 was 
effected negatively by the equipments break down. Which 
is expected? The percentage of outcome will depend on the 
failure rate of the chemistry lab equipments. 
287 
.. - Is 14 15 16 
Graph 50 
THROUGHPUT COMPARISON 
30 
25 
20 
15 
10 
0  SCENARIO 
_7 
wo  REFFý2HýICE1 
ci Co 
0Q 
I- 
0 
1 
0 
7.1.4 Inventory Status 
There is not much change in the inventory of all 
components whether in the Lab or Logistics with Reference 
Model. It is important for the Logistic department to 
adjust the inventory according to the need instead of 
having overstock in both areas Lab and Logistic. 
7.1.5 WIP 
Graph 51 indicates work in process. All tests have been 
increased, this increase representing not only the delay 
of performing the tests, but also the waste of resources 
and supplies, which in turn increase the overall 
expenditure while the throughput is low. 
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7.1.6 Cost of Test 
The costs of each test are not much different than the 
Reference Model (Graph 52) because of the staff and 
resources are still included in the calculation the tests 
value. The RIA section has not represented the 
calculation of their cost. The time spent to perform the 
test related to the functionality of the equipment. The 
total cost should be covering all expenses including 
equipment failure. 
Graph 52 
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7.2 Secondary Performance Measures 
7.2.1 Material Order Size 
The orders for reagent and control materials were 
increased by 20 to 30 percent while calibrator by 5 
percent. This is an indication of mismanagement of the 
supplies, as we have unreliable equipment the Lab and 
Logistic ordering more materials which will be an over 
stock. 
7.2.2 Queue Size 
As discussed in the lead-time, similarly the queue size 
(Graph 53) increased by 50 to 90%. The effect of the 
equipment reliability is covering all tests. 
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Graph 53 
7.2.3 Equipment Utilization 
The equipment utilization has been the same with only a 
drop in the Roche E Analyzer. (Graph 54) 
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7.2.4 Staff Utilization 
The staff utilization is lower than the reference (Graph 
55) except for the Medical Technology RIA which increased 
to the maximum, showing the unbalance of staffing 
distribution. Another reason for this would be the 
interruption in the equipment availability. During 
equipment downtime and repair time workers have no choice 
but wait until the machine becomes up and running, which 
in turn causes the low utilization of the staff. 
Graph 55 
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7.3 Conclusion 
The lead time increased by 70-100% and throughput 
decreased for all tests while the WIP increased 
tremendously. There is not much change in the inventory 
but the utilization of staff remained low. The effect of 
the equipment's reliability is very high. The hospital 
should make necessary steps to prevent or at least 
minimize any breakdown of the equipments. The plan to 
have backup units can be considered to prevent any delay 
of performing the requested tests. 
8. Scenario Eleven: Short of Staff 
If any department in the Hospital is not prepared and 
does not make the proper plan for staffing it would 
effect by any time shortage of existing staff levels. 
How would the Chemistry Lab cope with this situation? 
8.1 Primary Performance Measures 
8.1.1 Lead Time 
The lead time as shown in the Graph 56 increased by 50 to 
90% and also tremendously high in the OPIATES test. The 
staff effect to the overall outcome is very noticeable 
after the material shortage. 
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Graph 56 
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8.1.2 Material Flow time 
Most of the tests were not affected by staffing shortages 
to the degree they were affected by material inventory as 
illustrated in Graph 57 which consist of reagent, 
calibrator, and controller. 
Graph 57 
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8.1.3 Throughput 
Throughput of the test as indicated in the Graph 58 was 
effected negatively; some tests cannot be performed 
unless adequate staff is available, which affects the 
overall productivity and production rate. 
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Graph 58 
8.1.4 Inventory Status 
There is little change in the inventory of all components 
whether in the Lab or Logistics with the Reference Model 
except Test #8 Homocystime reagent which dropped by 50%. 
Another test, the HBAIC calibrator increased 
tremendously. The possible explanation for this increase 
and decrease in inventory level for some materials would 
be the staff available are expert on some certain tests 
and these staff mainly concentrate on these tests using 
the available materials. Some other tests that could not 
be made because of unavailability of the staff apparently 
will not use the available materials. Since the hospital 
orders materials regularly following an inventory policy, 
the inventory level for these materials that are not used 
in some tests because of staff shortage, accumulate and 
cause a high inventory level for these materials. 
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8.1.5 WIP 
Graph 59 indicates work in process. All tests have been 
increased as expected by staffing shortages. This is a 
natural outcome of this scenario. Since the work cannot 
be done timely because of staff shortage, the materials 
as well as the tests themselves have to wait until 
required staff become available, which cause a high WIP 
level. 
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8.1.6 Cost of Test 
The costs of each test are not much different than the 
Reference Model (Graph 60) because of the staff and 
resources are still included. 
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8.2 Secondary Performance Measures 
8.2.1 Materials Order Size 
The material orders for the calibrator and controller are 
increased by 20%, while the reagent has increased by the 
same %. 
8.2.2 Queue Sizes 
As discussed in the lead time, similarly the queue size 
(Graph 61) been increased by 50 to 90% and was 
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tremendously high in the Opiates test. The staff shortage 
affects the overall outcome and creates long queues. 
Graph 61 
8.2.3 Equipment Utilization 
The utilization of equipment has slightly dropped. The 
shortage of staff affected the equipment utilization in a 
negative way. This is understandably resulting of the 
insufficient staff to allocate to do the tests using 
available equipment (Graph 62) . Therefore, time to time 
equipment becomes idle which decreases the overall 
utilization of the equipment. 
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8.2.4 Staff Utilization 
The staff utilization is not effected as expected of the 
change (Graph 63) except the Medical Technology RIA which 
decreased by 50%, showing the unbalance of staffing 
distribution. In fact, the performance result is based on 
the available staff. The available staffs do their own 
work as usual with everyday pace. Therefore, the 
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utilization has not changed. However, when this 
measurement is based on the whole staff, then a lower 
level of average staff utilization would be expected. 
Graph 63 
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8.3 Conclusion 
Lead time increased by 70-100%. Throughput of all tests 
has been affected in a negative way by 50%. WIP 
increased considerably as there is not enough staff to 
perform the tests. The management of the Lab should be 
prepared for any shortage of staff not to cause any 
interruption in performing everyday operations, which may 
be very costly in urgent cases. 
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9. Scenario Twelve: Repair Time Longer Than Expected 
Failure rate is always calculated by the department 
depending on the equipment but the rate can be 1 to 99%. 
We put a high percentage for this scenario to know the 
Lab reaction if the rate is around 50%. 
9.1 Primary Performance Measures 
9.1.1 Lead Time 
The lead time as shown in the Graph 64 increased by 10 to 
50% in all of the tests except the FK506 test which 
increase 400%. This is apparently the result of long 
interruption of performing any test because of lengthy 
repair times. 
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9.1.2 Material Flow time 
More than 70% of all were tests are affected from the 
equipment failures. Most of the change from the 
increasing of both calibrator and controller components 
as illustrated in Graph 65, which consist of reagent, 
calibrator, and controller. 
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9.1.3 Throughput 
Throughput of the test as indicated in Graph 66 was 
effected negatively by equipment failures; the flow of 
material was high with limited component inventory. The 
long repair times make the equipment unavailable during 
these periods, which interrupt the normal flow of work, 
and as a result the throughput decreases considerably. 
Graph 66 
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9.1.4 Inventory Status 
There is little change in the inventory of all components 
whether in the Lab or Logistics with the Reference Model 
except Test #8, the Homocystime's reagent was dropped by 
50% and Test #11, the HBAIC's calibrator which increased 
tremendously by five times. 
9.1.5 WIP 
Graph 67 indicates work in process. The WIP level has 
increased considerably in all tests, which at the same 
time an indication of long lead time and decrease in 
throughput. 
Graph 67 
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9.1.6 Cost of Test 
The cost of each test are not much different than the 
Reference Model (Graph 68) except Folate test which 
dropped by 50%. 
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9.2 Secondary Performance Measures 
9.2.1 Material Order Sizes 
The material orders were the same as expected. 
9.2.2 Queue Sizes 
As discussed in the lead time, similarly the queue 
(Graph 69) been increased by 10 to 50% in all 
tests except FK506 test which increase 400%. 
size 
of the 
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Graph 69 
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9.2.3 Equipment Utilization 
The utilization of the equipment has been the same for 
all resources comparing with the Reference Model. (Graph 
70) 
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9.2.4 Staff Utilization 
The staff utilization is the same as the Reference Model, 
with the exception of Medical Technologist RIA (Graph 
71), showing the unbalance of staffing distribution. 
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9.3 Conclusion 
Lead time increased by 30 - 50%, the throughput decreased 
as a result of the equipment breakdown. Inventory did 
not change but the WIP increased. Staff on the other 
hand; remain low in all sections except the RIA which was 
reduced by half. 
10. Scenario Thirteen: Continuous Inventory Policy 
Continuous review would prevent zero stock at the same 
time reduce the inventory level. This is one of the 
inventory policies that are being adapted by the 
manufacturers. 
10.1 Primary Performance Measures 
10.1.1 Lead Time 
The lead time as shown in the Graph 72 is acting 
differently than the other scenarios; mostly reduced the 
different values in the same time slight increase or not 
showing of the other Sections. Continuous control of 
inventory policy made sure all the need materials 
available in the stock so that any interruption due to 
short of materials have been prevented, which in turn 
guaranteed the streamlined processes of tests. This has 
been reflected to lead time and most of the tests have 
been completed without waiting any material, which has 
generated a shorter lead time. 
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10.1.2 Material Flow time 
Materials flow time become faster positively for some of 
materials for the reagents, impacting on the throughput 
positively as illustrated in Graph 73 which consist of 
reagent, calibrator, and controller. The continuous 
availability of the materials resulted in supplying the 
needed materials internally more quickly and more 
smoothly, which has generated a shorter flow time in 
comparison to reference model. 
Graph 73 
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10.1.3 Throughput 
Throughput of the tests as indicated in the Graph 74 was 
affected positively. As the most of tests have short lead 
time as well as faster flow materials, expectedly the 
throughputs are higher. The coordination between the lab 
and logistic managing the supplies is needed to have more 
improvement. 
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10.1.4 Inventory Status 
There is slightly better inventory status now in the 
system. This is mainly result of a disciplined way of 
treating the inventory and making sure that all the 
needed materials are obtained timely so that the lab 
activities are sustained and any kind of interruption has 
been eliminated. The previous inventory policy, which was 
a reactionary policy and system was acting whenever there 
is a need for a material and was being ordered. Since 
system was triggered most of the time based on a need, 
the longer procurement periods caused late deliveries as 
well as irregular deliveries causing serious interruption 
in the lab activities, in turn causing very poor 
performance in the system. The continuous policy has 
created a discipline in the order time and quantity 
considering the need of the system as well as the 
supplier lead time so that material availability has 
restored and interruptions generated by poor supply chain 
activities have been eliminated, in turn generated better 
system performance in terms of all major metrics. 
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10.1.5 WIP 
Graph 75 indicates work in process. All tests have 
increased WIP with the impact outcome. The availability 
of the materials has generated a continuous flow of the 
needed materials. Since lab activities have kept its 
normal pace, the system acted as a push system causing 
higher WIP level. This is the result of the operation 
policy of the lab rather than the inventory policy 
adopted in the system 
Graph 75 
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10.1.6 Cost of Test 
The costs of each test are higher than the Reference 
Model (Graph 76) because of the staff and resources are 
spending more time for continuously monitoring the 
inventory. It is noted that five tests not showing the 
result; Vitamin D, BHCG, Carb, MTX, and Opiates. 
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10.2 Secondary Performance Measures 
10.2.1 Material Order Size 
The material orders have increased by more than 65% for 
the reagent whiles the calibrator and the controller by 
30%. This is because the inventory kept its maximum level 
and an order is placed for any item that is less than its 
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required level. This naturally has affected the level of 
inventory and increased considerably. 
10.2.2 Queue Size 
As discussed in the lead-time, similarly the queue size 
(Graph 77) was reduced to more than a third in some tests 
with the greatest change in the special Chemistry 
Section. 
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10.2.3 Equipment Utilization 
The utilization has been the same with exception Dade 
Behring Dimension RXL, Dade Behring Viva twin and the 
Roche Hitachi E modular Auto Analyzer. (Graph 78) 
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10.2.4 Staff Utilization 
The staff utilization is lower than the Reference Model 
(Graph 79) except the Medical Technology RIA which 
increased to the maximum; also the Medical Techno lost 
TDM showing the unbalance of staffing distribution. 
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Graph 79 
SCENA WO 
1.41$9516 
54.39 
99.98 
100 
49.04 
IEsuimoi 
  ®®CAL TECHNOLOGIST 
CORE c -e 4tSTRY 
Q ME AL TECHNOLOGIST 
RLA 
Q NEDICAL TECHNOLOGIST 
SPECIAL CHEMISTRY 
  WDICAL TECHNOLOGIST 
TOM 
  PFELOBOTOMIST 
1.129484 2.33 
23.51 
54.85 
1.831827 49.2 
10.3 Conclusion 
Improvement in the lead time in general, but in the RIA 
Section, it was very low because of free staff because 
the Vitamin D& BH tests were not performed. The mean 
material flow time is much better as reduced by 30-50%, 
throughput of all components are high relatively to the 
throughput of the tests that were become higher. This 
indicates that the material availability has affected the 
system performance positively especially for the metrics 
that are heavily depended on the availability of material 
or uninterrupted supply of needed materials, which 
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eliminated the delays or idleness for equipment and staff 
utilization. 
11. Scenario Fourteen: Batches Policy Adapted in 
Purchasing 
The Purchasing Department procures the needed items case 
by case which causes a delay for the Lab receiving the 
component. It is expected that purchase by batches would 
speed the process and eliminates some of the delayed 
generated by small size deliveries. 
11.1 Primary Performance Measure 
11.1.1 Lead Time 
The lead time as shown in the Graph 80 fluctuated between 
ten of the tests are high; five are less and one no 
record. The other factors like inventory of the 
components have the role of unbalanced lead time. on 
average the overall lead time has increased because of 
batching policy adopted in lab as well. The materials now 
spend more time in queues waiting to be used in 
processes, which in turn causes longer lead times. 
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11.1.2 Material Flow time 
More than 60% of all tests are affected in a negative way 
by this change as illustrated in Graph 81 which consistS 
of reagent, calibrator, and controller. As it is 
experienced in manufacturing organizations, although 
batch policy keeps the system busy all the time but cause 
serious WIP and longer lead times as well as longer mean 
flow time. The same result has been experienced in the 
health care system and when we ordered needed materials 
in batches and sent the needed materials in batches to 
the lab. This has generated more material availability in 
the stock, which eliminated some of the interruptions 
caused inadequate deliveries or shortage of materials, 
but delivering the needed materials to the lab in bulk 
(batch) has caused serious problems with some of the 
performance metrics, such as lead time, WIP and mean flow 
time. 
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11.1.3 Throughput 
Throughput of the test as indicated in Graph 82 was 
effected negatively by the batch policy; the flow of 
material was high waiting in front of the processing 
stations, causing longer queues and WIP. 
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11.1.4 Inventory Status 
There is some change in the inventory of all components 
whether in the Lab or Logistics with the Reference Model 
except Test #16, TDM Opiate which decreased tremendously. 
Since the materials are purchased in bulk now, the level 
of inventory naturally increased. However, although the 
frequency of orders is not stated here, the inventory 
level is also function of the frequency of order. 
Apparently the company now orders less frequently to use 
the available inventory, which balance the average 
inventory level in long term, therefore, the changes in 
inventory is not as dramatic as it is expected. 
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11.1.5 WIP 
Graph 83 indicates work in process. WIP levels for the 
materials used in all tests have increased similar to 
some of the scenarios which, in turn the result of 
increased level of volume of materials that flow within 
the system. 
Graph 83 
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11.1.6 Cost of Test 
The costs of each test are not much different than the 
Reference Model (Graph 84) because the staff and 
resources are still included in the test calculation. 
However, the increased level of material purchase has 
brought some advantages. There are two advantages here. 
One is that company gets some price discounts since it 
purchases the needed materials in bulk, and the second 
advantage is that the orders are made less frequently 
which reduces the order cost considerably. On the other 
hand, the increased level of quantities cause a high cost 
in inventory carrying cost. Therefore, in long term, 
these two positive and negative points balanced each 
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other and the overall cost has not changed as normally 
expected as a result of bulk purchases. 
Graph 84 
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11.2 Secondary Performance Measure 
11.2.1 Material Order Size 
The material order for the controller materials increased 
25%. The same as reagent, while the calibrator reduced by 
10%. 
11.2.2 Queue Size 
As discussed in the lead time, similarly the queue size 
(Graph 85) fluctuated; ten of the tests were high, five 
were less and one no record. 
Graph 85 
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11.2.3 Equipment Utilization 
The equipment utilization has been better as using the 
batches from the Reference Model with the exception of 
the Roche Hitachi E modular Auto Analyzer, which dropped 
to the minimum. (Graph 86) 
324 
Graph 86 
SCENARIO 
0.05468 
2.3608 
0.000652 
1b4.221 
1.64 
0.3629 
0.038 
3.625 
 ABBOTTTDXFLX 
 BIORAD VARIANT II 
[: )CORNING CHLORIDE 925 
ANALYZER 
o DADE BEI-RING BNII 
  DADE BEHRING DIM ENSION 
RXL 
ýDADE BEHRING VIVA TWIN 
  ROCHE HITACHI E 
MODULARAUTO 
ANALYSER 
C3 ROCHE HITACHI P 
MODULAR AUTO 
ANALYSER 
REFM34CE 
2.359011 
0,054064 
03799 
1941751 
1 659ceb z7 0.363087 3.82309 
0.06292 
11.2.4 Staff Utilization 
The staff utilization is more or less the same with 
Reference Model (Graph 87) except for the Medical 
Technology RIA which increased to the maximum, showing 
the unbalance of staffing distribution. Further, 
availability of materials in bulk kept the system busy 
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and generated almost the same level of utilization with 
the reference model. The buyer in the Logistic department 
has less work, as the numbers of orders are less. 
Graph 87 
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11.3 Conclusion 
In general, the lead time increased by 20 to 30% as well 
as inventory level for all components; material flow time 
is high effecting the throughput of the tests, staff 
utilization is the same except the RIA section that 
increased to 99%. This is normally an expected outcome 
when a batching policy adopted. As it is explained under 
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different performance metrics, batching has pros and cons 
and sometimes these two may balance each other generating 
much more acceptable results, which are the case for this 
study. 
12. Scenario Fifteen: No Adequate Funding 
There is comes a time were the Hospital lacks funds to 
cope with the increasing costs which has a major negative 
effect on almost all the metrics used to measure the 
system performance. 
12. Primary Performance Measures 
12.1 Lead Time 
The lead time as shown in the Graph 88 is increased by a 
different percentage. The other factors like inventory of 
the components has the role of not having equal increase 
of the lead time to the minimum. 
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12.2 Material Flow time 
More than 80% of all tests were affected by low 
funds as 
this affected material inventory as 
illustrated in Graph 
89 which consist of reagent, calibrator, and controller. 
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12.3 Throughput 
Throughput of the test as indicated 
in the Graph 90 was 
effected negatively by decreasing 
the fund. 
Graph 90 
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12.4 Inventory Status 
There is not much change in the 
inventory of all 
components whether in the Lab or Logistics with 
Reference 
Model except test number 16 TDM 
Opiate which increased 
without any usage. 
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12.5 WIP 
Graph 91 indicates work in process. All tests have been 
increased. 
Graph 91 
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12.6 Cost of Test 
The cost of each test is not much different than the 
Reference Model (Graph 92) because of the staff and 
resources are still included. 
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12.2 Secondary Performance Measures 
12.2.1 Material Order Size 
The material orders slightly increased for the Lab 
control while the other decreased by 5%. 
12.2.2 Queue size 
As discussed in the lead time, similarly the queue size 
(Graph 93) been increased by a different percentage. 
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12.2.3 Equipment Utilization 
The utilization has been the same. The maximum drop was 
the Roche Hitachi E modular auto Analyzer. (Graph 94) 
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12.2.4 Staff Utilization 
The staff utilization is lower than the reference (Graph 
95) except medical technology RIA which increased to the 
maximum, showing the unbalance of staffing distribution. 
Graph 95 
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12.3 Conclusion 
Lead time jumped to 10-30%, material flow time fluctuates 
among all components, throughput of the tests are lower 
while the WIP is high, which indicate the queue is long 
to perform the tests, utilization is the same except RIA 
which reached to 99%. 
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